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English Summary
There is a continuous need to evaluate new drug targets which allow the development of
antimicrobial therapies with minimal side effects in humans. Histidine kinases (HKs) are
essential components of two-component signal transduction (TCST) systems that are absent
in mammalian cells. Thus, they are considered drug target candidates. CaNik1p is a group III
HK of the most frequent human fungal pathogen Candida albicans. The relevance of this
group of enzymes for fungicidal activity was shown by the construction of Saccharomyces
cerevisiae transformants, in which CaNik1p and other group III HKs were expressed. These
transformants were sensitive to antifungals, to which wild-type S. cerevisiae was resistant.
However, the mode of action of the fungicides is still not completely understood.
To investigate the role of different domains of CaNik1p for fungicidal activity, wild-type
and mutated variants of CaNIK1 were constructed and heterologously expressed in S.
cerevisiae. Although group III HKs are known to be relevant for certain classes of
antifungals, it was not clear whether they are direct or indirect targets for these antifungals.
Via Saturation Transfer Difference-NMR we could show for the first time a direct interaction
between fludioxonil and CaNik1p, an example of group III HKs. The S. cerevisiae strains,
which expressed variants of the protein, which were mutated in the conserved HisKA,
HATPase_c and REC domains, showed complete loss of sensitivity against the tested
antifungals. The sensitivity to antifungals correlated with the phosphorylation state of the
MAP kinase Hog1p after treatment with fludioxonil. However, fludioxonil did not interfere
with the histidine kinase activity of the protein as revealed from in vitro kinase assays using
the purified protein and monitoring ATP consumption or autophosphorylation of the protein.
The kinase activity could even be detected in all of the mutated variants. Group III HKs are
characterized by consecutive HAMP domains in the N-terminal part of the protein. As the
function of these domains is largely unknown, we deleted them from the protein. Expression
of CaNik1p∆HAMP led to growth inhibition of the transformed S. cerevisiae that correlated
with constitutive phosphorylation of Hog1p. This could be reversed by additional point
mutation in the conserved His510 of the HisKA domain or by expression in S. cerevisiae with
single gene deletion mutants of the response regulator SSK1 or one of the components of the
Hog1 MAPK module. The expression of the mutated variants of CaNIK1 in C. albicans,
however, was not yet successful.
In conclusion, treatment with antifungals and deletion of HAMP domains led to severe
growth inhibition, which correlated with the activation of the MAP kinase Hog1p, and for
which the functionalities of the conserved domains of the HK CaNik1p were essential.
German Summary (Zusammenfassung)
Histidinkinasen (HK) sind essentielle Bestandteile von Zweikomponenten – Signaltrans-
duktionssystemen, die es in menschlichen Zellen nicht gibt. Daher werden sie als mögliche
Angriffspunkte für Wirkstoffe betrachtet, die antimikrobielle Therapien mit minimalen
Nebenwirkungen im Menschen ermöglichen. CaNik1p ist eine Histidinkinase (HK) der
Gruppe III aus dem humanpathogenen Pilz Candida albicans. Die Relevanz dieser
Enzymgruppe für die Wirkung von Fungiziden wurde durch die Herstellung von
Saccharomyces cerevisiae – Transformanten gezeigt, in denen CaNik1p und andere Gruppe
III HKs exprimiert wurden. Diese Transformanten waren für verschiedene antimykotische
Verbindungen empfindlich, für die der Wildstamm der S. cerevisiae resistent war. Die
genauen Wirkmechanismen dieser Fungizide sind jedoch noch nicht verstanden.
Um die Rolle von verschiedenen Domänen von CaNik1p für die fungizide Wirkung zu
untersuchen, wurden Punktmutationen in den konservierten Domänen HisKA, HATPase_c
und REC eingeführt und diese mutierten Proteine und das Wildtyp-Protein in S. cerevisiae
heterolog exprimiert. Obwohl die Relevanz der Gruppe III HK für Fungizide bekannt ist, war
die direkte Wechselwirkung noch nicht gezeigt worden. Mit dem rekombinant hergestellten,
aufgereinigten Protein CaNik1p konnten wir diese Wechselwirkung mit dem Wirkstoff
Fludioxonil über Sättigungstransferdifferenz-NMR erstmals zeigen. Außerdem erwiesen sich
die Transformanten, die die mutierten Proteine exprimierten, als resistent gegen die
Fungizide. Die Sensitivität gegenüber Fungiziden korrelierte mit dem
Phosphorylierungszustand der MAP kinase Hog1p nach Behandlung mit Fludioxonil.
Fludioxonil inhibierte jedoch die Kinaseaktivität des Proteins nicht, wie wir durch In-vitro
Kinaseaktivitätstests mit dem gereinigten Protein zeigen konnten. Die Kinaseaktivität konnte
selbst in den Proteinmutanten noch nachgewiesen werden. Gruppe III HK sind durch eine
Abfolge von HAMP Domänen im N-terminalen Bereich der Proteine charakterisiert. Da die
Funktion dieser Domänen noch weitgehend unverstanden ist, entfernten wir sie aus dem
Protein. Die Expression dieses verkürzten Proteins CaNik1p∆HAMP führte zur
Wachstumshemmung der S. cerevisiae-Transformante, was mit der konstitutiven
Phosphorylierung von Hog1 korrelierte. Durch zusätzliche Punktmutation in der HisKA-
Domäne (H510Q) oder durch Expression in S. cerevisiae Mutanten, in denen einzelne Gene
des HOG-Signalweges deletiert waren, konnte dieser Effekt aufgehoben werden. Die
Expression von mutierten Varianten von CaNIK in C. albicans war noch nicht erfolgreich.
Die Behandlung mit Fungiziden und die Deletion der HAMP Domänen führten zur
Reduktion des Wachstums, für die die Funktionalität der konservierten Proteindomänen
essentiell war.
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Introduction
1
1 Introduction
1.1 The pathogenic fungus Candida albicans
Fungi affect human life in many different ways. They are useful for humans in various
aspects, e.g., the production of antibiotics and alcoholic beverages, food processing (bread
and cheese), and being used as food (mushrooms). On the other hand, they can cause human
diseases, either directly or through their toxins, including mycotoxins and mushroom poisons
(1). Among all the fungi, only a few species are pathogenic for humans. The most frequently
diagnosed fungal infections are caused by pathogens from the genera Candida, Cryptococcus,
and Aspergillus (2).
The genus Candida belongs to the phylum Ascomycota, class Ascomycetes, order
Saccharomycetales (3). Candida species occur abundantly in the gastrointestinal tract and
vagina. At least 17 species of Candida are reported to cause human disease (4-5). Infection
with such opportunistic fungi has become a major concern in the caring of
immunocompromised patients. Candida spp. is the fourth most important cause of hospital-
acquired bloodstream infections, and up to 90 % of HIV patients have caught the mucosal
form of the pathogen at least once (6). Among the various pathogenic species of Candida,
e.g., C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, and C. krusei, C. albicans is the
most frequent pathogen in over 90 % of all invasive infections (5, 7).
First described in 1839, C. albicans is a commensal fungus that usually exists as a benign
member of the skin and mucosal flora, particularly within the gastrointestinal tract of humans
and other warm-blooded animals (8).
C. albicans is an opportunistic pathogen that can proliferate even in healthy people to
cause circumscribed infections of the skin, nails, and mucous membranes (8). Vulvovaginal
candidiasis is common and probably affects up to 75 % of women at least once in their
lifetime (9). In patients with deficient immune systems because of inherited disease,
malignancy, concurrent infection, or medical intervention, this commensal yeast can behave
as an aggressive pathogen, attacking virtually any organ system, and leading to death in as
many as 50 % of cases of bloodstream infections (8).
C. albicans is polymorphic organism that is able to grow in three different morphological
forms: as a unicellular budding yeast or as filamentous pseudohyphal and hyphal forms (Fig.
1.1) (10). This morphological plasticity of C. albicans is considered as a major virulence
factor (11).
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Fig. 1.1: Morphological forms of C. albicans. A) Yeast B) Pseudohypha C) Hypha. All scale
bars represent 10 µm (10).
1.2 Antifungal agents
1.2.1 Classification
According to their mechanism of action,  antifungals are mainly classified as inhibitors of
fungal sterols (targeting cell membrane), inhibitors of beta-glucan synthase (targeting cell
wall), or inhibitors of nucleic acid synthesis (12).
Antifungals targeting the cell membrane include polyenes, azoles, and allylamines. The
polyenes (e.g., Amphotericin B and Nystatin) function by binding strongly to ergosterol to
create drug-lipid complexes that intercalate into the fungal cell membrane to form a
membrane-spanning channel. This causes cellular ions, such as potassium ions, to leak out of
the cell, thereby destroying the membrane potential (13). The azoles (e.g., fluconazole) act by
targeting the ergosterol biosynthetic enzyme lanosterol demethylase (also referred to as
cytochrome P450) leading to severe membrane stress on the cell (13). Allylamine antifungals
(e.g., terbinafine) are also ergosterol biosynthesis pathway inhibitors, but they inhibit earlier
steps of the ergosterol biosynthesis pathway than azole derivatives, namely squalene
epoxidation (13).
The echinocandins (e.g., caspofungin and micafungin) are large lipopeptide molecules that
act as noncompetitive inhibitors of (1,3)-β-D-glucan synthase, an enzyme involved in fungal
cell wall synthesis. The disruption of the (1,3)-β-D-glucan network results in the loss of cell
wall integrity and severe cell wall stress (13).
Flucytosine is a fluorinated pyrimidine that interferes with pyrimidine metabolism and thus
with RNA/DNA and protein synthesis (12).
1.2.2 Problems with currently used antifungals
Despite the existence of several  antifungals in the market, toxicity and/or the development
of resistance represent major concerns (14). The toxicity of amphotericin B results from the
poor ability of the drug to differentiate between ergosterol from fungal cell membranes and
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cholesterol from mammalian cells (12). Moreover, amphotericin B and triazoles have been
found to be associated with hepatotoxicity (15). Because a glucan-rich cell wall is a target not
found in mammalian cells, echinocandins were originally predicted to be effective antifungal
agents with little collateral toxicity in mammalian cells. However, they lack activity against
some common opportunistic yeasts (Cryptococcus species) and some less common molds that
usually develop as breakthrough infections in severely immunocompromised patients (15).
In addition to the toxicity associated with the use of several antifungals, the development
of resistance has also been reported during the frequent administration of antifungals. Gene
mutations can induce resistance, and the development of a secondary multidrug
(echinocandin-azole)-resistant yeast strain has been described (16). Therefore, a great need
exists to develop new antifungals with lower toxicity to humans.
1.3 Histidine kinases and the two component system
1.3.1 Kinases
Kinases are enzymes that catalyze the transfer of a phosphate group, usually from ATP, to
an acceptor molecule (17). A protein kinase catalyzes the phosphorylation of protein
substrates. Kinases are also known as phosphotransferases (17). They constitute a key class of
enzymes responsible for the regulation of many biological phenomena (18). Kinases are
involved in almost every signal transduction pathway occurring in a living cell. Although
various types of biological molecules can be phosphorylated (proteins, nucleotides, sugars,
lipids, etc), the largest group of kinases is that of the protein kinases, which phosphorylate in
eukaryotes mainly at Ser/Thr, or Tyr residues and also at His residue (18). When the
phosphorylation of a protein kinase  is catalyzed by another molecule of the same kinase, the
phosphorylation is called autophosphorylation (17).
1.3.2 Histidine kinases as part of the two component system in prokaryotes and
lower eukaryotes
The presence of phosphohistidine in proteins was reported as early as the 1960s (19).
However, the important roles of histidine phosphorylation in cellular signal transduction were
not recognized until the 1980s, when “two component” systems were first identified in
various bacterial signaling pathways (20-21). The prototypical two component system is
composed of a histidine kinase (HK) protein, called the “sensor kinase”, and a response
regulator (RR) protein (Fig. 1.2A) (19). The sensor kinase often is a transmembrane protein
that detects extracellular stimuli and responds by modulating the activity of its cytoplasmic
Introduction
4
histidine kinase domain (HisKA). When activated, the sensor kinase autophosphorylates a
conserved histidine residue in the HisKA domain, after the binding of ATP to the ATP-
binding domain (HATPase_c). The phosphoryl group is then transferred to a conserved
aspartate residue in the receiver domain (REC) of a RR protein, resulting in the alteration of
RR activity. Many RRs have a DNA-binding domain and function as transcription factors
whose activity is regulated by aspartate phosphorylation in the receiver domain. Other RRs,
however, can interact directly with other proteins (22). Thus, extracellular signals are
transmitted by His-Asp phosphotransfer in two component systems. This mechanism of signal
transduction is ubiquitous among diverse prokaryotic signaling pathways that regulate
chemotaxis, sporulation, metabolite fixation, virulence, cell division, and responses to
environmental stress (19).
In eukaryotes, a multistep phosphorelay (Fig. 1.2B) seems to be more prevalent than the
simple two component format found in prokaryotes. All HKs in yeasts are hybrid HKs that
contain both a histidine kinase domain (HisKA) and a receiver domain (REC) within a single
polypeptide chain. In these enzymes, a phosphate group is first transferred from a conserved
histidine residue in the kinase domain to an aspartate residue in the receiver domain.
Subsequent phosphotransfer to an aspartate residue in the cognate RR is mediated by a third
protein, the histidine phosphotransfer protein (HPT), that carries a histidine-containing
phosphotransfer domain, in which a phosphohistidine intermediate is formed. Thus, signals
are transmitted by a three step His-Asp-His-Asp phosphotransfer in phosphorelay signaling
systems (19).
An essential reaction of HKs is its dimerization independently of whether it is a hybrid
(22). HK autophosphorylation occurs through a trans mechanism between two molecules in
the dimer. ATP bound to the ATP-binding domain of one molecule in the dimer is used to
phosphorylate the histidine residue of a kinase domain of the other molecule (22).
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Fig. 1.2: Elements of a typical two component signal transduction system. A) Simple two
component system that employs a histidine kinase (HK) and a response regulator (RR) B)
Multi-step phosphorelay that employs a hybrid HK with both histidine kinase and receiver
domains, a histidine-containing phosphotransfer protein (HPT), and a response regulator
(RR). Regions covered by consensus domains (HisKA ( ), HATPase_c ( ), REC ( ), and
transmembrane domains (black bars)) are indicated.
1.3.3 Differences between prokaryotic and eukaryotic two component signal
transduction systems
Several features distinguish eukaryotic two component signal transduction (TCST) systems
from those of prokaryotes.
The number of TCST systems differs greatly in bacteria and fungi. In Pseudomonas
aeruginosa,  more than 130 TCST systems have been revealed by genome sequence analysis
(23), whereas in Escherichia coli, about 30 HKs and 32 RRs have been reported (24). In
contrast to the high number of TCST systems identified in prokaryotes, only a limited number
have been found in eukaryotes. In the genome of the budding yeast S. cerevisiae, only one
phosphorelay system (SLN1-YPD1-SSK1, SKN7) has been found. The pathogenic yeast C.
albicans contains three HKs, namely CaSln1p, CaNik1p, and Chk1p (25). However,
filamentous fungi generally have a far greater number of hybrid HKs than yeast-type fungi.
Neurospora crassa, Aspergillus nidulans, and Aspergillus fumigates have 11, 15, and 14
hybrid sensor HKs, respectively (26).
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Hybrid HKs make up less than 20 % of HKs in bacteria, whereas more than 90 % of
eukaryotic HKs are hybrid HKs (27).
Prokaryotic RRs are predominantly transcription factors (at least 25 of the 32 in E. coli),
whereas only one eukaryotic RR with a DNA-binding domain, Skn7p, is known in S.
cerevisiae and C. albicans (28).
HPT proteins act as a key connector in the fungal phosphorelay system by relaying the
phosphate group from the Asp residue of the REC domain of the hybrid sensor kinase to the
Asp residue of a RR. However, in all fungi that have been studied, a single HPT protein has
been identified in their genomes (26). In bacteria, HPT proteins are rare, e.g., SpoB
phosphotransferase in the bacterium Bacillus subtilis, which is involved in the regulation of
sporulation induction (29).
Many bacterial HKs (e.g., EnvZ) are able to phosphorylate and dephosphorylate
(phosphatase activity) the cognate RR, e.g., the EnvZ/OmpR osmoregulation system in E. coli
(22). To date, none of the HKs in fungi has been established as having phosphatase activity.
1.3.4 The high osmolarity glycerol (HOG) pathway as a model of fungal two
component signal transduction systems
The best understood TCST system in fungi is the SLN1-YPD1-SSK1 module in S.
cerevisiae; this module regulates the activity of the downstream mitogen activated protein
kinase (MAPK) module, namely Hog1 (Fig. 1.3). In the absence of osmotic stress,
transmembrane HK ScSln1p is active, so that the RR Ssk1 is phosphorylated via the HPT
protein Ypd1p (30-31). Under these conditions, Ssk1p cannot activate the MAP3K Ssk2p so
that the MAPK Hog1p remains inactive. Under conditions of high osmolarity, ScSln1p is
inactive, and the resulting accumulation of the unphosphorylated RR Ssk1p activates the
downstream MAPK module so that the MAPK Hog1p is phosphorylated (30-31).
Phosphorylated Hog1p upregulates the transcription of genes encoding enzymes that play a
key role in glycerol production in order to maintain the intracellular water balance, thus
allowing growth under high-osmolarity conditions (26). Likewise, the disruption of ScSLN1
results in the accumulation of unphosphorylated Ssk1p and, thus, the constitutive activation of
the HOG cascade, which is lethal (30).
Introduction
7
Fig. 1.3: Regulation of the Hog1 MAPK module by the TCST system SLN1-YPD1-SSK1 in
S. cerevisiae. A) under normal osmolarity B) in the presence of osmotic stress
1.3.5 Relevance of studying two component signal transduction systems
TCSTs are involved in the adaptation of bacteria, lower eukaryotes, and plants to various
environmental signals. Genome analysis has shown that such systems do not exist in
Caenorhabditis elegans, Drosophila, mouse, and humans (22). The apparent absence of
phosphorelay systems in the human genome might allow the development of antibiotics that
specifically target TCST systems or phosphorelay proteins in pathogenic bacteria and fungi
(19, 26, 32). Mammals do indeed contain some HK-like proteins, such as the Nm23
metastasis suppressor, the histone H4 HK, and the G protein β-subunit kinase, although
sensor-type HKs have not been reported (26, 33).
1.3.6 Classification of the eukaryotic histidine kinases
According to the classification of Catlett et al. 2003, the putative fungal HKs fall into 11
classes (34). All eukaryotic HKs have HisKA, HATPase_c, and REC domains as conserved
domains, whereas each class is characterized by additional characteristic domains. For
example, HKs of group VI contain transmembrane domains such as ScSln1p and CaSln1p in
S. cerevisiae and C. albicans, respectively. Group III HKs are characterized by additional
amino acid repeats in the N-terminal region with a length of approximately 90 amino acids
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each. The repeats contain evolutionary conserved amino acid sequences called HAMP
domains. This abbreviation is attributable to the frequent occurrence of such domains in
Histidine kinases, Adenylcyclases, Methyl accepting chemotaxis proteins, and Phosphatases,
which are proteins associated with signal transduction in both prokaryotic and lower
eukaryotic organisms (35). More than 26,400 proteins with HAMP domains exist in the
SMART data base. These domains have been shown to play an active role in intramolecular
signal transduction in prokaryotic sensor kinases. They are composed of about 50 amino acid
residues each with two amphipathic helices (36-38) that probably rotate when the sensor
domain of the protein is activated, as recently elucidated from nuclear magnetic resonance
(NMR) analysis (39-40). Unlike bacterial HKs, which usually possess a single HAMP
domain, fungal group III HKs have several consecutive HAMP domains. Examples of group
III HKs are CaNik1p in C. albicans and Os1p in N. crassa.
Despite the larger numbers of HKs in filamentous ascomycetes than in yeasts, all of the
ascomycetes contain virtually the same downstream histidine phosphotransfer proteins and
RR proteins, suggesting extensive cross talk or redundancy among HKs (34).  However,
fungal hybrid sensor kinases are evidently more diverse than this initial estimate. For
example, the Cryptococcus neoformans Tco2 hybrid sensor kinase contains two histidine
kinase domains and two REC domains in a single polypeptide that cannot be classified into
any of the 11 classes proposed by Catlett et al. (2003) (26).
1.3.7 Group III histidine kinases as a target for antifungals
Several chemical classes of fungicides (Fig. 1.4), which are known for their activity on
filamentous fungi, such as phenylpyrroles (fludioxonil), dicarboximides (iprodione), and the
polyketide secondary metabolites of ambruticins, have been shown to target the osmotic stress
signal transduction pathway (Fig. 1.3) (41-43). The compounds exert their antifungal effects
by activating the Hog1 MAPK module, resulting in the accumulation of both glycerol and
free fatty acids. In the absence of high external osmolarity, artificial induction of excess
intracellular glycerol is assumed to cause the leakage of cellular contents and ultimately
results in cell death (44).
Heterologous functional expression of CaNik1p and other group III HKs in S. cerevisiae
has enabled the transfer of sensitivity to antifungals activating the Hog1 MAPK module
establishing the function of these HKs as mediators for antifungal activity (45-48) and
providing an easy tool for testing the effects of genetic manipulation of the HKs. S. cerevisiae
is usually resistant to these fungicides because of its lack of group III HKs (34).
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In Hik1p, a group III HK from Magnaporthe grisea, phosphate acceptance on both the
conserved histidine and aspartic acid residues in the HisKA and the receiver domains is
essential for susceptibility to phenylpyrroles and ambruticin VS4 (45-46, 48). Additionally,
mutations in the HAMP domains of several group III HKs are frequently associated with
fungicide resistance, showing the dependence of fungicide activity on these domains (47, 49).
However, whether the group III HKs are direct or indirect targets for the antifungals inducing
the Hog1 MAPK module has not been experimentally demonstrated.
Fig. 1.4: Structures of various antifungals inducing the Hog1 MAPK module.
1.3.8 The histidine kinase CaNik1p from C. albicans
CaNik1p is considered to be a cytosolic enzyme, as it lacks the indicative hydrophobic
amino acids for membrane-spanning domains (50). The protein is not essential for survival,
and a gene deletion mutant can be generated (50-52). CaNik1p plays an important role in
hyphal formation of C. albicans on solid media (25, 51). Additionally, the deletion mutant of
CaNIK1 has been found to be less virulent in a mouse model of systemic candidiasis (25).
CaNik1p belongs to group III HKs (34). Based on homology with other HKs, the histidine
residue H510 and the aspartate residue D924 in CaNik1p (Fig. 1.5) have been identified as the
essential phosphorylatable residues for the HisKA and the REC domains, respectively (52).
The ATP-binding domain, HATPase_c, of CaNik1p comprises characteristic N and G1 boxes,
with two asparagine residues (N623 and N627) and two glycine residues (G663 and G665),
respectively (52). Both boxes are known to be essential for ATP binding (53). Mutation of a
single Asn residue in the N box is associated with complete inhibition of ATP binding in the
bacterial HK EnvZ (54). In addition, mutation of the two Gly residues of the G1 box leads to
the same effect in the HK ETR1 in Arabidopsis thaliana (55).
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CaNik1p has been described as possessing four full-length amino acid repeats of 92 amino
acids each and one repeat truncated to 72 amino acids (52). Originally, one HAMP domain
was allocated to each of these repeats. However, recently, the sequences of about 6500
HAMP domains from ca. 5500 distinct proteins have been analyzed leading to a new
classification scheme with 4 clusters of canonical sequences and 3 more divergent clusters
(38). We have applied this scheme to the HK CaNik1p, i.e., to the amino acid repeats from
CaNik1p, and have identified nine divergent HAMP domains (47). To date, the role of the
HAMP domains in controlling signal transduction downstream of group III HKs is unclear.
Mutational analysis of the various domains of CaNik1p, being a group III HK, would be of
interest in order to determine the way that the domains affect the fungicidal mechanism of
compounds activating the Hog1 MAPK module.
Fig. 1.5: Various domains of CaNik1p and their role in the phosphorylation of the protein.
1.4 Strategies for genetic manipulation of C. albicans
The C. albicans genome consists of eight chromosomes (historically named 1-7 and R)
that constitute a haploid genome size of 14,851 kilobases (kb), containing 6,419 open reading
frames (ORFs) longer than 100 codons (56).
In 2004, C. albicans was selected by Jones and coworkers as the first eukaryotic pathogen
for genome sequencing (57). They used the diploid genome of the widely-used clinical
isolate, SC5314, to sequence the genome of C. albicans (58). Thereafter, sequences of the
majority of the C. albicans genes were available, making gene targeting in this organism
much easier, faster, more efficient, and precise. Soon after, the Candida Genome Database
(CGD) was established (59) based on the genome sequence of C. albicans enriched with
published literature on C. albicans (57). The CGD (www.candidagenome.org) is a freely
available valuable resource for researchers in the field, as it provides a reliable source of
organized data, tools for data analysis, and information about the current research community.
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Molecular analysis of C. albicans is particularly challenging for many reasons. First, C.
albicans has no clearly defined sexual cycle (8). Second, the organism is diploid (58, 60), and
in most cases, both alleles of the gene must be manipulated. Third, contrary to the most
studied yeast (S. cerevisiae), C. albicans lacks natural plasmids, such as the 2-µm plasmid, for
use in transformation and shows slower transformation and recombination frequencies,
making the manipulation of both alleles of a gene more challenging (61-62). Fourth, the
codon CUG is translated abnormally by C. albicans as serine rather than leucine (63), and it
is found at least once in approximately two-thirds of the ORFs (56). Therefore, when using
marker gene sequences from other organisms for gene manipulation in C. albicans, or in cases
of the heterologous expression of C. albicans genes, the codons need to be optimized. Fifth,
the use of selectable markers has been particularly challenging, because some markers, e.g.,
the URA3 gene, have effects on the virulence of the pathogen (64). In addition, C. albicans
shows natural resistance to drugs such as G418, hygromycin B, and cycloheximide, which are
used for selection in S. cerevisiae (61).
Previously, mutations were randomly introduced into the C. albicans genome by exposure
to UV or chemical mutagens. These methods led to undesirable mutations that could not be
repaired (57).
Fonzi and Irwin used a clinical isolate of C. albicans (SC5314) to make a strain (CAI4)
that was auxotrophic for growth on uridine-deficient media (65). They disrupted both copies
of the URA3 gene in C. albicans by using the imm434 region of the λgt10 bacteriophage. This
allows the use of URA3 as a selectable marker when genes are disrupted. The method is
popularly known as the ‘‘URA blaster method’’. In this technique, the gene of interest is
disrupted by using a cassette that carries the URA3 gene flanked by two hisG sequences from
Salmonella typhimurium. After the initial transformation, the transformants are selected on
uridine-deficient media. Because two direct repeats of the hisG sequence in close proximity
are unstable in the genome, spontaneous intrachromosomal recombination events can occur
between these hisG sequences. Such recombination events will excise the URA3 gene and
leave behind one copy of the hisG sequence in the genome. The loop out event allows the
recycling of the URA3 marker for the disruption of the second allele. The use of URA3 is
specifically advantageous, because it can also be counter-selected. Therefore, in the next step,
the cells that excise the URA3 gene by a recombination event between the hisG direct repeats
can be selected on 5-FOA (5-fluoroorotic acid), whereby 5-FOA is converted to the toxic
form (5-flurouracil) in strains expressing the functional URA3 gene. An additional second
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transformation step potentially generates cells that are null for the gene of interest (57) (Fig.
1.6A).
Fig. 1.6: Schematic diagram of some gene deletion cassettes that are used in C. albicans (8,
57). A) The URA blaster method,  B) the URA flipper method, C) the UAU1 method, and D)
the method developed by Noble and Johnson (66).
Introduction
13
The URA blaster method has many drawbacks (57). First, the CAI4 strain has been shown
to have defective expression of 14 different proteins when compared with its parent, SC5314
(67). Second, exposure to 5-FOA in the second step is potentially mutagenic and can
introduce chromosomal rearrangements (68). Third, this method leaves a single copy of URA3
at the locus of the gene of interest. Researchers have discovered that the expression of URA3
at ectopic loci in the genome can affect the virulence of C. albicans (64, 67), and overall, the
change in the chromosomal location of the URA3 gene affects C. albicans Ura3 activity,
hyphal morphogenesis, adherence, and lethality in mice (69). Phenotypic changes in about 30
% of the contemporary published papers have been, upon re-evaluation, attributable to the
expression of URA3 at an ectopic location in the genome and are not caused by the deletion of
the gene of interest per se (67). Fourth, when using the URA blaster method for gene
manipulation, the recombination between hisG repeats leaves a foreign sequence (one copy of
the hisG sequence) in the genome. In instances when a promoter region of an adjacent gene is
within or just following the termination region of the gene of interest, a foreign sequence that
is left behind could be detrimental as it might affect the expression of the adjacent gene (57).
As a result of the problems associated with the URA blaster method, alternative versions of
the URA blaster cassette or entirely new deletion cassettes were developed. Morschhauser et
al., 1999 introduced the use of the FLP recombinase system to make a recyclable URA3
cassette (‘‘URA flipper’’) (70). In this method (Fig. 1.6B), the URA3 marker is flanked by
two direct repeats of the Flp recombinase recognition site (FRT). The expression of the FLP
recombinase gene is controlled by the inducible SAP2 promoter (secreted aspartyl proteinase
family 2). After transformation, the SAP2 promoter is activated, and FLP is expressed. To
activate the SAP2 promoter, the cells are grown in medium containing yeast carbon base and
bovine serum albumin at pH 4.0. The expressed Flp recombinase then recognizes the FRT
sites and excises the URA3 gene by homologous recombination, making the auxotrophic
marker available for the second transformation. This method avoids the use of 5-FOA and its
associated mutagenic potential to counter-select for the URA3 gene. However, similar to the
URA blaster cassette, the URA flipper cassette also leaves behind a foreign sequence (a single
FRT sequence) in the genome, at the locus of the gene of interest. Nevertheless, the foreign
sequence left behind is extremely small, only 34 bp (57),  in comparison with that of the hisG
sequence (1149 bp) (65).
Enloe and coworkers constructed a UAU1 cassette (Fig. 1.6C) for gene deletion in the
parent strain BWP17 (auxotrophic for URA3, ARG4, and HIS1) (71). The UAU1 cassette
allows the disruption of both copies of the gene of interest within a single transformation step.
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The UAU1 cassette comprises the URA3 gene disrupted by the ARG4 gene, but the 5` end
sequence of the URA3 gene carries a 530 bp sequence homologous to its 3`end sequence.
Therefore, when transformed into the genome, recombination loops out the ARG4 gene and
makes a functional copy of URA3. This unique feature of the UAU1 cassette allows the
selection of rare instances in which both alleles of the gene are replaced by mitotic
recombination or gene conversion in a single transformation step. These rare double-deleted
cells are detected by the presence of both ARG4 and URA3 markers (57). However, the
potential homozygous deletion mutants need to be confirmed to rule out possible allelic
triplications, in which a wild-type allele is retained in spite of two alleles having been
replaced by the cassette (57). This condition might arise via known triplicated alleles in the
genome, an increase in ploidy, tandem duplications, or translocations (71).
Noble and Johnson constructed parent strains that were auxotrophic for LEU2, HIS1, and
ARG4 nutritional markers. The main strains constructed were: SN87 (auxotrophic for LEU2
and HIS1), SN95 (auxotrophic for HIS1 and ARG4), and SN152 (auxotrophic for LEU2,
HIS1, and ARG4) (66). All these strains were constructed via the URA blaster method except
that they have one copy of URA3 expressed at the native locus. Employment of these strains
allows C. albicans genes to be disrupted without the use of the URA3 marker. These markers
are not recyclable and are left at the locus of the gene of interest (Fig. 1.6D). Extensive tests
indicate that the expression of any of the above-mentioned nutritional markers in ectopic
genomic locations does not affect the virulence of C. albicans (57). The use of heterologous
marker genes from C. maltosa or C. dubliniensis strains has also been initiated when
disrupting genes in C. albicans to decrease recombination events at the endogenous locus of
the marker gene.
Some researchers have chosen to avoid entirely the use of nutritional markers to
manipulate the C. albicans genome. This is necessary if the genes of interest are in pathways
affected by nutritional status (57).
Köhler and coworkers have developed a strategy involving inosine monophosphate
dehydrogenase (IMH3) as a selectable marker for C. albicans genetic manipulation (72).
IMH3 directs the de novo synthesis of GMP and is inhibited by mycophenolic acid (MPA).
Köhler et al. overexpressed IMH3 from a plasmid in the strain CAI4 and found that the
successful transformants were far more resistant to MPA compared with the wild-type strains.
However, the method was not developed to the level of chromosomal integration (57).
Wirsching and coworkers used MPA resistance as a dominant selectable marker for
chromosomal gene disruptions; they employed a form of the IMH3 gene that was mutated so
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as to avoid reintegration of the fragment into the normal chromosomal copy of IMH3 in C.
albicans (73). They adapted the URA flipper strategy to this system, whereby FRT
recombination sites were positioned to flank the FLP recombinase gene (driven by the SAP2
promoter) and the IMH3 gene (replacing URA3 selectable marker) to generate a ‘‘MPAR
flipper’’ cassette (57).
The group of Morschhauser used the drug nourseothricin (NST) as a dominant selection
marker for gene disruption (74). They introduced, into C. albicans cells, the streptothricin
acetyl transferase (SAT1) gene (from bacterial transposon Tn1825), which confers resistance
to the drug NST. This method, called the SAT1 flipper, circumvents problems related to the
use of nutritional markers and auxotrophic host strains. In addition, the FLP recombinase
system has been included in the SAT1 flipper cassette to allow for the recycling of the
selection marker SAT1 without the use of mutagenic substances that might lead to undesirable
mutations in the genome. The homozygous mutants obtained after two rounds of insertion and
recycling of the SAT1 flipper cassette differ from the wild-type parental strain only in the
absence of the target gene (replaced by a single FRT sequence) and can be used for the
inactivation of additional genes and the generation of complemented strains by employing the
same strategy. Because of the previously mentioned advantages of the SAT1 flipper cassette,
it was adopted in this work to delete CaNIK1 in C. albicans; its principle is described in detail
in 4.11.3 (Page 74).
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2 Aims of the work and experimental design
An urgent need exists to develop new antifungals with new targets that are absent in
humans, as most of the antifungals that are present on the market are associated with
problems of either toxicity and/or resistance. Group III HKs, e.g., CaNik1p from Candida
albicans, are part of TCST systems that are absent in mammalian cells. Moreover, they are
present in most pathogenic fungi and have been reported to play an essential role in the
virulence of these fungal species. Noteworthy, they have been found to be fundamental for
conferring sensitivity to many antifungals that are known to exert their effect by inducing the
Hog1 MAPK module. Therefore, group III HKs represents an attractive approach for
developing a new promising class of antifungal agents. Despite numerous reports that have
confirmed the basic role of these kinases for fungicidal activity, many questions remain
unanswered. For example, do the antifungals interact directly with the class III HKs? If so, do
they interfere with their kinase activity? On the other hand, in C. albicans, CaNik1p plays an
important role in hyphal formation (virulence factor) on solid media. However, the role of the
various domains of the protein for hyphal formation has not been investigated as yet.
Therefore, the aims of the present work are:
1- Investigation of the relevance of various domains of CaNik1p for fungicidal activity
and for activation of the Hog1 MAPK module after fungicidal treatment.
2- Study of the relevance of various protein domains for the kinase activity of the protein
and investigation of the correlation between such kinase activity and the antifungal
mechanism.
3- Investigation of whether group III HKs, with CaNik1p as an example, are direct
targets or mediators for the action of the antifungals, by using fludioxonil as a
representative example.
4- Relevance of the various domains of CaNik1p for the phenotypic behavior of C.
albicans, e.g., hyphal formation on solid medium.
To fulfil the above aims, the following methods were applied by using Saccharomyces
cerevisiae as a model organism for the expression of CaNIK1:
1- Site-directed mutagenesis in various domains of CaNik1p including the conserved
phosphorylatable residues of the HisKA and REC domains of the protein, in addition
to the complete deletion of the characteristic domains of group III HKs, the HAMP
domains.
Aims of the work and experimental design
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2- Transformation of S. cerevisiae with various plasmids harboring the mutated variants
of CaNIK1.
3- Testing the resultant transformants for:
- Antifungal susceptibility in comparison with the sensitive transformant expressing the
wild-type CaNIK1.
- Phosphorylation of the MAPK Hog1p, as an indicator for the activation of the Hog1
MAPK module, by Western blot after fungicidal treatment of various transformants.
4- Expression and purification of the His-tagged CaNik1p and its mutated variants
followed by investigation of their in vitro kinase activity either by the Kinase-Glo plus
kit or by incubation with radioactive [γ-32P] ATP.
5- Study of the direct interaction between the purified CaNik1p and fludioxonil by using
Saturation Transfer Difference-NMR.
6- In vitro kinase assay of the purified CaNik1p in the presence of fludioxonil.
7- Transfer of the mutated variants of CaNIK1 to C. albicans via deletion of both alleles
of the CaNIK1 in C. albicans and reintegration of these mutated variants. For such a
genetic manipulation in C. albicans, the SAT1 flipper cassette has been used.
Materials and Methods
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3 Materials and Methods
3.1 Materials
3.1.1 Solutions & Buffers
3.1.1.1 General solutions
10X PBS
NaCl 80 g/l
KCl 2 g/l
Na2HPO4 14.4 g/l
KH2PO4 2 g/l
pH 7.3
Washing buffer
NaH2PO4 x H2O 0.52 g/l
Na2HPO4 x 2H2O 8.80 g/l
NaCl 2.83 g/l
KCl 0.372 g/l
pH 7
Lysis buffer A (for routine cell disruption)
Prepared by dissolving one tablet of complete ULTRA protease inhibitor (Roche) and one
tablet of PhosSTOP Phosphatase Inhibitor Cocktail (Roche) in 10 ml washing buffer.
Lysis buffer B (for cell disruption prior to purification of CaNik1p and its mutants)
Prepared by dissolving two tablets of complete ULTRA protease inhibitor, Mini, EDTA-
free (Roche) and one tablet of PhosSTOP Phosphatase Inhibitor Cocktail in 8 ml washing
buffer.
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3.1.1.2 For Protein methods
SDS-PAGE gels
Separating gel (% Acrylamide) Stacking gel
(4 %
Acrylamide)7.5 12.5
Deionized H2O 6 ml 4 ml 2.9 ml
Lower Tris (1.5 M Tris-HCl, pH
8.8) 3 ml 3 ml -
Upper Tris (0.5 M Tris-HCl, pH
6.8) - - 1.25 ml
Acrylamide/Bis-acrylamide  stock
solution (30 %, mixed in ratio
37.5:1) (Rotiphorese Gel 30, Roth)
3 ml 5 ml 0.85 ml
20 % (w/v) SDS 60 µl 60 µl 25 µl
10 % (w/v) APS 60 µl 60 µl 25 µl
TEMED 15 µl 15 µl 7 µl
Above amounts are sufficient for preparation of 2 minigels.
5x Laemmli buffer
Glycerin 2 ml
20 % (w/v) SDS 5 ml
Tris-HCl, pH 6.8, 0.5 M 2.5 ml
β-Mercaptoethanol 100 µl
Bromophenol blue 50 mg
Coomassie Staining solution
Coomassie brilliant R250 0.7 g
Ethanol 25 ml
Acetic acid 8 ml
Water 67 ml
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Destaining solution
Ethanol 40 %
Acetic acid 10 %
BCA-Reagent A
BCA 10 g/l
Na2CO3 17.1 g/l
Na2Tartrat. 2H2O 1.9 g/l
NaHCO3 9.5 g/l
pH Adjusted to 11.25 with 10 N NaOH
BCA-Reagent B
CuSO4.5H2O 40 g/l
10x TGS buffer
Tris-HCl 25 mmol/l
Glycine 192 mmol/l
SDS 0.1 % (v/v)
pH 8.3
TBS-T Buffer
Tris-HCl 20 mmol/l
NaCl 140 mmol/l
Tween 20 0.1 % (v/v)
pH 7.4
Blot buffer:
Tris base 3,03 g/l
Glycine 14,4 g/l
2x NPI buffer
NaH2PO4.2H2O 7.8 g
NaCl 17.54 g
pH 8
Water  to 500 ml
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Imidazole Stock solution (1 M)
Imidazole 6.804 g
Water to 100 ml (pH adjusted to 8)
Buffers for purification of His-tagged CaNik1p using Ni+2-agarose beads
NPI-10
(equilibration buffer)
NPI-50
(washing buffer)
NPI-500
(elution buffer)
2x NPI buffer: 25 ml 250 ml 25
Imidazole Stock
solution (1 M)
0.5 ml 25 ml 25
Water to 50 ml 500 ml 50
Final concentration
of imidazole (mM)
10 50 500
3.1.1.3 Kinase assay
10x Kinase buffer A
Tris-HCl 400 mM
MgCl2.6H2O 200 mM
BSA 50 mg
pH 7.5
Water to 50 ml
ATP stock solution (10 mM)
100 mg of ATP powder (Sigma) was dissolved in 19.7 ml 1x kinase buffer A and the
solution was divided into aliquots of 500 µl before storage at -20 ˚C.
8x Kinase buffer B
Tris-HCl 50 mM
KCl 50 mM
MgCl2 5 mM
Dithiothreitol 2 mM
pH 7.5
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Flow-through buffer (used as a negative control in the in vitro kinase assay via the
Kinase-Glo Plus kit)
500 µl of the 10-4 diluted imidazole stock solution (1 M) was added to 9.5 ml washing
buffer to reach a final concentration of 0.005 mM imidazole.
Hot ATP stock solution
[γ-32P] ATP (FP301, 370 MBq (100 µCi/10 µl), 3 µM ATP, Hartman Analytic) was
diluted with 1x kinase buffer B (10 µl hot ATP + 90 µl 1x kinase buffer B) resulting in a
final concentration of 1 µCi/1 µl (when diluted on the day of arrival) with a molar
concentration of 0.3 µM for ATP in a total volume of 100 µl. The hot ATP stock
solution was stored at -20 °C.
3.1.1.4 For molecular biology methods
EDTA (0.5 M, pH 8)
186.1 g disodium EDTA.2H2O was added to 800 ml water and then stirred while the pH
was adjusted to pH 8 by using NaOH pellets (about 20 g).
10x TE (Tris-EDTA) buffer
Tris-HCl 100 mmol/l
EDTA 10 mmol/l
pH 8 or 7.5
50x TAE (Tris-acetate EDTA) buffer
Tris base 242 g/l
EDTA (0.5 M) (pH 8) 100 ml
Concentrated acetic acid 57 ml
Ethidium bromide stock solution
12.5 mg ethidium bromide was dissolved in 10 ml water, and the solution was stored at 4 °C
in a dark container.
Ethidium bromide working solution
For visualization of DNA under UV, 8.5 µl ethidium bromide stock solution was added
to 20 ml agarose solution in TAE buffer (at 50 °C).
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Breaking buffer
Triton X-100 200 µl
20 % SDS 500 µl
NaCl 58.44 mg
Tris-HCl , pH 7.5, 1 M 100 µl
EDTA, 500 mM, pH 8 20 µl
Water to 10 ml
2 M lithium acetate
10.2 g lithium acetate dihydrate was dissolved in 50 ml water (pH was adjusted to 8.4-
8.9). The solution was sterilized by filtration through a Steriflip-NY Filter.
50 % PEG-3350
25 g PEG-3350 was dissolved in 12.5 ml water by heating in a microwave oven. The
solution was made up to 50 ml with water before it was sterilized by filtration through
the Steriflip-NY Filter.
Yeast transformation mixture (Must be freshly prepared)
2 M lithium acetate 200 µl
50 % PEG-3350 800 µl
β-mercaptoethanol 7.7  µl
The solution was subjected to vortexing for proper mixing.
Denatured salmon sperm DNA (10 mg/ml)
Salmon sperm DNA (10 mg) was dissolved in 1 ml filter-sterilized TE buffer (pH 8). The
DNA solution was boiled for 5 min and chilled quickly on ice before being divided into
aliquots of 50 µl and stored at -20 °C. Each aliquot could be used in the transformation of
yeast for up to three freeze-thaw cycles.
3.1.1.5 Solutions of antimicrobial agents
Ampicillin Stock solution (Must be freshly prepared)
The ampicillin stock solution was prepared by dissolving 100 mg ampicillin powder in 10
ml sterile water.
Ampicillin working solution
1  ml ampicillin stock solution  was  added to 100 ml of LB broth or LB agar to give a
Materials and Methods
24
final concentration of 100 µg/ml.
Chloramphenicol Stock solution
The chloramphenicol stock solution was prepared by dissolving 340 mg chloramphenicol
powder in 10 ml 100 % ethanol. The solution was stored at -20 °C in a dark container to
avoid light degradation.
Chloramphenicol working solution
0.5 ml chloramphenicol stock solution  was  added to 100 ml of LB broth or LB agar to
give a final concentration of 170 µg/ml.
Nourseothricin (NST) stock solution
The NST stock solution was prepared by dissolving 100 mg NST powder in 1 ml water.
The solution was sterilized by filtration through a Minisart membrane filter before storage
at –20 °C in aliquots of 250 µl.
NST working solutions
200, 20, 10, or 5 µl from the NST stock solution were added to 100 ml YPD broth or
YPD agar to give a final concentrations of 200, 20, 10, or 5 µg/ml, respectively.
Stock solutions of antifungal agents
The antifungals fludioxonil (Fluka), iprodione (Fluka), and ambruticin Vs3 (produced as
described and kindly provided by K. Gerth and R. Jansen (HZI, Braunschweig) (75))
were prepared as stock solutions in methanol at a concentration of 10 mg/ml and stored
at -20 °C.
When fludioxonil was studied for its effect on the in vitro kinase activity of the
CaNik1p, it was freshly prepared for each experiment as a stock solution in
dimethylsulfoxide (DMSO) (10 mg/ml).
3.1.2 Media
All media were prepared in deionized water and sterilized by autoclaving unless otherwise
specified. For the preparation of solid medium, 1.5 % agar was added to the liquid medium
before autoclaving.
YPD broth
50 g YPD broth (Sigma) was dissolved in 1 liter water.
YPD agar
65 g YPD agar (Sigma) was dissolved in 1 liter water.
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Drop out 1 solution (stored at RT)
Adenine sulfate 400 mg
L-phenylalanine 500 mg
L-Glutamic acid 1 g
L-Aspartic  acid 1 g
L-Threonine 2 g
Adenine Sulfate 400 mg
Water to 250 ml
For complete dissolution of the amino acids, the solution was stirred for 4 h, followed
by sterilization via filtration through a Bottle-Top 500 ml Nalgene membrane filter.
Drop out 2 solution (stored at 4 C)
L-Tryptophan 200 mg
L-Histidine HCl 200 mg
L-Arginine HCl 200 mg
L-Methionine 200 mg
L-Tyrosine 300 mg
L-Leucine 600 mg
L-Isoleucine 300 mg
L-lysine HCl 300 mg
L-Valine 1.5 g
L-Serine 4 g
Water to 1000 ml
For complete dissolution of the amino acids, the solution was stirred for 4 h, followed
by sterilization via filtration through a Bottle-Top 500 ml Nalgene membrane filter.
10x Galactose/Raffinose solution
Galactose 200 g
Raffinose 100 g
Water to 1000 ml
For complete dissolution of the sugars, the solution was stirred for 4 h, followed by
sterilization via filtration through a Bottle-Top 500 ml Nalgene membrane filter.
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SD-ura
Yeast nitrogen base without amino acids 6.7 g
Dextrose 20 g
Deionized water to 875  ml
The solution was sterilized by autoclaving and made up to 1 liter by the addition of 25
and 100 ml of sterile drop out 1 and 2 solutions, respectively.
SG-ura
Yeast nitrogen base without amino acids 6.7 g
Deionized water to 775  ml
The solution was sterilized by autoclaving and made up to 1 liter by the addition of
25, 100, and 100 ml of sterile drop out 1, drop out 2, and 10x galactose/raffinose
solutions, respectively.
Uracil stock solution
Uracil 100 mg
Water to 100 ml
The solution was sterilized by filtration through a Steriflip-NY Filter.
Uracil working solution
800 µl from the uracil stock solution was added to 20 ml SD-ura for cultivation of the
reference strains of S. cerevisiae BWG1-7a and BY4741 (auxotrophic strains for uracil).
LB medium
Tryptone 10 g
Yeast extract 5 g
NaCl 10 g
pH 7
Water to 1000  ml
NZY+ broth
NZ amine (casein hydrolysate) 10 g
Yeast extract 5 g
NaCl 5 g
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pH 7
Water to 945 ml
After autoclaving, the following supplements were added after sterilization via a
Steriflip-NY filter:
1 M MgCl2 12.5 ml
1 M MgSO4 12.5 ml
20 % glucose solution in water 20 ml
3.1.3 Kits
Kit Company
Miniprep Qiagen plasmid DNA Extraction Qiagen, Hilden, Germany
QIAquick Gel Extraction Qiagen, Hilden, Germany
Kinase-Glo® Plus (V3771) Promega
QuikChange site-directed mutagenesis Strategene
Protino® Ni-NTA Agarose Macherey Nagel, Düren, Germany
In-Fusion® HD Cloning Clontech Laboratories
ECL, advance Western blotting detection GE Healthcare
Tab. 3.1: Kits used in this study.
3.1.4 Software and Web interfaces
Software or Web interface Used in
Adobe Photoshop 7.0 ME Adjusting acceptable resolution of images
Aida image analyzer V:4.15
Opening the format files of the images
obtained from the phosphorimage analyzer
BAS reader
Reading out image data from the
phosphorimage analyzer
EasyWin Documentation of agarose gels
End Note X3 and X6 Managing references in Microsoft Office
Word
Excel 2007, Origin 6 Numerical data analysis and creating graphs
Geospiza’s FinchTV Chromatogram viewer of DNA sequences
Plasm 2.0.4.29 Drawing of plasmid maps
Materials and Methods
28
Software or Web interface Used in
Gen5, Version 1.06, BioTek
Instruments
Measurement of absorption and fluorescence
Image Reader, Fujifilm Chemiluminescence detection
Chromeleon Software version 6.8,
Dionex, Thermo Scientific
Data analysis of chromatograms in the LC-
MS/MS
Xcalibur software version 2.1, Thermo
Scientific
Analysis of data obtained from the mass
spectrometer
Mascot Daemon-aided version 2.8,
Matrix Science
Application that automates the submission
of data files to Mascot server
Mascot server version 2.3.02, Matrix
Science
Protein identification with MS data
Proteome Discoverer program Version
1.3, Thermo Scientific
Analysis of qualitative and quantitative
proteomics data obtained from MS.
http://web.expasy.org/protparam/ Determination of MW and extinction
coefficient of a protein
http://blast.ncbi.nlm.nih.gov/Blast.cgi Blasting of DNA and protein sequences
http://tools.neb.com/NEBcutter2/ Determination of restriction sites in DNA
sequences
http://web.expasy.org/translate/ Translation of DNA sequences
http://www.candidagenome.org/ Determination of sequences of various genes
and the phenotypes associated with their
expression in C. albicans Sc5314.
http://www.bioinformatics.org/sms/rev
_comp.html
Conversion of a DNA sequence into its
reverse, complement, or reverse-
complement counterpart
http://eu.idtdna.com/analyzer/Applicat
ions/OligoAnalyzer/
Analysis of the properties of the designed
primers.
http://www.ebi.ac.uk/Tools/msa/clusta
lw2/
Multiple alignment of DNA and protein
sequences
http://domaindraw.imb.uq.edu.au./ Designing of schematic diagrams illustrating
the presence and the position of one or more
motifs or domains in certain protein
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Software or Web interface Used in
http://www.brenda-enzymes.org/ Information about properties of reference
enzymes.
http://smart.embl-heidelberg.de/ To obtain information about various
domains in the protein data base.
http://pfam.sanger.ac.uk/search Identification of possible conserved domains
in a protein.
http://www.ebi.ac.uk/Tools/msa/clusta
lw2/
Alignment of multiple sequences of
proteins.
Tab. 3.2: Software and web interfaces used in this study.
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3.1.5 Plasmids
Plasmid Relevance and properties Reference(source)
pYES2 Shuttle vector for transformation of E. coli
and S. cerevisiae. Invitrogen
pYES2-CaNIK1-TAG Used in the construction for all mutants of
the CaNIK1. (47)
pYES2-CaNIK1(H510Q)
pYES2-CaNIK1-TAG containing point
mutation in the codon of His510 (CAT to
CAA; His to Gln).
This study
pYES2-CaNIK1(D924N)
pYES2-CaNIK1-TAG containing point
mutation in the codon of Asp924 (GAT to
AAT; Asp to Asn).
This study
pYES2-CaNIK1(H510Q,
D924N)
pYES2-CaNIK1-TAG containing point
mutations in the codons of His510 (CAT to
CAA; His to Gln) and Asp924 (GAT to
AAT; Asp to Asn).
This study
pYES2-CaNIK1(N627D)
pYES2-CaNIK1-TAG containing point
mutation in the codon of Asn627 (AAT to
GAT; Asn to Asp).
This study
pYES2-CaNIK1(G663A,
G665A)
pYES2-CaNIK1-TAG containing point
mutation in the codons of Gly663 (GGA)
and Gly665 (GGT) into GCA (Ala) and
GCT (Ala) respectively.
This study
pYES2-CaNIK1ΔHAMP
pYES2-CaNIK1-TAG containing deletion of
the HAMP domains (sequence encoding the
amino acids 63-485 in the CaNik1p).
This study
pYES2-CaNIK1ΔHAMPup
pYES2-CaNIK1-TAG containing deletion of
HAMP domains and its upstream part in the
CaNIK1 (sequence encoding the amino
acids 1-485 in the CaNik1p).
This study
pYES2-
CaNIK1ΔHAMP(H510Q)
pYES2-CaNIK1ΔHAMP containing point
mutation in the codon of His510 (CAT to
CAA; His to Gln).
This study
pYES2-CaNIK1ΔHAMPup
(H510Q)
pYES2-CaNIK1ΔHAMPup containing point
mutation in the codon of His510 (CAT to
CAA; His to Gln).
This study
pYES2-CaNIK1Δ224-
315Δ327-418 aa
pYES2-CaNIK1-TAG containing deletion of
sequences encoding the  amino acids 224-
315 and 327-418 in the CaNik1p.
(47)
pSFS2A Contains the SAT1 flipper cassette. (74)
pNIK Contains the CaNIK1 deletion cassette. This study
Tab. 3.3: Plasmids used in this work.
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3.1.6 Oligonucleotides
Name Sequence (5’ 3’) Relevance
F2Gln CTAGCGAACATGTCGCAAGAGATACGTACACC Construction of
point mutation in the
HisKA domain at
His510
R2Gln GGTGTACGTATCTCTTGCGACATGTTCGCTAG
AAsnF GATGTGGTGTTGATGAATGTGCAAATGCCTGTAATG Construction of
point mutation in the
REC domain at
Asp924
AAsnR CATTACAGGCATTTGCACATTCATCAACACCACATC
TAsnF CTTAACTTGGCTGGTGATGCTATTAAGTTTAC Construction of
point mutation in the
HATPase_c domain
at N box (N627)
TAsnR GTAAACTTAATAGCATCACCAGCCAAGTTAAG
F1ATP GTGTTAGCGACACGGCAATAGCTATAGAGAAAGACAA
Construction of
double point
mutations in the
HATPase_c domain
at the G1box (G663
and G665)
R1ATP TTGTCTTTCTCTATAGCTATTGCCGTGTCGCTAACAC
HMPF1 AGGGAATATTAAGCTTATGAACCCCACTAAAAAACCACG
Deletion of the
HAMP domains
(sequence encoding
the amino acids 63-
485 in the CaNik1p)
HMPR1 GTTCGCGTTTTTGGATTTTTCTAG
HMPF2 TCCAAAAACGCGAACAGGAATACTGCGGCTAGAGAAGCTG
HMPR2 GCTCGGTACCAAGCTTTCAGTGGTGATGGTGATGATGTCC
HisKF2 GAATGCAAGCTTATGAGGAATACTGCGGCTAGAG
Deletion of the
HAMP domains and
its upstream part in
the CaNIK1
(sequence encoding
the amino acids 1-
485 in the CaNik1p)HisKR GTATTGTCTAGAGTCAGTGGTGATGGTGATGATG
Tab. 3.4A: Primers used for the construction of mutated variants of CaNIK1.
Name Sequence (5’ 3’) Target sequence
F1 CCTCTATACTTTAACGTCAAGG -96 to -75
R2Gln GGTGTACGTATCTCTTGCGACATGTTCGCTAG 1535-1514
Fseq GGGAATCGCTTCAAAGGAATAC 1442-1463
Rseq CGAATCTTCTCCGTAGCTTCG 2819-2800
F4 CTCGTCAATCAGAAACTTGCAGTTAG 2647-2672
Tab. 3.4B: Primers used for sequencing of CaNIK1 in the pYES2 vector.
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Name Sequence (5’ 3’) Relevance
F1NIK CTATAGGGCGAATTGGGTACCATAGAGTGGGACATAGGTGGAG Amplification of
the CaNIK1-
upstream
sequence.
R1bNIK AACTTCCTCGAGGGGGGGCCCTGGAGAGAGAGGGAGAAACTCG
F2NIK CTAGAGCGGCCGCCACCGCGGCTAACGACTCAAGCGTCAGCTTG Amplification of
the CaNIK1-
downstream
sequence
R2NIK AAAGCTGGAGCTCCACCGCGGGGTCACGTGATGTTGCATAAACTG
F1SAT TTGTAGCCACTGAAACCACG Check for the
existence of the
SAT1 flipper
cassette
R1SAT TCTCCCCCTTCACACTTCAC
F4NIK GGGCCCCCCCTCGAGGAAGTT Amplification of
pNIK by inverse
PCR for the
design of the
CaNIK1
integration
cassette
R3NIK TTTAGTGGGGTTCATTGGAGAGAGAGGGAGAAACTCG
F3NIK ATGAACCCCACTAAAAAACCACG
Amplification of
CaNIK1-TAG
and its mutated
variants for the
design of the
CaNIK1
integration
cassette
R5NIK AACTTCCTCGAGGGGGGGCCCTCAGTGGTGATGGTGATGATG
Tab. 3.4C: Primers used for the construction of CaNIK1 deletion and integration cassettes.
Tab. 3.4: Oligonucleotides used in this study. Bold bases represent the restriction sites. Single
bold underlined bases are those that were used to introduce the point mutations. Dot-
underlined bases are the overlapping bases that allowed the ligation of DNA fragments via the
In-Fusion enzyme. Double underlined bases represent the initiation codon ATG. The letters F
and R in the names of the primers refer to the primers being forward and reverse, respectively.
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3.1.7 Strains
Species and strain
designation
Genotype Transformed with Reference
(Source)
TOP10
F- mcrAΔ(mrr-hsdRMS-
mcrBC) φ80lacZΔM15
ΔlacΧ74 recA1 araD139
Δ(ara-leu) 7697
galUgalKrpsL (StrR) endA1
nupGλ-
pYES2-CaNIK1-TAG (47)
XL1-Blue
supercompetent
cells
recA1 endA1 gyrA96 thi-1
hsdR17 supE44 relA1 lac [F´
proABlacIqZΔM15 Tn10
(Tetr)]
Point mutated variants of the
CaNIK1 harbored in the pYES2 Stratagene
Stellar™
Competent Cells
F–, endA1, supE44, thi-1,
recA1, relA1, gyrA96, phoA,
Φ80d lacZΔ M15, Δ (lacZYA -
argF) U169, Δ (mrr- hsdRMS
- mcrBC), ΔmcrA, λ–
- pYES2-CaNIK1ΔHAMP
- pYES2-CaNIK1ΔHAMPup
-pNIK Clontech
DH5α
F– Φ80lacZΔM15 Δ(lacZYA-
argF) U169 recA1 endA1
hsdR17 (rK–, mK+)
phoAsupE44 λ– thi-1 gyrA96
relA1
pSFS2A (74)
Tab. 3.5: E. coli strains used in this study.
Species and
strain
designation
Genotype Transformed with Reference
(Source)
S. cerevisiae
BWG1-7a
Mat a ura3-52 leu2-3,112
his4-519 ade1-100
- (76)
YES BWG1-7a pYES2 This study
NIK BWG1-7a pYES2-CaNIK1-TAG (47)
H510 BWG1-7a pYES2-CaNIK1(H510Q) This study
D924 BWG1-7a pYES2-CaNIK1(D924N) This study
N627 BWG1-7a pYES2-CaNIK1(N627D) This study
G1 BWG1-7a pYES2-CaNIK1Δ(G663A, G665A) This study
ΔHa BWG1-7a pYES2-CaNIK1ΔHAMP This study
ΔHupa BWG1-7a pYES2-CaNIK1ΔHAMPup This study
ΔHaH510 BWG1-7a pYES2-CaNIK1ΔHAMP(H510Q) This study
ΔHupaH510 BWG1-7a
pYES2-
CaNIK1ΔHAMPup(H510Q)
This study
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Species and
strain
designation
Genotype Transformed with Reference
(Source)
S. cerevisiae
ΔH3H4 BWG1-7a
pYES2-CaNIK1Δ224-315Δ327-418
aa
(47)
BY4741
Mat a his3Δ 1; leu2Δ 0;
met15Δ 0; ura3Δ 0
- (77)
ΔHb BY4741 pYES2-CaNIK1ΔHAMP This study
ΔHupb BY4741 pYES2-CaNIK1ΔHAMPup This study
ΔHbH510 BY4741 pYES2-CaNIK1ΔHAMP(H510Q) This study
ΔHupbH510 BY4741
pYES2-
CaNIK1ΔHAMPup(H510Q)
This study
Δssk1 BY4741, YLR006c::kanMX4 - (78)
Δpbs2 BY4741, YJL128c::kanMX4 - (78)
Δhog
BY4741,
YLR113w::kanMX4
- (78)
NIKb Δhog Δhog pYES2-CaNIK1-TAG This study
H510bΔhog Δhog pYES2-CaNIK1(H510Q) This study
N627bΔhog Δhog pYES2-CaNIK1(N627D) This study
G1bΔhog Δhog pYES2-CaNIK1Δ(G663A, G665A) This study
HDbΔhog Δhog pYES2-CaNIK1(H510Q, D924N) This study
ΔHbΔssk1 Δssk1 pYES2-CaNIK1ΔHAMP This study
ΔHbΔpbs2 Δpbs2 pYES2-CaNIK1ΔHAMP This study
ΔHbΔhog Δhog pYES2-CaNIK1ΔHAMP This study
ΔHupbΔssk1 Δssk1 pYES2-CaNIK1ΔHAMPup This study
ΔHupbΔpbs2 Δpbs2 pYES2-CaNIK1ΔHAMPup This study
ΔHupbΔhog Δhog pYES2-CaNIK1ΔHAMPup This study
C. albicans
Sc5314 Sequenced wild type - (79)
NIKa *
nik1-1∆::SAT1-FLIP /nik1-
2∆:: SAT1-FLIP
CaNIK1 deletion cassette,
integrated in both alleles of the
CaNIK1 gene
This study
NIKhom2 * nik1-1∆:: FRT /nik1-2∆::FRT - This study
Tab. 3.6: S. cerevisiae and C. albicans strains used in this study. * The genotype of the strain
has been confirmed only by PCR.
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3.2 Methods
3.2.1 Maintenance of cultures
Overnight cultures were prepared from separate colonies and processed as follows:
3.2.1.1 Long term storage:
Overnight cultures (20 ml) were centrifuged at 5000 rpm for 5 min. The supernatant was
rejected, and the cell pellet was resuspended in the remaining supernatant. In a sterile
cryotube, 625 µl from the cell suspension was mixed with 375 µl 80 % sterile glycerol
solution to give a final concentration of 30 % glycerol. The glycerol stock tubes were then
stored at -80 ˚C.
3.2.1.2 Cryo-stocks for routine cultivation of cultures
The overnight culture was distributed in cryotubes, so that each contained 2 ml, and stored
at -20 ˚C.
3.2.2 Measurement of growth of cultures
3.2.2.1 OD measurement
Optical density at 620 nm (OD620nm) was determined in sample volumes of 180 µl in 96-
well microtiter plates by using the scanning microplate spectrophotometer µQuant.
3.2.2.2 Cell number counting
Cells were counted by using a Neubauer improved hemocytometer cell counting chamber
(Fig. 3.1). The chamber consisted of nine large squares, each occupying 0.1 µl and having an
area of 1 mm2. The square in the center was divided into 5 × 5 small squares (each 0.04 mm2).
The chamber was filled with 10 μl cell suspension, and the cells were counted under the
microscope in five small squares on the same diagonal within the central large square. The
resulting number was multiplied by 5×104 to obtain the cell number per ml. To avoid too high
a cell density, the cell suspensions were diluted in phosphate-buffered saline (PBS), and the
dilution factor was included in the calculation of the cell density.
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Fig. 3.1: Schematic diagram of the hemocytometer counting chamber (80).
3.2.3 Cultivation in Erlenmeyer flasks
In all experiments, the cultivation of organisms was performed in baffled Erlenmeyer
flasks that contained medium to not more than 1/5 their volume. The culture flasks were
shaked at 160 rpm in the shaker incubator Multitron Standard, Infors HT.
3.2.4 Cultivation of bacterial strains
E. coli strains were cultivated in LB or NZY+ medium at 37 °C. To select and maintain the
transformed cells, ampicillin or chloramphenicol was added to the medium at final
concentrations of 100 µg/ml or 170 µg/ml, respectively.
3.2.5 Heterologous expression of CaNik1p and its mutated variants in
Saccharomyces cerevisiae
S. cerevisiae transformed with pYES2 vector (Fig. 3.2) was selected and maintained on
SD-ura, a synthetic medium deficient in uracil and containing glucose as a carbon source. The
expression of the transgenes was controlled via the galactose promoter (GAL1). Therefore, to
induce the transgene expression, the transformed strains were incubated in SG-ura, a synthetic
medium deficient in uracil and containing galactose (to induce the GAL1 promoter) and
raffinose (to enhance the growth) as carbon sources.
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Fig. 3.2: Map of pYES2 vector (81).
Before induction of transgene expression, the transformants were cultivated at 30 °C in
SD-ura for 36 h to obtain high cell densities. The cells were then pelleted and washed with
SG-ura. To induce transgene expression, subsequent cultures were prepared in SG-ura as
follows: an overnight culture (starting OD620nm = 0.3), then a preculture (starting OD620nm =
0.3, 2-3 h), and ultimately a working culture. The starting OD620nm of the working culture and
its cultivation period differed according to the purpose of the experiment (Tab. 3.7). For
cultivation of the reference strains of S. cerevisiae, uracil was added at a final concentration of
40 mg/l to either SD-ura or SG-ura.
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Purpose of experiment
Working culture
Starting
OD620nm
Cultivation
period
Detection of phosphorylation of Hog1p in transformants of
S. cerevisiae
0.3 15 min
Sensitivity of the transformants to various antifungals* 0.03 24 h
Production of CaNik1p and its mutated variants ** 0.3 6 h
Tab. 3.7: Starting OD620nm and incubation period of the working cultures used for
heterologous expression of CaNik1p and its mutated variants in S. cerevisiae depending on
the purpose of the experiment. (*: performed in 96-well microtiter plates, **: performed in
1 liter baffled flasks (5 flasks each containing 200 ml culture) with no preculture being
prepared).
3.2.6 Cultivation of C. albicans strains
C. albicans strains were cultivated in YPD medium at 30 °C. To select and maintain strains
transformed with the SAT1 flipper cassette, NST was added to the medium at a final
concentration of 200 µg/ml.
3.2.7 Protein methods
3.2.7.1 Protein extraction
3.2.7.1.1 Mikro-dismembrator (small scale)
Samples containing 10 ml cultures were centrifuged at 5000 rpm and RT for 4 min. The
supernatant was discarded, and the cell pellet was resuspended in the residual medium. The
cell suspension was dropped into a 50 ml falcon tube full of liquid N2 to form cell pearls that
could be stored at -30 °C until further disruption. The resulting cell pearls were then
transferred into a 5 ml shaking flask (made of PTFE), which was pre-cooled in the liquid N2
and contained a grinding ball. The shaking flask was immersed in liquid nitrogen for a few
seconds, before disruption of the cell pearls by the shaking of the flask at 2000 rpm for 2 min
in the Mikro-dismembrator. The resulting powder was transferred quickly into a 2 ml pre-
cooled tube and allowed to thaw on ice. After this thawing step, the suspension was
centrifuged at 8000 rpm and 4 °C and for 5 min. Some of the supernatant (15 µl) was kept for
the determination of protein concentration as in 3.2.7.2.2, whereas the remainder was mixed
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with an equal volume of lysis buffer A and shock-frozen in liquid N2 before being stored at -
80 °C.
3.2.7.1.2 Grinding by mortar (large scale, for purification of the heterologously
expressed CaNik1p)
1 liter of the culture was centrifuged at 5000 rpm and RT for 4 min. The resulting cell
pellets were collected in one falcon tube (50 ml) and washed with 10 ml washing buffer. The
washed cell pellets were suspended in 10 ml lysis buffer B, which was then dropped into 50
ml falcon tube full of liquid N2 to form cell pearls. The resulting cell pearls were stored at -80
°C. For cell disruption, the cell pearls were poured into a mortar that had previously been pre-
cooled by the addition of liquid N2 and were gently ground with the pre-cooled pestle. During
grinding, liquid N2 was added from time to time to keep the disrupted cells in the frozen state.
Grinding was continued until a fine homogeneous white powder of the disrupted cells was
obtained. The resulting powder was transferred into a pre-cooled 50 ml falcon tube and left on
ice for 2 h until a homogeneous suspension of the disrupted cells was obtained without any
frozen clumps.
3.2.7.2 Protein quantification
3.2.7.2.1 BCA method
The bicinchoninic acid (BCA) method (82) was used for determination of the protein
concentration in total protein extracts obtained from S. cerevisiae strains. The principle of the
BCA assay relies on the formation of a Cu2+-protein complex under alkaline conditions,
followed by the reduction of the Cu2+ to Cu1+. The amount of reduced Cu1+ is proportional to
the amount protein present. Cysteine, cystine, tryptophan, tyrosine, and peptide bonds have
been shown to be able to reduce Cu2+ to Cu1+. BCA forms a purple-blue complex with Cu1+ in
alkaline environments (Fig. 3.3), thus providing a basis for monitoring the reduction of Cu2+
by proteins at an absorbance of 570 nm. Lysozyme was used as a standard protein and was
prepared in a stock solution of 10 mg/ml in water, from which serial dilutions were further
prepared.
In a clean reservoir, BCA-Reagent A and B were mixed at a ratio of 50:1 to form the assay
solution. The assay was performed in 96-well microtiter plates in which 5 µl from the protein
samples and various dilutions of lysozyme were applied as duplicates in different wells.
Either lysis buffer A or B was used as negative control. The assay solution (195 µl) was
applied to all samples. The plate was gently shaken for a few seconds before incubation at 37
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°C for 30 min. The absorbance was then measured at 570 nm, and the protein concentrations
were determined from standard curves of lysozyme after subtraction of the background of the
control.
Fig. 3.3: The principle of the BCA reaction. Two molecules of BCA bind to each molecule of
copper that had been reduced by a peptide-mediated reaction.
3.2.7.2.2 NanoDrop spectrophotometer
The concentration of purified CaNik1p and its mutated variants was determined by
measuring the absorbance at 280 nm by using the NanoDrop 1000 spectrophotometer. The
mass extinction coefficient of the protein was determined as E1% = 4.7 (83).
3.2.7.3 SDS polyacrylamide gel electrophoresis (SDS-PAGE)
Protein extracts were denatured by being heated at 95 °C for 10 min in the presence of the
anionic detergent SDS and the reducing agent β-mercaptoethanol. In this step, the proteins are
complexed by SDS and become negatively charged, thereby disrupting their subunits. During
electrophoresis, the proteins were separated according to their molecular weight while
migrating toward the anode (84). The protein samples were heated at 95 °C with 5x Laemmli
buffer for 10 min before application into the wells of the stacking gel, and the gel was allowed
to run at 80 V and 500 mA for 30 min and then at 120 V and 500 mA until the dye front had
reached the end of the separating gel. To estimate the molecular weight of the separated
proteins, the protein marker Precision Plus Protein Dual Color Standard (Bio-Rad) was loaded
in parallel with the samples. Electrophoresis was carried out in a Mini Protein II
Electrophoresis System and was run in 1x TGS buffer (SDS-PAGE running buffer). For
routine SDS-PAGE, a 12.5 % separating gel was prepared, whereas for the separation of
CaNik1p and its mutated variants, a 7.5 % separating gel was used.
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3.2.7.4 Western blot
The separated proteins were transferred from SDS-PAGE gel onto a PVDF membrane by
semi-dry transfer in a blot buffer. The transferred proteins were detected by the corresponding
antibodies (Tab. 3.8).
A PVDF membrane and 2 filter papers (3 mm, Whatman) were cut according to the size of
the gel (0.5 mm excess in width and length) and the membrane was moistened with methanol
followed by washing with water. The membrane and the filter papers were incubated in the
blot buffer till the transfer was started. After electrophoresis, the gel was incubated in the blot
buffer for 30 min.
To start the transfer, the filter paper was placed toward the anode side of the Trans-Blot
Semi-Dry Electrophoretic Transfer Cell, followed by the membrane which was completely
covered with blot buffer before adding the gel and finally the other filter paper. The transfer
was performed at 250 mA and 15 V for 30 min. The membrane was washed with TBS-T
buffer for 5 min before being blocked by incubation with 5 % milk powder in TBS-T buffer at
RT for 1 h. The membrane was washed with TBS-T buffer for 4 x 10 min.
For detection of phosphorylated Hog1p, the membrane was incubated at 4 ˚C with the P-
p38 Ab (1:1000 in 5 % BSA in TBS-T) overnight. The membrane was then washed with
TBS-T buffer for 4 x 10 min, incubated with the anti-rabbit Ab (1:6666 in 5 % BSA in TBS-
T) at RT for 1 h followed by washing with TBS-T buffer for 4 x 10 min. The bound HRP-
linked anti-rabbit Ab was visualized by detection of chemiluminescence that resulted from the
addition a peroxidase–specific chemiluminescence substrate (ECL, advance Western blot
detection kit) via the CCD camera of the LAS-3000. For detection of total Hog1p, the
membrane was washed with TBS-T for 2 x 10 min, stripped by incubation in 1× Re-Blot Plus
Solution (Millipore) for 15 min, and washed with TBS-T buffer for 2 x 10 min. The
membrane was blocked with milk powder in TBS-T buffer and then incubated with Hog1 Ab
(1:2000 in 5 % BSA in TBS-T) at RT for 2 h and detection was done as previously
mentioned.
For the detection of CaNik1p and its mutated variants, the FLAG-tagged proteins were
detected by incubating the blocked membrane with monoclonal anti-FLAG M2-Peroxidase
Ab (1:50000 in 5% BSA in TBS-T) at 4 ˚C for 1 h. Blocking with milk powder, washing steps
and visualization of the bound antibodies were carried out as previously mentioned.
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Name Clone Epitope
Produced
in
Company and
Cat. No.
P-p38 mAb
Phospho-p38
MAPK
(Thr180/Tyr182)
Rabbit
Cell Signaling,
9215
Hog1 pAb Hog1 (y-215) Rabbit Santa Cruz, 9075
Anti-rabbit* mAb Rabbit IgG Goat
CellSignalling,
7074
Anti-
FLAGM2-
Peroxidase*
mAb
FLAG tag
(DYKDDDDK)
Mouse
cell culture
Sigma Aldrich,
A8592
Tab. 3.8: Antibodies used for Western blots (* Ab is conjugated to HRP).
3.2.8 CaNik1p purification from the cell lysate
The suspension with the disrupted cells obtained in 3.2.7.1.2 was centrifuged at 8000 rpm
4 °C for 5 min. Ni+2-agarose beads (MachereyNagel) were used to capture the His-tagged
CaNik1p and its mutated variants from the cell lysate, 2 ml agarose beads were sufficient to
bind all the tagged protein in the cell lysate resulting form 500 ml working culture (OD620nm
0.6-0.8). The beads were equilibrated with NPI-10 buffer as mentioned in the manufacturer’s
protocol before incubation with the cell lysate in 50 ml falcon tube, which was immersed in
ice and shaken gently for 1 h. The unbound proteins were removed by centrifugation at 500 g
and 4 °C for 10 min with subsequent rejection of the supernatant. To remove the non-
specifically bound proteins, the beads were washed for 6 x 10 min with NPI-50 buffer (10x
volumes of beads) by centrifugation at 500 g and 4 °C. The bound proteins were eluted by
gentle shaking of the beads with of NPI-500 buffer (1x volume of beads) for 2 min while
immersed in ice, followed by centrifugation at 500 g and 4 °C for 5 min. The elution step was
repeated three times, and the supernatants (containing the eluted proteins) were pooled. To
remove any residual beads, the eluate was passed through a Steriflip-NY Filter. The purified
protein solution, which contained imidazole (500 mM), was then concentrated by
centrifugation at 2000 g and 4 °C by using a 50 kDa MWCO Viva 20 spin column. The
concentrated protein solution was ten-fold diluted with washing buffer and then concentrated
again by ultrafiltration. The dilution process was repeated until the concentration of imidazole
Materials and Methods
43
reached 0.005 mM. The concentration of the purified protein was determined as in 3.2.7.2.2
before being shock-frozen in liquid N2 and stored at -80 °C.
3.2.9 Protein identification by MALDI TOF-MS
After electrophoresis, protein bands of interest were excised from the gel by a clean
scalpel, washed three times with deionized water, and then left to dry at 37 °C for 15 min. The
dried protein bands were sent to the Cellular Proteome Research unit, HZI for further
identification of the protein by MALDI TOF-MS.
3.2.10 Detection of phosphorylated peptides by LC-MS/MS
(Performed by Dr. Josef Wissing and Dr. Manfred Nimtz, Cellular Proteome Research
unit, HZI)
Proteins were extracted with chloroform/methanol by using the method of Wessel and
Flügge (85). For tryptic digestion, the extracted proteins were resolubilized in 50 mM TEAB
(triethylammonium bicarbonate), reduced for 1 h at 56 °C with TCEP (triscarboxyethyl
phosphine) and alkylated with MMTS (methylmethane thiosulfonate) for 20 min. Reduced
and alkylated proteins were digested with trypsin at a final ratio of 50:1 (protein : protease)
and incubated at 37 °C overnight. The digest was dried in a SpeedVac centrifuge. After
evaporation of all the liquid in the SpeedVac, the peptides were desalted onto Zip Tip’s.
Peptides were resolubilized in 3 % ACN containing 0.2 % TFA and adsorbed to RP18
material. After washing with the binding solution, the peptides were eluted with 60 % ACN
containing 0.2 % TFA. To remove the organic phase, the peptides were dried in a SpeedVac,
resolubilized in 12 µl 3 % ACN containing 0.2 % TFA and centrifuged in an ultracentrifuge.
Peptides were used then ready for LC-MS/MS analysis.
LC-MS/MS analysis was performed on a DionexUltiMate 3000 n-RSLC system connected
to an LTQ Orbitrap Velos mass spectrometer (Thermo Scientific). Peptides were loaded onto
a C18 pre-column (3 µm, Acclaim, 75 μm x 20 mm, Dionex) washed for 3 min at a flow rate
of 6 μl/min. Subsequently, peptides were separated on a C18 analytical column (3-μm,
Acclaim PepMap RSLC, 75 μmx 25 cm, Dionex) at 350 μl/min via a linear 30-min gradient
from 100 % solution A (0.1 % formic acid in water) to 25 % solution B (99.9 % acetonitrile
with 0.1 % formic acid) followed by a 15 min gradient from 25 % solution A to 80 % solution
B. The LC system was operated by Chromeleon Software, which was embedded in Xcalibur
software. The effluent from the column was electro-sprayed (Pico Tip Emitter Needles, New
Objectives) into the mass spectrometer. The mass spectrometer was controlled by Xcalibur
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software and operated in the data-dependent mode allowing the automatic selection of a
maximum of 5 double- and triple-charged peptides and their subsequent fragmentation. A
dynamic exclusion allowed up to 3 repeats.  Peptide fragmentation was carried out by using
LTQ settings (min signal 2000, isolation width 4, normalized collision energy 35, default
Charge State 4, and activation time 10 ms).  MS/MS raw data files were processed via Mascot
Daemon-aided searching against the UniProtKB/Swiss-Prot protein database or by using the
Proteome Discoverer program. The following search parameters were used: enzyme, trypsin;
maximum missed cleavages, 1; fixed modification: carbamidomethylation (C); variable
modifications: oxidation (M), phosphorylation of S, T, and Y, respectively; peptide tolerance,
5 ppm; MS/MS tolerance, 0.4 Da.
3.2.11 Investigation of the interaction between fludioxonil and purified CaNik1p
via Saturation Transfer Difference-NMR (STD-NMR)
(Performed by Prof. Dr. Christiane Ritter, Macromolecular Interactions unit, HZI)
The possibility of the interaction between fludioxonil and CaNik1p was investigated via
STD-NMR. The NMR spectrum of a saturated solution of fludioxonil in deuterated DMSO
was recorded, after the addition of various concentrations of purified CaNik1p by using a
BrukerAvance III spectrometer operating at a proton Larmor frequency of 600.28 MHz and
equipped with a triple resonance cryoprobe platform. The final concentration of fludioxonil in
the mixture was 100 µM. As control, fludioxonil was incubated with the flow-through of the
ultrafiltration step in the purification protocol of CaNik1p (3.2.8).
3.2.12 In vitro kinase assay of the purified CaNik1p and its mutated variants
3.2.12.1 Kinase-Glo Plus kit
The kinase activity of purified CaNik1p and its mutated variants was determined by the
Kinase-Glo Plus kit in white opaque 96-well microtiter plates. The assay is based on the
detection of the ATP consumption during a kinase reaction (Fig. 3.4). ATP is quantified via
the luciferin-luciferase reaction. The higher the kinase activity (or ATPase activity), the lower
the final luminescence value as more ATP is consumed in the kinase reaction.
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Fig. 3.4: Principle of the Kinase-Glo plus Kit (86).
The kinase reaction mixture (50 µl) (Tab. 3.9) comprised ATP and the purified protein. No
additional substrate was required, as CaNik1p undergoes autophosphorylation. The mixture
was incubated in the wells of microtiter plate at 30 °C for 2:30 h. The Kinase-Glo reagent (50
µl) was added and the plate was sealed with aluminum foil and incubated at 30 °C for 20 min.
The plate was transferred to a luminescence microtiter plate reader (Synergy, Biotek) and
after additional 10 min the luminescence was measured. The flow-through buffer (3.1.1.3)
was used as negative control in the same plate. The control buffer contained the same
imidazole concentration (0.005 mM) as all protein samples, which were obtained at the end of
the purification procedure (3.2.8). The influence of fludioxonil on the kinase activity of
purified CaNik1p was studied by addition of 40 µM (10 µg/ml) fludioxonil (5 % volume of
the total kinase reaction) to the reaction mixture. The solvent of fludioxonil, DMSO, was used
as a negative control in a separate sample.
Component Volume added to the kinase
reaction (µl)
ATP (100 µM) in 1x kinase
buffer A
10
(final concentration 20 µM)
Protein sample X
10x kinase buffer A 4
Water 50- (14+X)
Tab. 3.9: Components of the kinase reaction mixture when the kinase-Glo Plus kit was used
for the in vitro kinase assay of CaNik1p and its mutated variants.
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3.2.12.2 Incubation with the radiolabeled [γ-32P] ATP
The purified protein (0.5 µM) was incubated in kinase buffer B containing hot ATP (1
µCi) and 110 µM ATP (cold ATP) in a final volume of 10 µl at 30 ˚C for 1 h. Denatured
protein (preheated at 95 ˚C for 10 min) was used as a negative control in a separate kinase
reaction. After incubation, the reaction was stopped by the addition of LDS buffer (NP0007,
Invitrogen) and β mercaptoethanol (final concentration of 2.5 %) followed by heating at 95 ˚C
for 10 min. The denatured proteins were loaded on NuPAGENovex 10 % Bis-Tris precasting
gels (NP0301PK2, Invitrogen). Proteins were separated via gel electrophoresis at 150 mV for
1 h in the presence of NuPAGE MES SDS (NP0002, Invitrogen) as running buffer. To
estimate the molecular weight of the separated proteins, the protein marker Precision Plus
Protein Dual Color Standard was used. The protein bands were visualized after
electrophoresis by staining with InstantBlue (Expedeon) for 1 h. The gel was exposed to a
phosphor screen at RT for 4 h after being washed with PBS overnight to minimize
background resulting from unreacted hot ATP. The phosphor screen was scanned via the
phosphorimage analyzer BAS2500. The influence of fludioxonil on the autophosphorylation
of CaNik1p was investigated at a final concentration of 40 µM (10 µg/ml). The solvent of
fludioxonil, DMSO, was used as a negative control.
3.2.13 Molecular biology methods
3.2.13.1 Isolation of plasmid DNA from E. coli
Plasmid DNA was isolated from 4 ml overnight bacterial cultures by using the Miniprep
Qiagen plasmid DNA Extraction kit according to the manufacturer’s instructions.
3.2.13.2 Isolation of genomic DNA from C. albicans (74)
Cells from 10 ml overnight culture were pelleted and washed with deionized water before
being suspended in 200 µl breaking buffer (3.1.1.4). 200 µl glass bead (0.25-0.5 mm, Roth)
and 200 µl phenol/chloroform/isoamyl alchohol mixture (25:24:1, Roth) were added to the
cell suspension, and the cells were broken by vortexing for 5 min. TE buffer (200 µl) was
then added, and the suspension was mixed for 45 sec by gentle inverting before being
centrifuged at 10,000 rpm for 5 min. The upper aqueous layer was carefully transferred into a
2 ml tube. For precipitation of the DNA, a 2.3 volume of 100 % ethanol was added, and the
solution was mixed by inversion before centrifugation at 10,000 rpm for 2 min. The
supernatant was carefully rejected, and the precipitated DNA pellet was left to dry at 37 °C
till complete evaporation of any residual ethanol. The pelleted DNA was dissolved in 100 µl
Materials and Methods
47
10 mM Tris-HCl (pH 7.5) containing RNaseA (10 µg/ml). The DNA concentration was
determined as in 3.2.13.6 and stored at -20 °C.
3.2.13.3 Amplification of DNA by Polymerase Chain Reaction (PCR)
DNA Polymerases DreamTaq (Fermentas) and Phusion High-Fidelity (New England
Biolabs) were used for routine PCR and cloning purposes respectively. The conditions of the
PCR and the various concentrations of components were adjusted according to the
manufacturer’s protocol for each DNA polymerase. After adjusting the annealing temperature
of the primers, the thermocycler was programmed to run the PCR cycles.
3.2.13.4 Agarose gel electrophoresis
The DNA fragments were separated according to their size by electrophoresis in 0.5-1 %
agarose gels. The required amount of agarose was dissolved in 1x TAE buffer by heating the
mixture in a microwave oven. Ethidium bromide solution was added to the agarose solution
and mixed well. This solution was poured into a gel tray. The DNA samples were mixed with
6x loading buffer (New England Biolabs) and loaded onto the solidified gel. Electrophoresis
was performed at 100 V in 1x TAE buffer. To estimate the size of nucleic acids, a 2-Log
DNA Ladder (New England Biolab) was run parallel to the samples in the same gel. A
combined system of UV-Transilluminator and gel documentation was used to visualize and
photograph the fluorescence of the DNA-bound ethidium bromide.
3.2.13.5 Purification of DNA from agarose gel
The DNA fragments of interest were excised from the gel by a clean scalpel and further
purified via the QIAquick Gel Extraction Kit according to the manufacturer’s protocol.
3.2.13.6 Measurement of DNA concentration
The concentration of the DNA was measured via the NanoDrop 1000 spectrophotometer
by measuring the absorbance at 260 nm. The purity of the DNA was determined by
calculating the ratio of absorbance at 260 nm to absorbance at 280 nm. Pure DNA has an
A260/A280 ratio of 1.7 - 1.9.
3.2.13.7 Sequencing of inserts and constructs
All vector constructs were confirmed by DNA sequencing in order to ensure correct
insertions or mutations. After isolation of the plasmid (30 µl, 250-500 ng/µl), it was sent
together with primers (5 µl, 10 pmol) spanning the target sequences either to the Eurofins
company (Ebersberg, Germany) or the GMAK sequencing service unit in HZI
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(Braunschweig, Germany) for sequencing. Tab. 3.4B shows the various primers that were
used for the sequencing of the different constructs.
3.2.13.8 Transformation of chemically competent E. coli by heat shock method
An aliquot (50 µl) of chemically competent E. coli cells (Stellar or XL1-Blue) was
transformed with the desired plasmid by heat shock. The transformation and further
cultivation procedures were performed according to the manufacturer’s instructions.
3.2.13.9 “Quick and dirty” transformation of S. cerevisiae
The “Quick and dirty” method (80) was used for the transformation of the reference strains
of S. cerevisiae BWG1-7A or BY4741 with the pYES2 vector harboring the mutated variants
of CaNIK1.
In a sterile 2 ml tube, 3 µl denatured salmon sperm DNA, 5 µl plasmid DNA (1 µg), and
100 µl yeast transformation mixture (3.1.1.4) were mixed together. A large yeast colony of
freshly growing S. cerevisiae was picked from a YDD agar plate and suspended in the
previous mixture. The cell suspension was incubated for 30 min at 37 °C with shaking at 160
rpm. The suspension was centrifuged for 5 min at 3000 rpm, and the resulting pellet was
suspended in 100 µl sterile water before being streaked on an SD-ura agar plate. The plate
was incubated for 3-4 days at 30 °C. The resulting colonies, which represented transformed
cells, were cultivated in SD-ura and then processed as in 3.2.1.
3.2.13.10 Transformation of C. albicans by electroporation
YPD (20 ml) was inoculated with 300 µl cryo-stock culture of C. albicans Sc5314 and
incubated overnight at 30 °C with shaking at 160 rpm.  A working culture (50 ml) was
prepared from the overnight culture with a starting OD620nm = 0.08 and was incubated at 30 °C
with shaking at 160 rpm. After 2:30 h, the culture (OD620nm = 0.2) was transferred into a
sterile 50 ml falcon tube and centrifuged for 5 min at 5000 rpm. The supernatant was
discarded, and the cell pellet was suspended in 8 ml sterile deionized H2O. One ml of both
10× TE buffer (pH 7.5) and 1 M lithium acetate (pH 7.5) was added, and the tube was
inverted gently for proper mixing before incubation at 30 °C with shaking at 160 rpm for 50
min. 250 µl 1 M dithiothreitol (DTT) was then added, and the tube was further incubated at
30 °C for 25 min with shaking at 160 rpm. Sterile cold deionized H2O (40 ml) was added, and
the cells were centrifuged for 5 min at 5000 rpm and 4 °C.
From this step until the end of the transformation process, the cells were always kept on
ice or at 4 °C. After centrifugation, the supernatant was discarded, and the cells were
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suspended in 25 ml sterile cold deionized H2O and centrifuged for 5 min at 5000 rpm and 4
°C (5804R, Eppendorf). After centrifugation, the supernatant was rejected, and the cells were
suspended in 1 ml sterile cold 1 M sorbitol. The suspension of cells was transferred into 2 ml
tubes (pre-cooled on ice) and centrifuged for 5 min at 5000 rpm and 4 °C. The supernatant
was discarded, and the cells were resuspended in the remaining liquid to obtain a dense
suspension (ca. 200 µl). The cell suspension (40 µl) was mixed with 5 µl of the purified DNA
fragment (at least 1 µg) that harbored the deletion cassette in a pre-cooled 2 ml tube; mock
cells (cells without DNA) were also prepared. The tubes were then immersed in ice for 5 min
before the cells were transferred into a pre-cooled electroporation cuvette (0.2 mm) that was
then placed into an Equibioelectroporator at 1.5 kV, 25 µF, 200 Ω. After electroporation, the
cuvette was placed back on ice, and immediately 1 ml YPD medium was added. The cells
were suspended by pipetting up and down. The cell suspension was then transferred into a 2
ml tube, which was incubated at 30 °C for 5 h with shaking at 160 rpm. 100 μl cell suspension
was then streaked onto a YPD agar plate containing 200 μg/ml NST. As a control, 100 µl 10-4
and 10-5 diluted cell suspension was streaked onto YPD agar plates without NST in order to
determine the number of viable cells. The remaining cell suspension was centrifuged at 5000
rpm for 2 min, and the supernatant was discarded. The cells were resuspended in the
remaining liquid and streaked onto a YPD agar plate containing 200 μg/ml NST. The plates
were incubated for 2 days at 30 °C, and the resulting colonies were analyzed by colony PCR
for the desired allelic replacement.
3.2.13.11 Restriction digestion of DNA fragments
The reaction conditions for digestion of DNA fragments with restriction enzymes (all
purchased from New England Biolabs) were as recommended by the manufacturer.
3.2.13.12 Cloning of PCR products
For ligation of the purified DNA fragments, either T4 DNA ligase (New England Biolabs)
or the In-Fusion HD Cloning Kit (Clontech) was used.
The T4 DNA ligase was used to ligate the restriction enzyme digest of pYES2 vector and
the corresponding PCR product to yield the plasmid pYES2-CaNIK1∆HAMPup.
The In-Fusion HD Cloning Kit (Fig. 3.5) enables directional cloning of one or more
fragments of DNA into vectors. The cornerstone of the In-Fusion Cloning technology is the
In-Fusion enzyme, which fuses DNA fragments e.g. PCR-generated sequences and linearized
vectors, efficiently and precisely by recognizing 15 bp overlapping sequences at their ends.
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This 15 bp overlap can be engineered by designing primers for the amplification of the
desired sequences. The guidelines of the manufacturer for the design of the primers were
followed to ensure that PCR products will be obtained containing ends that were homologous
to those of the linearized vector. The In-Fusion enzyme was used to delete the sequence
encoding all the HAMP domains in CaNIK1 (yielding the plasmid pYES2-CaNIK1∆HAMP).
In addition, it was used to construct the CaNIK1 deletion cassette in the pNIK plasmid.
Fig. 3.5: The In-Fusion HD Cloning system. A) Protocol B) Ability to ligate multiple
fragments in a single reaction (87).
3.2.13.13 QuikChange site-directed mutagenesis kit as a tool to introduce point
mutations
The QuikChange site-directed mutagenesis kit is used to introduce point mutations and to
delete or insert single or multiple amino acids. The mutagenesis is performed by using
PfuTurbo DNA polymerase and a temperature cycler. It depends on the design of primers that
contain the desired mutation and anneal to the same sequence on opposite strands of the
plasmid. The oligonucleotide primers, each complementary to opposite strands of the vector,
are extended during temperature cycling by the DNA polymerase. The use of mutagenic
primers generates a mutated plasmid containing staggered nicks. After temperature cycling,
the product is treated with DpnI. The DpnI endonuclease (target sequence: 5´-Gm6ATC-3´) is
specific for methylated and hemimethylated DNA and is used to digest the parental DNA
template and to select for mutation-containing synthesized DNA. Therefore, the DNA should
be isolated from a dam+ E. coli strain to be susceptible for DpnI digestion. The nicked vector
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DNA containing the desired mutations is then transformed into XL1-Blue supercompetent
cells.  The overall principle of the kit is illustrated in Fig. 3.6.
Fig. 3.6: Overview of the principle of the QuikChange site-directed mutagenesis kit (88).
3.2.14 Susceptibility testing of the transformed S. cerevisiae strains
The antifungal susceptibility test was carried out in sterile CytoOne 96-well plates as
illustrated in Fig. 3.7. 135 µl of SG-ura was transferred into wells of the 2nd column, whereas
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90 µl was added to wells of the 3rd to 11th column. In the 2nd column, 2 µl of the stock solution
of the antifungal in methanol was added into three repetitive wells so that the concentration of
the antifungals in the wells (135 µl SG-ura) was 2x the planed final concentration of the
antifungal. To another three wells of the 2nd column, 2 µl of methanol without antifungal (as a
control) was applied. The antifungal was serially diluted by transferring 45 µl from wells of
the 2nd column to wells of the 3rd column, mixed thoroughly by pipetting up and down 5 times
and repeating this step up to the 10th column. From the 10th column, the 45 µl was rejected so
that the 11th column received neither antifungal nor methanol.
A preculture of the transformed strain in SG-ura was prepared (3.2.5). After 2-3 h
incubation, the preculture was diluted with SG-ura to an OD620nm of 0.06, from which 90 µl
was added to all wells containing SG-ura medium, starting with the 11th column, to attain a
final OD620nm of 0.03. The plate was incubated at 30 °C with shaking at 500 rpm in a
microtiter plate shaker (Titramax 1000). After 24 h incubation, the OD620nm was measured and
the IC50 was determined.
1 2 3 4 5 6 7 8 9 10 11 12
A
B 3000 1000 333 111 37 12 4 1.3 0.47 No
antifungal
C 3000 1000 333 111 37 12 4 1.3 0.47 No
antifungal
D 3000 1000 333 111 37 12 4 1.3 0.47 No
antifungal
E
methanol
No
methanol
F
methanol
No
methanol
G
methanol
No
methanol
H
Three-fold serial dilution
Fig. 3.7: Schematic diagram illustrating the three-fold serial dilution followed for IC50
determination of antifungals. : Antifungal concentration (ng/ml) (Initial concentration is
for example 3000 ng/ml), : Control, methanol without antifungals.
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4 Results
4.1 Detection of purified CaNik1p by Coomassie staining of SDS-PAGE
and Western blot
The plasmid pYES2-CaNIK1-TAG (47) was used for the expression of the wild-type
CaNik1p protein fused to a HIS/FLAG tag at the C-terminus (Fig. 4.1). The expressed dual-
tagged CaNik1p was purified from the protein extract of strain NIK via the HIS-tag by using
Ni+2-agarose beads. The purification procedure was evaluated by separation with SDS-PAGE
followed by Coomassie staining and the purified protein was detected by Western blot with
anti-FLAG Ab (Fig. 4.2). The purified protein appeared at the expected molecular weight
(121 kDa), and the band was excised and analyzed by MALD-TOF-MS. According to a
Mascot data base search, the resulting peptide mass spectrum (Appendix II, page 98) was
identified as CaNik1p.
Fig. 4.1: Scheme of the HIS-FLAG-tagged CaNik1p. (The HIS/FLAG tag is not drawn to
scale).
Fig. 4.2: Purified CaNik1p detected by Coomassie staining of SDS-PAGE and Western blot
by using anti-FLAG Ab as indicated in A and B, respectively. M: Marker and 1: Purified
CaNik1p.
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4.2 Construction of various mutations in the CaNIK1 gene
The plasmid pYES2-CaNIK1-TAG (47) was used as a template for all mutations of the
CaNIK1 generated in the present work. All mutations and the strategies utilized for their
construction are illustrated in Fig. 4.3.
Fig. 4.3: Schematic representation of all the mutations of CaNIK1 and the strategies used in
their construction.
All point mutations in CaNIK1 were performed by using the QuikChange site-directed
Mutagenesis Kit (Strategene). Point mutations in the HisKA (H510Q), HATPase_c ((N627D)
or (G663A, G665A)) and REC (D924N) domains were constructed by using the appropriate
primers (Tab. 3.4). The design of mutagenic primers containing the desired mutations, PCR
conditions, digestion with DpnI, and transformation in competent cells were carried out
according to the manufacturer’s instructions.
Two variants of CaNik1p, from which the HAMP domains were deleted, were constructed.
The first (CaNIK1ΔHAMP) contained only a deletion of the sequence encoding HAMP
domains (63-485 aa) in CaNIK1, whereas the second (CaNIK1ΔHAMPup) contained a
deletion of the sequence encoding HAMP domains and its upstream part in CaNIK1 (1-485
aa).
For construction of the plasmid pYES2-CaNIK1ΔHAMP, the pYES2 vector was linearized
by using the restriction enzyme HindIII, and the pYES-CaNIK1-TAG plasmid was used as a
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template for amplification of the following CaNIK1 fragments. The sequence of CaNIK1
upstream of the fragment encoding the HAMP domains (1-186 bp) was amplified by using the
HMPF1 and HMPR1 primers (Tab. 3.4). HMPF1 included the homologous 15 bp stretch with
the end of the linearized vector downstream the galactose promoter. The CaNIK1 fragment
(1454-3243 bp) located downstream the sequence encoding the HAMP domains and extended
by the HIS-FLAG tag was amplified by using the HMPF2 and HMPR2 primers. HMPF2 and
HMPR2 shared 15 bp homologous stretches with the 172-186 bp fragment of CaNIK1 and
with the other end of the HindIII-linearized pYES2 vector, respectively. HindIII restriction
sites were introduced to the sequences of the HMPF1 and HMPR2 primers (Tab. 3.4). After
separation of the PCR-amplified fragments by electrophoresis (Fig. 4.4), the gel pieces
carrying the amplification products were excised, and the DNA was purified by using the
QIAquick Gel Extraction kit. The purified fragments were ligated into the HindIII-digested
pYES2 vector by using the In-Fusion enzyme according to the manufacturer’s instructions to
yield the plasmid pYES2-CaNIK1ΔHAMP.
For the construction of pYES2-CaNIK1ΔHAMPup, the CaNIK1 fragment (1454-3243 bp)
located downstream the sequence encoding the HAMP domains and extended by the HIS-
FLAG tag was amplified from pYES-CaNIK1-TAG by using the forward primer HisKF2 and
the reverse primer HisKR (Fig. 4.4). The primers HisKF2 and HisKR contained the HindIII
and XbaI restriction sites respectively. The HindIII - XbaI-restricted PCR fragment was
ligated to HindIII - XbaI-cleaved pYES2 (Fig. 4.4) to yield the plasmid pYES2-
CaNIK1ΔHAMPup .
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Fig. 4.4: Various fragments used in the construction of pYES2-CaNIK1ΔHAMP and pYES2-
CaNIK1ΔHAMPup separated by agarose gel electrophoresis.
4.3 Confirmation of the different constructed mutations of CaNIK1
4.3.1 Restriction enzyme digestion of the constructed plasmids
The integrity, correct gene insertions and insertion of mutations in the different plasmids
(Fig. 4.5) were analyzed by restriction enzyme digestion. The resulting products were
separated by gel electrophoresis (Fig. 4.6) and showed the expected bands. Final confirmation
was achieved by sequencing.
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Fig. 4.5: Maps of the various plasmids used in the transformation of S. cerevisiae.
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Fig. 4.6: Restriction digestion of the constructed plasmids containing different mutated
variants of the CaNIK1 gene.
4.3.2 Coomassie staining of SDS-PAGE of the expressed mutated variants of
CaNik1p
To check for the successful expression and purity of the mutated variants of CaNik1p,
samples resulting from protein purification procedures were separated by SDS-PAGE and
stained with Coomassie (Fig. 4.7). All protein samples showed a single band at the expected
MW except the samples containing protein with point mutations in the HATPase_c domain,
namely CaNik1p(N627D) and CaNik1p(G663A, G665A). In the respective gels (lanes 6 and
7), two bands could be seen, of which the one with the higher molecular weight was the
respective CaNik1p mutant. The smaller protein (MW 70 kDa) was identified as heat shock
protein 71 (Hsp71), also called Ssa1, by MALDI-TOF-MS analysis (Appendix II, page 99).
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Fig. 4.7:  Coomassie-stained SDS-PAGE of all the produced and purified mutated variants of
CaNik1p.
4.4 Yield of the purified CaNik1p and its mutated variants after
expression in various transformants
The expression and purification of CaNik1p and its mutated variants in various S. cerevisiae
strains were carried out according to 3.2.5 and 3.2.8, respectively. The yields of different
proteins obtained from the cell pellets of a 1 liter working cultures in SG-ura (OD620nm 0.6-
0.8) and after 5-6 h cultivation are presented in Tab. 4.1. It is obvious that expression of the
protein variants in the wild-type strain BWG1-7a resulted in yields of less than 0.1mg/l
working culture. Only from the protein being mutated in Asp924 (CaNik1p(D924N)) a
significantly higher amount could be obtained (0.5 mg/l). We wondered whether the
expression of a second HK in S. cerevisiae might be down regulated by the HOG pathway or
the MAP kinase Hog1p and used the single gene deletion mutant Δhog of S. cerevisiae as a
host for protein expression. Indeed, the yields of all proteins could significantly be increased,
reaching almost 1 mg/l for the wild-type protein and the mutated protein CaNik1p(H510Q).
Therefore, when high yields of purified proteins were required, e.g. for further in vitro kinase
assays with the purified proteins, the deletion mutant Δhog was used as host for protein
expression.
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Tab. 4.1: The yield of various proteins expressed in various strains of S. cerevisiae. The yield
values are the average of three independent experiments. (ND: Not done)
4.5 Susceptibility testing of the constructed mutants against various
antifungals
We had previously shown that S. cerevisiae became susceptible to the selected antifungals,
when CaNik1p was heterologously expressed (47). Thus we investigated the antifungal
susceptibility of S. cerevisiae transformants, in which CaNIK1 mutated variants were
expressed.
The S. cerevisiae transformants were treated with various concentrations of the antifungals
fludioxonil, iprodione and ambruticin VS3. As shown in Fig. 4.8, the strain (YES)
transformed with the empty vector was resistant to all fungicides, whereas strain NIK was
susceptible to the selected antifungals. The H510Q and D924N point mutations in the HisKA
and REC domains, respectively, led to complete loss of susceptibility as indicated in strains
H510 and D924. Although the N627D replacement in the HATPase_c domain (strain N627)
decreased partially the fungicide susceptibility in comparison with the strain NIK, the double
point mutations (G663A, G665A) were also associated with complete loss of susceptibility to
the tested antifungals (strain G1). The IC50 values of the different antifungals are listed in
Tab. 4.2.. The IC50 is defined as the concentration of the antimicrobial agent at which the
growth of the culture is reduced to 50 % in comparison to the untreated culture.
Yield (mg/l working culture) of various proteins expressed in S. cerevisiae
Protein
Strain transformed with plasmid harboring the
CaNIK1 or one of its mutated variants
BWG1-7a Δhog
CaNik1p 0.09 0.85
CaNik1p(H510Q) 0.052 1.02
CaNik1p(D924N) 0.54 ND
CaNik1p(N627D) 0.008 0.052
CaNik1p(G663A,G665A) 0.008 0.06
CaNik1p(H510Q, D924N) ND 1
CaNik1p∆HAMP ND 0.2
CaNik1p∆HAMP(H510Q) 0.13 ND
CaNik1p∆HAMPup ND 0.24
CaNik1p∆HAMPup(H510Q) 0.06 ND
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Fig. 4.8: Susceptibility of S. cerevisiae strains transformed with various mutants of CaNIK1 to
different antifungals.
Antifungal IC50 (ng/ml) for S. cerevisiae transformed with
pYES2-CaNIK1-TAG pYES2-CaNIK1(N627D)
Fludioxonil 220 2616
Ambruticin VS3 19 824
Iprodione 190 2478
Tab. 4.2: The IC50 (ng/ml) of the antifungals tested against various transformants of S.
cerevisiae. The other transformants were totally resistant, even at the highest concentrations
of the tested antifungals as shown in Fig. 4.8.
4.6 Functional HisKA, HATPase_c and REC domains are essential for the
phosphorylation of the Hog1p after fludioxonil treatment
Treatment with fludioxonil led to phosphorylation of the MAPK Hog1p, i.e., to the
activation of the Hog1 MAPK module, in S. cerevisiae transformed with full–length and
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truncated forms of the CaNIK1 gene (47). Therefore, phosphorylation of Hog1p was also
analyzed after fludioxonil treatment (10 µg/ml for 15 min) of S. cerevisiae transformed with
the CaNIK1 gene carrying the H510Q, N627D and D924N point mutations. To establish the
functionality of the HOG pathway in the tested transformants, sorbitol (1 M) was used as a
positive control, since it is known to stimulate phosphorylation of the MAPK Hog1p via the
induction of osmotic stress (89). The results (Fig. 4.9) demonstrated the complete abolishment
of the phosphorylation of Hog1p in S. cerevisiae transformants carrying the D924N and the
H510Q point mutations of the CaNIK1 gene, whereas only a partial loss of the
phosphorylation was observed in the transformant having the N627D substitution. Treatment
of the transformants with 1 M sorbitol was associated with the phosphorylation of Hog1p
thereby indicating the functionality of the HOG pathway in these transformants.
Fig. 4.9: Detection of phosphorylation of Hog1p by Western blot after treatment of various
transformants with fludioxonil. Phosphorylation of Hog1p (upper panel, Hog1-P) is examined
after treatment of strains YES, NIK, N627, D924 and H510 with fludioxonil (10 µg/ml) and
sorbitol (1 M). Total Hog1p (lower panel, Hog1) was also detected. Hog1p appears at a site
corresponding to 50 kDa.
4.7 Saturation Transfer Difference-NMR (STD-NMR) confirms the direct
interaction between the CaNik1p and fludioxonil
The NMR spectrum of a saturated solution of fludioxonil in deuterated DMSO was
recorded after the addition of various concentrations of the purified CaNik1p. Fig. 4.10 shows
the characteristic chemical shifts of the aromatic protons of fludioxonil in the region between
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7.1 and 7.6 ppm. The intensities of the fludioxonil peaks decreased proportionally according
to the increase in the concentration of the purified CaNik1p in comparison with the spectrum
of the sample containing fludioxonil together with the flow-through from CaNik1p
ultrafiltration. This indicated the direct interaction between the compound and the protein.
Fig. 4.10: STD-NMR spectrum showing the interaction of fludioxonil with various
concentrations of purified CaNik1p.
4.8 In vitro kinase assay of purified CaNik1p and its mutated variants
4.8.1 Kinase-Glo Plus kit
The kinase activity of the purified CaNik1p and its mutated variants was determined by
using the Kinase-Glo Plus kit as shown in Fig. 4.11. The luminescence of the samples that
contained no proteins but flow-through buffer was set as 100 %, as no ATP was consumed in
these samples.  The kinase activity of the various purified proteins was indicated by a
decrease of the ATP concentration, which resulted in decreased luminescence. From Fig. 4.11,
it can be observed that all proteins possessed kinase activity. In comparison with CaNik1p, the
kinase activity of CaNik1p(D924N) was decreased, whereas that of CaNik1p∆HAMP was
increased by more than two-fold. Surprisingly, the point mutation H510Q in the HisKA
domain slightly decreased the kinase activity of CaNik1p, whereas the point mutation N627D
in the HATPase_c domain increased the kinase activity to a similar level as was observed for
CaNik1p∆HAMP.
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Fig. 4.11: Assay of the kinase activity of the purified CaNik1p and its mutated variants using
Kinase-Glo Plus kit.
4.8.2 Detection of the autophosphorylation of the protein via radiolabeled [γ-32P]
ATP
As the Kinase-Glo plus assay is based on the detection of the consumption of the substrate,
but not of the formation of a product, we performed kinase assays with the purified CaNik1p
and its mutated variants with radiolabeled [γ-32P] ATP. After scanning of the gel-exposed
phosphor screens with the phosphorimage analyzer, the autophosphorylation was detected via
the appearance of radioactive bands indicating the incorporation of the radiolabeled phosphate
in the protein. Heat denatured protein was used as negative control. As shown in Fig. 4.12A,
the autophosphorylation of the CaNik1p (lane 1) could be detected in comparison with the
heat denatured CaNik1p, which showed no radioactive bands (lane 2). All point-mutated
variants of CaNik1p ((H510Q), (N627D), and (D924N)) still showed autophosphorylation.
Unexpectedly, even a double mutation in the conserved phosphorylatable residues, His510
and Asp924, did not inhibit the autophosphorylation of the protein (CaNik1p (H510Q,
D924N)). Also the protein which was mutated in the G1 box of the HATPase_c domain
(CaNik1p(G663A, G665A)) was still able to undergo autophosphorylation (Fig. 4.12B).
Deletion of HAMP domains did not inhibit the autophosphorylation of the protein, even
after an additional point mutation in H510 (Fig. 4.12C). Thus, the autophosphorylation of the
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purified proteins did not correlate with the antifungal susceptibility of the respective S.
cerevisiae transformants.
Fig. 4.12: Detection of the autophosphorylation of the purified CaNik1p and its mutated
variants using radiolabeled [γ-32P] ATP.
4.8.3 Effect of fludioxonil on the in vitro kinase activity of the purified CaNik1p
4.8.3.1 Kinase-Glo Plus kit
The effect of fludioxonil on the kinase activity of CaNik1p was investigated by using the
Kinase-Glo Plus kit. The luminescence of the samples that contained no proteins but flow-
through buffer and DMSO (the solvent of fludioxonil) was set as 100 % luminescence, as no
ATP was consumed in such samples. Fludioxonil was incubated with CaNik1p for 30 min at
30 °C before starting the kinase reaction by addition of ATP and further incubation at 30 °C
for 2:30 h. In comparison with the luminescence obtained from the kinase reaction containing
CaNik1p and DMSO, the luminescence of the kinase reaction was not affected after
incubation of the protein with fludioxonil at a final concentration of 10 µg/ml (40 µM) (Fig.
4.13). This indicates that fludioxonil does not interfere with the in vitro kinase activity of
CaNik1p.
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Fig. 4.13: Determination of the effect of fludioxonil on the kinase activity of purified
CaNik1p using Kinase-Glo Plus kit.
4.8.3.2 Radiolabeled [γ-32P] ATP
The effect of fludioxonil on the autophosphorylation of CaNik1p was also investigated via the
detection of phosphorylated protein after incubation with radiolabeled [γ-32P] ATP.
Fludioxonil was incubated with CaNik1p at 30 °C for 30 min before starting the kinase
reaction by addition of both cold and hot ATP and further incubation at 30 °C for 1 h. As
demonstrated in Fig. 4.14, the intensity of the radioactive bands in the sample containing
CaNik1p and DMSO (the intensity indicates the incorporation of the radiolabeled phosphate
in the protein via the kinase reaction) was not affected by the incubation of the protein with
fludioxonil at a final concentration of 10 µg/ml. This shows that fludioxonil does not interfere
with the autophosphorylation of CaNik1p.
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Fig. 4.14: Determination of the effect of fludioxonil on the autophosphorylation of the
purified CaNik1p using radiolabeled [γ-32P] ATP.
4.9 LC-MS/MS peptide analysis showed that the Ser1071 is
autophosphorylated
The possibility of the phosphorylation of residues other than H510 and Asp924 in CaNik1p
was investigated by LC-MS/MS peptide analysis. The purified CaNik1p (1.5 µg, 1.25 µM)
was incubated in 10 µl kinase buffer A at 30 °C, either with or without 20 µM ATP. After
2:30 h, the kinase reaction was terminated by boiling at 95 °C with 5x Laemmli buffer. Both
protein samples were then separated by SDS-PAGE, and bands of the protein at the expected
MW were excised and sent for LC-MS/MS peptide analysis as mentioned in 3.2.10.
The analysis of the possible phosphorylation of the different residues in the various
peptides was performed by Dr. Josef Wissing and Dr. Manfred Nimtz (Cellular Proteome
Research unit, HZI). Only Ser1071 (Fig. 4.15) was identified as being phosphorylated with a
probability of more than 99.1 %. However this phosphorylation was not dependent on the
presence of ATP. It has to be taken into account that sample pretreatment includes treatment
with acidic solution. Under these conditions, phosphorylated histidine or aspartic acid is not
stable and thus the phosphorylated state of these residues cannot be evaluated by the applied
method.
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Fig. 4.15: Schematic diagram of CaNik1p and its corresponding sequence indicating the
conserved phosphorylatable residues and the newly identified Ser1071.
4.10 Deletion of HAMP domains from CaNik1p
4.10.1 Deletion of HAMP domains in the transformants led to growth inhibition
that could be reversed by point mutation of the His510
Transforming S. cerevisiae with CaNIK1 variants in which all the HAMP domains were
deleted resulted in the ΔHa and ΔHupa strains which were able to grow on SD-ura agar
plates, where expression of the mutated variants of CaNik1p proteins is not induced (Fig.
4.16). Surprisingly no growth was observed on SG-ura plates on which galactose induced the
expression of the CaNik1pΔHAMPup and CaNik1pΔHAMP (Fig. 4.16), whereas deletion of
two pairs of HAMP domains did not affect the growth of the transformed strain ΔH3H4 (47)
(Fig. 4.16B). Additional inactivation of the HisKA domain by the H510Q point mutation
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restored normal growth of the resultant transformed strains ΔHaH510 and ΔHupaH510 (Fig.
4.16).
Fig. 4.16: Growth inhibitory effect resulting from the expression of CaNik1p∆HAMPup and
CaNik1p∆HAMP in the transformed S. cerevisiae could be reversed by the additional point
mutation H510Q, as shown in A and B, respectively. Strains BWG1-7a, YES, NIK, ∆Hupa,
∆HupaH510, ∆Ha, ∆HaH510, and ∆H3H4 were streaked on SD-ura and SG-ura agar plates
and incubated at 30 °C for 4 days. SG-ura induces the expression of the transgenes via the
galactose promoter. Strain BWG1-7a is the reference strain, which is auxotrophic for uracil.
4.10.2 The growth inhibitory effect could be reversed in the deletion mutants of
the response regulator Ssk1p and components of the Hog1 MAPK module
Transformation of S. cerevisiae strains, in which individual genes are deleted that either
encode the RR Ssk1p (strain Δssk1), or one of the components of the Hog1 MAPK module,
such as the MAP2K Pbs2p (strain Δpbs2) and the MAPK Hog1p (strain Δhog) with the
plasmids pYES2-CaNIK1ΔHAMPup and pYES2-CaNIK1ΔHAMP restored normal growth
on SG-ura plates (Fig. 4.17A and Fig. 4.17B). The reference strain for such mutants was
BY4741. Therefore, as a control, this strain was also transformed with the plasmids pYES2-
CaNIK1ΔHAMPup (strain ΔHupb) and pYES2-CaNIK1ΔHAMP (strain ΔHb). Following
transformation, the strain showed the same phenotype (Fig. 4.17) as that observed with the
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reference strain BWG1-7a in Fig. 4.16. In addition, simultaneous H510Q point mutation
restored normal growth of the resultant transformed strains ΔHbH510 and ΔHupbH510 (Fig.
4.17).
Fig. 4.17: Growth inhibitory effect resulting from the deletion of HAMP domains could be
reversed by transforming S. cerevisiae containing single gene deletion mutants in one of the
components of the Hog1 MAPK module or in the RR SSK1. A and B present transformants
with the plasmids pYES2-CaNIK1ΔHAMPup and pYES2-CaNIK1ΔHAMP, respectively.
Strains BY4741, ∆Hupb∆hog, ∆Hupb∆pbs2, ∆Hupb∆ssk1, ∆HupbH510, ∆Hupb, ∆Hb∆hog,
∆Hb∆pbs2, ∆Hb∆ssk1, ∆HbH510, and ∆Hb were streaked onto SD-ura and SG-ura agar
plates and incubated at 30 °C for 4 days. BY4741 is the reference strain, which is auxotrophic
for uracil.
4.10.3 Expression of CaNiK1pHAMP leads to constitutive phosphorylation of
the Hog1p
To analyze further the involvement of Hog1p activity in the growth inhibitory effect
associated with the induction of expression of CaNik1pΔHAMP, the phosphorylation state of
Hog1p was investigated. Because of the growth inhibitory effect of CaNik1pΔHAMP
expression, the transformant ΔHa was first cultivated on the glucose–containing medium SD-
ura, which does not induce CaNik1pΔHAMP expression, in order to produce sufficient
biomass for protein analysis. Subsequently, the expression of CaNik1pΔHAMP was induced
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by incubating the cells in the galactose–containing medium SG-ura. Gene expression and
protein synthesis were allowed to occur for 180 min before fludioxonil was added. Expression
of CaNik1pΔHAMP was established by Western blot (Fig. 4.18). Phosphorylation of Hog1p
was examined after another 15 min and 30 min (in total 195 min and 210 min respectively)
(Fig. 4.19). After fludioxonil treatment, phosphorylation of Hog1p was observed in the
transformant NIK1 carrying the full-length protein and in the transformant ΔHa, whereas no
phosphorylation was detected in the strains with the empty plasmid (YES) or with the
additional H510Q mutation (ΔHaH510). Hog1p was phosphorylated in the transformant ΔHa,
even without the presence of fludioxonil, whereas such constitutive phosphorylation was not
observed in the transformants NIK and ΔHaH510 (Fig. 4.19).
Fig. 4.18: Confirming the expression of CaNik1p∆HAMP from strain ∆Ha after cultivation in
SG-ura by Western blot. The expressed CaNik1p, CaNik1p∆HAMP, and
CaNik1p∆HAMP(H510Q) in the isolated protein extracts from the strains NIK, ∆Ha, and
∆HaH510, respectively, were detected by Western blot by using an anti-Flag antibody. The
strains were cultivated in SG-ura for 180 min. CaNik1p, CaNik1p∆HAMP, and
CaNik1p∆HAMP(H510Q) appear at sites corresponding to 121, 75, and 75 kDa, respectively.
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Fig. 4.19: Detection of phosphorylation of Hog1p by Western blot in the strain ΔHa. The
phosphorylation of Hog1p (upper panel, Hog1-P) was detected in strains YES, NIK, ΔHa, and
ΔHaH510 after cultivation in SG-ura for 195 and 210 min.  Fludioxonil was added after 180
min at a final concentration of 10 µg/ml. Total Hog1p (lower panel) was also detected. Hog1p
appears at a site corresponding to 50 kDa.
4.11 Deletion and reintegration of the CaNIK1 gene in C. albicans Sc5314
4.11.1 Construction of the CaNIK1 deletion cassette
The SAT1 flipper cassette (Fig. 4.20A) was used in the construction of the CaNIK1
deletion cassette (Fig. 4.20C). Basically, the upstream (-448 to -1) and downstream (+3247 to
+3750) sequences flanking CaNIK1 (+1 to +3246) (Fig. 4.20B) were amplified by PCR from
the genomic DNA of Sc5314 and ligated to the SAT1 flipper cassette via the In-Fusion
cloning enzyme.
Fig. 4.20: Schematic representation of the design of the CaNIK1 deletion cassette.
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The plasmid pSFS2A (Fig. 4.21) was digested with KpnI, ApaI and SacII to yield the SAT1
flipper cassette and the remaining backbone of the pSFS2A plasmid. The CaNIK1-upstream
sequence was amplified with the primers F1NIK and R1bNIK, which share 15 bp of
homology with the ends of the KpnI- and ApaI-restricted pSFS2A, respectively. The CaNIK1-
downstream sequence was amplified with the primers F2NIK and R2NIK, which included 15
bp of overlap with both termini of the SacII-digested pSFS2A.
The PCR fragments representing the CaNIK1-upstream and -downstream sequences were
purified from the agarose gel (Fig. 4.22) and ligated with the two fragments resulting from
digestion of pSFS2A with KpnI, ApaI and SacII via the In-Fusion enzyme to yield the
plasmid pNIK (Fig. 4.21).
Fig. 4.21: Maps of the pSFS2A and pNIK plasmids.
Fig. 4.22: PCR-amplified CaNIK1-upstream and -downstream flanking sequences that were
used for construction of the CaNIK1 deletion cassette.
Results
74
4.11.2 Confirmation of the constructed plasmid pNIK by restriction digestion
The constructed plasmid pNIK (Fig. 4.21) which comprises the CaNIK1 deletion cassette
was confirmed with regard to its integrity and correct insertion via digestion with KpnI and
SacI (Fig. 4.23). Subsequently, it was further confirmed by sequencing.
Fig. 4.23: Restriction digestion of the plasmid pNIK in comparison with pSFS2A.
4.11.3 Integration of the CaNIK1 deletion cassette into the genome of C. albicans
Sc5314
The SAT1 flipper cassette (74) was used as basis for the construction of the CaNIK1
deletion cassette (as indicated in 4.11.1). The principle of the cassette is shown in Fig. 4.24.
The SAT1-flipping strategy allows gene deletion in prototrophic C. albicans wild-type strains
with the help of a recyclable dominant selection marker. The SAT1 flipper cassette consists of
the caSAT1 marker, which confers resistance to the antibiotic NST, and the caFLP gene,
which encodes the site-specific recombinase FLP. The addition of flanking sequences of the
target gene allows specific genomic insertion of the SAT1 flipper cassette by homologous
recombination (Fig. 4.24A) and selection of NST-resistant transformants, which are able to
grow in the presence of high concentration of NST (200 µg/ml). Expression of the FLP
recombinase results in the subsequent excision of the cassette, which is bordered by direct
repeats of the FLP recognition sequence FRT, from the genome of the wild-type strain (Fig.
4.24B). Therefore, the cells that undergo flip excision will grow slowly (NST-sensitive), as
small colonies, on YPD agar plates containing a low concentration of NST (≤ 20 µg/ml) in
comparison with the cells that do not undergo flip excision and will grow as large colonies
Results
75
(NST resistant). The heterozygous mutant (NST sensitive) can then be used for a second
round of gene deletion (Fig. 4.24C). The homozygous mutant (Fig. 4.24D) obtained after two
rounds of insertions and recycling of the SAT1 flipper cassette differs from the wild-type
parental strain only by the absence of the target gene and can be used for the inactivation of
additional genes and the generation of complemented strains by using the same strategy (74).
Fig. 4.24: The principle of deletion of the CaNIK1 gene in the wild strain Sc5314 using the
SAT1 flipper method. The expected sizes after PCR amplification of the genomic DNA of the
wild strain Sc5314 and the resulting mutants using the primers F1NIK and R2NIK are given
on the right side.
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The wild strain Sc5314 was transformed by electroporation with the CaNIK1 deletion
cassette that was obtained by digestion of the plasmid pNIK with KpnI and SacI. The
electroporated cells were spread on YPD agar plates containing 200 µg/ml NST as a selection
marker. After 2 days of incubation, some of the resulting colonies were analyzed by colony
PCR with the primers F1NIK and R2NIK to check whether the CaNIK1 deletion cassette had
been integrated successfully into the CaNIK1 gene (Fig. 4.25). PCR showed that the colony
NIKd underwent integration in a single allele, whereas the colonies NIKa and NIKc appeared
to undergo integration in both alleles of the CaNIK1 gene in a single step. On the other hand,
the colony NIKb did not undergo homologous recombination.
Fig. 4.25: Colony PCR of electroporated Sc5314 with the CaNIK1 deletion cassette after
growing on NST-YPD agar plates (200 µg/ml).
4.11.4 Excision of the SAT1 flipper cassette
In the SAT1 flipper cassette, the site-specific recombinase FLP is under the control of the
inducible promoter MAL2. Therefore, for the recycling of the SAT1 flipper cassette (Fig.
4.24B and D), the transformants should be cultivated in YPM medium that contains maltose
instead of glucose. However, the MAL2 promoter is leaky, and the FLP recombinase is also
expressed in YPD medium (74). Therefore, recycling of the SAT1 flipper cassette can also be
achieved by growing the transformants overnight in YPD medium without selective pressure
(74).
Colonies NIKa and NIKd were selected for further genetic manipulation. For recycling of
the SAT1 flipper cassette, the transformant NIKd was cultivated in YPD medium overnight
and the cells were streaked on YPD agar plates containing various concentrations of NST (20,
10, 5 µg/ml) before incubation at 30 °C for 2 days. Small colonies (NST sensitive), which
should represent the cells that had undergone flip excision, could be observed only on the
NST plates at 10 and 5 µg/ml, whereas that of 20 µg/ml showed only large colonies.  Several
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small colonies (NIKd1-NIKd10) were selected from the NST plates (10 µg/ml) (Fig. 4.26)
and analyzed by colony PCR for the induction of the FLP recombinase by using the primer
sets (F1NIK and R2NIK) and (F1SAT and R1SAT). As shown in Fig. 4.27A, only one colony
(NIKd1) underwent flip excision. However, the colony still contained the SAT1 flipper
cassette. Moreover, and confirming these result, the colony NIKd1 was able to grow either on
solid or in liquid YPD medium containing NST at a concentration of 200 µg/ml.
Fig. 4.26: Selection and screening for NST-sensitive C. albicans transformants in which the
SAT1 flipper cassette was excised by FLP-mediated recombination. The plate shows large
colonies of NST-resistant transformant and small colonies of NST-sensitive derivatives
(indicated by arrows) which, after the induction of FLP expression, were grown for 2 days at
30 °C on a YPD plate containing 10 µg/ml NST.
For the recycling of the SAT1 flipper cassette in the transformant NIKa, the transformant
was cultivated in YPD medium in 5 repetitive overnight cultures (each overnight culture was
prepared from the previous one), and finally the cells were streaked on YPD agar plates
containing various concentrations of NST (5, 10, 20 µg/ml) before incubation at 30°C for 2
days. These consecutive overnight cultures were essential to ensure that the flip excision
occurred in both alleles of the transformant. No colonies were observed on the NST plates at
10 and 20 µg/ml, whereas several small colonies could be observed on the NST plate at 5
µg/ml. A single colony (NIKhom2) was selected for further analysis. The cells of NIKhom2
were unable to grow in the presence of a high concentration of NST (200 µg/ ml). In addition,
PCR analysis (Fig. 4.27B) revealed the successful recycling of the SAT1 flipper in both copies
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of the integrated CaNIK1 deletion cassette. Therefore, the NIKhom2 mutant could be used for
further complementation analysis of CaNIK1 and its mutated variants.
Fig. 4.27: PCR screening of NST-sensitive derivatives that underwent FLIP excision after
growing colonies NIKd (A) and NIKa (B) in YPD medium without selective pressure. The
expected sizes when using the set of primers F1NIK and R2NIK are illustrated in Fig. 4.24,
whereas for F1SAT and R1SAT it is 3768 bp.
4.11.5 Reintegration of CaNIK1 and some of its mutated variants
To study the effect of the (H510Q) mutation and deletion of HAMP domains of the
CaNIK1 gene in C. albicans, we planned to construct CaNIK1 reintegration cassettes. These
cassettes should have contained the CaNIK1-tagged gene and its mutated variants that could
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be PCR amplified from the different plasmids that harbored different mutations of the
CaNIK1 and were used in the transformation of S. cerevisiae.
The SAT1 flipper cassette was used for the construction of the reintegration cassettes of
CaNIK1 and its mutated variants. These could be used for complementation of the CaNIK1
(Fig. 4.28) or incorporation of its mutated variants into the homozygous mutant of CaNIK1
(NIKhom2).
Fig. 4.28: Schematic representation of the planned reintegration of CaNIK1-TAG into the
genome of the homozygous deletion mutant of CaNIK1.
To construct the CaNIK1-TAG reintegration cassette, the SAT1 cassette should be flanked
from the upstream side by both the CaNIK1 gene in addition to its upstream sequence and
from the downstream side by the downstream sequence of the CaNIK1 gene as shown in Fig.
4.28A.
The whole pNIK was amplified by PCR by using the primers F4NIK and R3NIK (Fig.
4.29A, Fig. 4.30A). R3NIK had an additional 15 bp of homology to the first 15 bp of the
CaNIK1 gene. CaNIK1-TAG, CaNIK1(H510Q), and CaNIK1∆HAMP were amplified from
the plasmids pYES2-CaNIK1-TAG, pYES2-CaNIK1(H510Q), and pYES2-CaNIK1∆HAMP,
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respectively, by using the primers F3NIK and R5NIK (Fig. 4.29B and C). The primer R5NIK
shared 15 bp of homology with the F4NIK primer.
Fig. 4.29: PCR amplification of various fragments required to construct the integration
cassettes of the CaNIK1-TAG and its mutated variants. The primers used for the PCR were
F4NIK and R3NIK for sample in gel A, whereas F3NIK and R5NIK were used for samples in
gel B and C.
To construct the plasmid that would contain the reintegration cassettes (Fig. 4.30B), the In-
Fusion enzyme was used to ligate the PCR amplified pNIK with CaNIK1-TAG. Before fusion
of the previous fragments, digestion of the PCR amplified pNIK with DpnI was performed to
avoid interference in the transformation of the competent cells from the pNIK that was used
as template in the PCR. After incubation of the DNA fragments with the In-Fusion enzyme,
the mixture was used to transform Stellar competent E. coli cells and the transformed cells
were streaked on LB agar plates containing chloramphenicol (170 µg/ml). Some of the
resulting colonies were cultivated in LB medium containing chloramphenicol (170 µg/ml),
and plasmids were isolated from the overnight cultures and digested with KpnI and SacI to
test for successful ligation of the fragments with In-Fusion enzyme. Analysis of the plasmids
by restriction enzyme digestion (Fig. 4.31) showed that the ligation was unsuccessful, in
addition the resulting colonies, represented cells that were transformed with DpnI-undigested
pNIK.
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Fig. 4.30: Map of pNIK showing the binding sites of the primers F4NIK and R3NIK and map
of the plasmids supposed to harbor the CaNIK1 reintegration cassettes as indicated in A and
B, respectively.
Fig. 4.31: Restriction enzyme digestion of plasmids supposed to contain the CaNIK1-TAG
reintegration cassettes.
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5 Discussion
5.1 Relevance of constructing mutations in the heterologously expressed
CaNik1p
The sensitivity of C. albicans to the antifungals targeting the Hog1 MAPK module
depends on the genetic background of the strain. Janine Wesolowski showed that strain
CAF2-1 was resistant to these fungicides, whereas strain 1386 was sensitive to the tested
antifungals (90). This could be explained by the development of resistance to these
antifungals (91).
Because of the diploid nature of C. albicans, targeted point mutations or deletions of
defined protein domains still represent a technical challenge. As S. cerevisiae acquires
susceptibility to various antifungals when transformed with a plasmid encoding CaNIK1, this
has encouraged further use of the same transfectant as a model organism to investigate the
involvement of various CaNik1p domains in fungicidal activity. To achieve this goal, point
mutations were introduced in the HisKA, HATPase_c, and REC domains of CaNik1p. In
addition, a deletion mutant for all HAMP domains was generated. The plasmids harboring the
mutated variants of CaNIK1 were used to transform S. cerevisiae followed by testing viability
and determining sensitivity to fungicides and phosphorylation of the MAPK Hog1p upon
fungicidal treatment.
5.2 Effect of point mutations of the heterologously expressed CaNik1p
5.2.1 Sensitivity of the transformants to the antifungals
We previously showed that expression of the group III HK from the human fungal
pathogen C. albicans, CaNIK1, in S. cerevisiae resulted in susceptibility of the transformants
to the fungicides fludioxonil, iprodione, and ambruticin VS3 (47). For other group III HKs,
mutations in the conserved phosphate-accepting residues of the HisKA and the REC domains
had previously been shown to confer fungicide resistance (46, 48). Thus, we were interested
to investigate the role of the HisKA, HATPase_c, and REC domains from CaNik1p in
fungicide activity, since they are conserved in all HKs. However, only class III HKs were
found to be important for fungicide activity.
To prevent the primary phosphorylation of the histidine residue and the subsequent His-
Asp phosphate-transfer in the HisKA and the REC domains, respectively, the point mutations
H510Q and D924N were generated. The N627D mutation and the (G663A, G665A) double
mutation were supposed to inactivate the ATP-binding site (HATPase_c). The obtained
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results were in agreement with those obtained from other group III HKs, as the functionality
of the above-mentioned domains was essential for the sensitivity of the transformed yeast for
the tested fungicides, as demonstrated by the complete resistance of strains H510 and D924 in
comparison with strain NIK and by the reduced or complete loss of the fungicidal sensitivity
of strains N627 and G1. The single replacement of the Asn residue in the N box appears to be
insufficient to completely inhibit ATP binding, contrary to the double mutation of the Gly
residues in the G1 box.
5.2.2 Phosphorylation of the Hog1p after treatment of the transformants with
fludioxonil
In agreement with the fungicidal susceptibility of the various constructed transformants,
similar patterns of Hog1p phosphorylation were obtained after treatment of such
transformants with fludioxonil. Phosphorylation was totally abolished in strains H510 and
D924 and partially inhibited in strain N627. We present clear evidence that the conserved
phosphorylatable residues of CaNik1p, His510, and Asp924 are essential for fungicidal
activity and for the activation of the Hog1 MAPK module resulting from treatment with
fungicide.
5.3 The direct interaction of fludioxonil with the CaNik1p
Heterologous functional expression of CaNik1p and other group III HKs enabled the
transfer of fungicidal sensitivity to S. cerevisiae establishing the essential role of this class of
HKs for antifungal activity (45-48). However, no clarification had been obtained as to
whether group III HKs are the direct targets of the fungicides or mediators of their action,
leading finally to the activation of the Hog1 MAPK module and the accumulation of
intracellular glycerol in the absence of high external osmolarity, followed by cell bursting (44,
48). We studied the interaction between the protein and the fungicide fludioxonil by STD-
NMR. Discussions with the Dept. of Structural Biology (Prof. Dr. Christiane Ritter) had
revealed that this would be the most suitable method because of the size of the protein (121
kDa). The intensities of the characteristic peaks of the aromatic protons of fludioxonil
decreased proportionally to the increase of the purified CaNik1p concentration. This can only
be explained by a direct interaction between the compound and the protein. Thus, for the first
time, CaNik1p, as a member of group III HKs, has been experimentally confirmed as being a
direct target for fludioxonil, as an example for antifungals activating the Hog1 MAPK
module.
Discussion
84
5.4 Effect of mutations and incubation with fludioxonil on the in vitro
kinase activity of the purified CaNik1p
We analyzed the kinase activity of CaNik1p for two reasons. First, to establish
experimentally that the conserved phosphorylatable residues of HisKA (His510) and REC
(Asp924) domains are essential for the phosphorylation of CaNik1p and further to correlate
such results with data obtained from the fungicidal susceptibility of the transformants that
express the corresponding mutated variants of CaNik1p. Second, we wanted to investigate the
way that fludioxonil affected the kinase activity of CaNik1p, particularly after observing the
direct interaction of the fungicide with purified CaNik1p via STD-NMR. However,
biochemical analysis of phosphorelay signaling is more problematic than that of conventional
protein kinase signaling systems, because the phosphorylated histidine and aspartate residues
are unstable (92). As a consequence, no progress has been made in the production of anti-
phosphohistidine or anti-phosphoaspartate antibodies that can be used in Western blots for the
detection of proteins phosphorylated at these residues (92). Therefore, we decided to analyze
the kinase activity of the purified CaNik1p and its mutated variants after heterologous
expression through in vitro methods, either by using the Kinase-Glo plus kit or via incubation
with radiolabeled [γ-32P] ATP.
Indeed, the in vitro kinase activity of group III kinase DhNik1p from Debaryomyces
hansenii has previously been investigated by using Kinase-Glo plus kit (93). However, no
confirmation has been experimentally obtained, for any of the fungal group III HKs, that the
conserved phosphorylatable residues of the HisKA (His residue) and the REC (Asp residue)
domains are really the only residues that can be phosphorylated in the protein.
ATP concentrations are determined with the Kinase-Glo plus kit. As ATP concentrations
decrease with increasing kinase activity, the resulting data are correlated to the enzyme
activity. However, they can be falsified by any other ATP-consuming reaction, i.e., ATPase
activity. Therefore, we have also used radioactively labeled ATP as a substrate, so that the
radioactive phosphate group is incorporated into the protein, and the formation of specific
reaction products can be observed. As group III HKs dimerize and autophosphorylate, no
additional protein substrate is required.
Results obtained from both the Kinase-Glo plus kit or after incubation with the
radiolabeled [γ-32P] ATP were in agreement. The kinase activity of the purified CaNik1p was
successfully detected by both methods. Unexpectedly, the protein mutated at His510 still
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possessed kinase activity. Even the CaNik1p(H510Q, D924N) double mutant with the
additional substitution of the other possible phosphorylatable residue (Asp924) was still able
to undergo autophosphorylation as indicated after incubation with the radiolabeled [γ-32P]
ATP. Nevertheless, these data do not eliminate the possibility that they are not
phosphoaccepting residues in the protein, since additional residues might contribute to the
kinase activity of the protein and have not been identified by former researchers.
Surprisingly, kinase activity can still be detected for the proteins CaNik1p(N627D),
detected by both methods, and CaNik1p(G633A, G665A), after incubation with the
radiolabeled [γ-32P] ATP. However, the presence of the Hsp71 protein as dominant interacting
protein with any of the mutants of the HATPase_c domain might explain some of these
results. The ATPase activity of Hsp71 (94) could be the reason that the consumption of ATP
is tremendously increased when the in vitro kinase activity of CaNik1p(N627D) is detected
via the Kinase-Glo plus kit. Nonetheless, the ability of the HATPase_c-mutated variants of
CaNik1p to undergo autophosphorylation after incubation with the radiolabeled [γ-32P] ATP
is still unclear. We cannot account for it by the partial inhibition of the ATP-binding domain,
since the autophosphorylation of CaNik1p(N627D) is obviously enhanced in comparison with
the wild-type CaNik1p after incubation with the radiolabeled [γ-32P] ATP.
The deletion of HAMP domains was also associated with the enhancement of kinase
activity of CaNik1p∆HAMP, by more than two-fold in comparison with CaNik1p, as
indicated by data obtained by the Kinase-Glo plus kit. An explanation for this result is a
possible HAMP domain–mediated negative regulation of the kinase activity of CaNik1p. In
agreement with the results of the full-length protein, additional point mutation of the
conserved phosphorylatable residue in the HisKA domain (CaNik1p∆HAMP(H510Q)) does
not affect the autophosphorylation of CaNik1p∆HAMP as shown by the results after
incubation with the radiolabeled [γ-32P] ATP.
The direct interaction between fludioxonil and purified CaNik1p, as revealed by STD-
NMR, stimulated our interest to investigate the way that the fungicide affected the in vitro
kinase activity of the purified protein. Therefore, the in vitro kinase activity of purified
CaNik1p was investigated after incubation with fludioxonil, either via the Kinase-Glo plus kit
or via incubation with radiolabeled [γ-32P] ATP. Both experiments showed that the fungicide
does not interfere with kinase activity. At the beginning of our work, the concept of the
inhibition of the HK activity of CaNik1p by the antifungals was strongly accepted by us as an
explanation for the growth inhibition observed after fungicidal treatment of S. cerevisiae
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transformed with CaNIK1. Later on, this assumption seemed to be incorrect, as the
transformant H510 with CaNIK1(H510Q), which is supposed to be unable to exhibit HK
activity, is able to grow normally in SG-ura. However, the possibility that the in vivo
interaction of fludioxonil with CaNik1p might require additional players to be able to affect
the HK activity of the protein cannot be neglected.
5.5 Phosphorylation of the Ser1071 residue of CaNik1p
Although the detection of the phosphorylatable serine residue in a HK of TCST seems to
be strange, previous researchers have reported similar results with other HKs, e.g., DegS in B.
subtilis (95) and the amoebal HK DokA (96). These data might explain why
CaNik1p(H510Q) still possesses kinase activity, even after the simultaneous substitution of
the other possible phosphorylatable residue (Asp924).
5.6 Deletion of HAMP domains in the heterologously expressed CaNik1p
We showed previously that the heterologous expression of truncated variants of the
CaNik1p protein, in which several HAMP  domains were deleted, did not result in the
inhibition of growth of the respective S. cerevisiae transformants (47). Whereas in the
previous report, only selected HAMP domains were deleted, in the present work, we deleted
all HAMP domains from CaNik1p (CaNik1p∆HAMP and CaNik1p∆HAMPup) and observed
that the expression of this truncated protein in the transformed S. cerevisiae strain was
associated with severe growth inhibition. This phenotype could be reversed by additional
point mutation in the conserved phosphorylation site of the HisKA domain (H510) or by the
expression of CaNIK1∆HAMP (or CaNIK1∆HAMPup) in single gene deletion mutants of the
response regulator SSK1 or in one of the components of the Hog1 MAPK module, namely the
MAP2K PBS2 and the MAPK HOG1. This establishes that the inhibition of growth of the
transformant upon expression of CaNik1p∆HAMP is dependent on the conserved phosphate-
accepting histidine residue of the HisKA domain and the functionality of the Ssk1 – Pbs2 -
Hog1 branch of the HOG pathway. Expression of both CaNik1p∆HAMP and
CaNik1p∆HAMPup was associated with the same phenotypes in the different transformants
of S. cerevisiae. Therefore, we focused on the transformant harboring CaNik1p∆HAMP in the
following experiments. We could further show that the inhibited growth of the strain ∆Ha,
expressing CaNik1p∆HAMP, correlated with the constitutive phosphorylation of Hog1p
without any external stimulation. This was also abolished after mutation of the conserved
phosphate-accepting histidine residue (CaNIK1∆HAMP(H510Q)).
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5.7 Both antifungals and HAMP domains activated the Hog1 MAPK
module via the same mechanism
Our results allow the conclusion that similarity exists in the mechanism of growth
inhibition observed in S. cerevisiae transformed with CaNIK1, either by fungicidal activity or
after deletion of the HAMP domains. First, the conserved phosphate-accepting histidine
residue of the HisKA domain (H510) is essential for both treatment with fungicides and the
deletion of all the HAMP domains to exert their inhibitory effects on the growth of the yeast.
Second, phosphorylation of the MAPK Hog1p is induced after fungicidal treatment or
deletion of HAMP domains from CaNIK1 used to transform S. cerevisiae. Moreover, the
phosphorylation of Hog1p is totally abolished in both cases after additional substitution of the
conserved phosphorylatable His residue of the HisKA domain (H510Q). Third, the
components of the Hog1 MAPK module (Pbs2p and Hog1p) in addition to the RR Ssk1p are
essential players for the CaNik1p∆HAMP-mediated growth inhibition in the transformed S.
cerevisiae. Likewise, we have reported that the same players are found to be essential for
maintaining the sensitivity of the transformed S. cerevisiae to antifungals (47). Based on the
previous data, we propose the following model (Fig. 5.1) to explain the similarity between
antifungal treatments and the expression of CaNik1p∆HAMP in terms of the activation of the
Hog1 MAPK module. Since the only possible mechanism for the activation of the Hog1
MAPK module, i.e., the phosphorylation of the MAPK Hog1p via the RR Ssk1p, is the
existence of such RR in the dephosphorylated form (97), we conclude that either the
expression of CaNik1p∆HAMP or the fungicidal treatment of S. cerevisiae transformed with
CaNIK1 inhibits phosphate transfer to Ssk1p from the active HK ScSln1p via Ypd1p, and that
such inhibition requires a phosphorylated CaNik1p at the H510 residue. However, the
mechanism by which the phosphorylated CaNik1p interferes with the phosphate transfer in
the cascade Sln1p-Ypd1p-Ssk1p needs to be further investigated.
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Fig. 5.1: Schematic model for activation of the Hog1 MAPK module after fungicidal
treatment or deletion of HAMP domains in S. cerevisiae transformed with CaNIK1. The
scheme shows S. cerevisiae transformed with either CaNIK1 in the absence of stimulus (A)
and after treatment with antifungals (B) or transformed with CaNIK1∆HAMP (C).
5.8 Deletion and reintegration of CaNIK1 in Sc5314
We were interested to delete the CaNIK1 gene in the wild-type strain Sc5314 for two
reasons. First, most of the available information about the relevance of CaNIK1 in C. albicans
was obtained from an analysis of its homozygous deletion mutant, which was constructed by
the URA blaster method. Because of the disadvantages of this method, as mentioned in 1.4,
we wished to reconsider the role of CaNIK1 in the phenotypic behavior of C. albicans via the
construction of a homozygous mutant of the gene independently of the utilization of the
auxotrophic marker URA3. Second, the main reason was to introduce indirectly the mutated
variants of CaNIK1, which are harbored by the plasmids used for the transformation of S.
cerevisiae. We hoped that this could be achieved by PCR amplification of the CaNIK1-TAG
and its mutated variants and the reintegration of these amplicons into the constructed
homozygous mutant of CaNIK1. The resulting transformants should allow the investigation of
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the role of each domain on the phenotypic behavior of the resulting transformants, e.g.,
hyphal formation on various solid media. Moreover, we were curious to examine the way that
deletion of the HAMP domains would affect the growth of resulting transformants of C.
albicans. The SAT1 flipper cassette, containing the NST resistance marker, was used for the
construction of the CaNIK1-deletion and -reintegration cassettes. The homozygous mutant
NIKhom2 (nik1/nik1) was successfully constructed and confirmed by PCR for the deletion
of both alleles of CaNIK1 and undergoing the flip excision. We decided to delay further
confirmation by the complex technique of Southern blotting until the complete design of the
CaNIK1 integration cassettes, as the reintegration of mutated variants of CaNIK1 was our
main aim. However, all the trials to ligate the amplicons of the CaNIK1-TAG and its mutated
variants with pNIK, amplified by inverse PCR, via the In-fusion enzyme were unsuccessful.
To check for the possible absence of nucleotides at the termini of the various DNA fragments
(a possibility that would hinder the ligation process), the ends of the different amplicons were
examined for their integrity by sequencing, and no missing nucleotides were detected. An
acceptable reason for the inability of the In-fusion enzyme to ligate the DNA fragments could
be the large size of the resulting plasmid, as the ligation of CaNIK1-TAG (3.3 kbp) and the
inverse PCR-amplified pNIK (8.4 kbp) would result in a plasmid of 11.7 kbp.
5.9 Conclusions
The present work allowed us to conclude the following:
1- Functional HisKA, HATPase_c, and REC domains are essential for the antifungal
mechanism of the compounds activating the Hog1 MAPK module.
2- CaNik1p is a direct target for fludioxonil.
3- Fludioxonil does not interfere with the in vitro kinase activity of the protein.
4- Another phosphorylatable residue (Ser1071) exists in CaNik1p beside those that are
well known from the structural homology (His510 and Asp924) of HisKA and REC
domains, respectively.
5- HAMP domains negatively regulate the activation of the Hog1 MAPK module by
CaNik1p.
6- In S. cerevisiae transformed with CaNIK1, the tested antifungals and deletion of
HAMP domains lead to growth inhibition by activation of the Hog1 MAPK module via
the response regulator Ssk1p. In both cases, the activation of the Hog1 MAPK module
is dependent on the conserved phosphorylation site of the HisKA domain (H510).
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6 Outlook
Group III histidine kinases are present in various fungi, which are pathogenic for humans,
animals or plants. However, besides the relevance for the susceptibility of these fungi to
several classes of fungicides, knowledge about the function of these enzymes is still limited.
Thus, neither the regulatory mechanisms of the downstream signal transduction pathways
were unambiguously identified nor the endogenous signal leading to activation or inhibition.
As we are now able to produce significant amounts of the protein and mutated variants
recombinantly, further studies are possible with the isolated, purified protein.
We observed that the protein was phosphorylated, even when conserved phosphorylatable
amino acids were replaced by others. Thus further studies on possible phosphorylatable
residues are required. To avoid excessive construction of mutants, a high-throughput method
could be used, e.g. a short peptide array, covering all amino acids of the CaNik1p, could be
used as substrate in the kinase reaction. Subsequently, the relevance of the detected
phosphorylated residues has to be confirmed by mutational analysis.
Moreover, the analysis of the interaction between the fungicides and the protein could be
extended to the mutated variants and to other classes of fungicides. The NMR – studies have
to be complemented by other methods of structural analysis and by kinetic studies of the
interaction.
In addition the interaction between group III histidine kinases and other phosphorelay systems
is not well understood. The S. cerevisiae transformants are ideal tools to address this question,
as the interaction to the endogenous SLN1-YPD1-SSK1 phosphorelay of S. cerevisiae could
by investigated by examining the possibility of the interaction of CaNik1p with ScSln1p,
Ypd1p, or Ssk1p via the yeast two-hybrid system. Previous reports had shown that CaNik1p
is not able to complement a deletion of ScSln1p. However, these results should be reevaluated
as the unusual codon usage of C. albicans was not taken into consideration at that time.
Finally, the function of the different domains of CaNik1p, particularly the HAMP domains,
and of the phosphorylation state of the protein for the role of this protein in Candida albicans
needs to be investigated requiring new efforts to replace the wild-type gene by mutated gene
variants in C. albicans. Subsequently these investigations could be extended to other
pathogenic fungi.
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Appendix I (Equipments and Materials)
Equipment Type and producing Company
Analysis balance PC4400, Mettler Sartorius
Automatic micropipettes
Discovery Comfort 2–20, 20–200 and 100-
1000 μl, Abimed HTL.
Eppendorf Reference 0.5–10, Eppendorf.
Blotting apparatus Trans-Blot SD Semi-Dry Transfer Cell,Bio-Rad
Bunsen Burner Fireboy, Integra BiosciencesFireboy eco, Integra Biosciences
Centrifuges
5804R, Eppendorf
5402, Eppendorf
5415, Eppendorf
Clean bench HLB 2448 HeraeusHera Safe, Therma Electron Corp.
Densitometer GS-800, Bio-rad
Electroporator Micropulser, Biorad
Gel documentation system RH-2, dark room hood, Herolab
Hemocytometer cell counting chamber Neubauer improved, Assistent Germany
Horizontal gel electrophoresis HORIZON™ 58 Gel Casting System, LifeTechnologies
Horizontal gel electrophoresis Wide Mini-Sub Cell GT Cell, Biorad
Magnetic stirrer plate MR 2002, Heidolph
Microplate shaker incubator Titramax 1000, Heidolph
Microplate spectrophotometer μQuant, BioTek
Microplate reader for chemiluminescence Synergy™4, BioTek
Microscope Zeiss, Germany
Microwave Hi Speed, Brother
Mikro-Dismembrator Mikro-Dismembrator U, B. Braun BiotechInternational
Multichannel pipette Transferpette 30–300 μl, Brand
NanoDrop 1000 spectrophotometer, Thermo
Scientific.
Determination of DNA and purified
CaNik1p concentrations
Oven UN, Memmert
pH meter pH 211 Microprocessor pH Meter, HannaInstruments
Phosphorimage analyzer BAS2500, Fujifilm
Pipet Aid Easypet, EppendorfCellMate Matrix, Thermo Scientific
Pipette Dispenser Eppendorf
Polyacrylamide Gel Electrophoresis
chamber Minigel-Twin, Biometra
Power supply Powerpac 1000 and 200 , Biorad
Rocking shaker Duomax 1030, Heidolph
Scanning microplate spectrophotometer µQuant, Biotek
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Shaker incubator Multitron Standard, Infors HT
Thermocycler Personal Cycler, Biometra
Thermomixers
5437, Eppendorf
Comfort 5355R, Eppendorf
Thermostat 5320, Eppendorf
Vaccum pump XF54 230 50, MilliporeKN4, Neuberger
Vortex Vortex Genie 2, Scientific Industries
Waterbath Wbn 14, Memmert
Western blot imaging system LAS-3000, Fujifilm
Material and company Used in
Minisart Membranfilter (pore size 0.2
µm), Sterile filtration of volumes less than 50 ml
Bottle-Top 500 ml Filter 0.2 μm,
Nalgene 595-4520
Sterile filtration of volumes more than 50
ml
Steriflip-NY Filter 0.2 µm, Millipore.
- Sterile filtration of volumes less than 50
ml.
- In CaNik1p purification, for separation of
the Ni+2 agarose beads from the eluate
solution of the protein.
Pipette tips Starlab S1111-0006, S1111-
2021 and S1111-3000
For pipetting with the automatic
micropipettes
Combitipsplus 5 and 10 ml, Eppendorf Repeated transfer of the same volume by
using the pipette dispenser
Safe-Lock-Tubes ( 2ml), Eppendorf Centrifugation of volumes lower that 2 ml
Cryovials 2ml, Corning 5380542 Storage of aliquots of cultures as stocks
Centrifuge tubes 15 ml und 50 ml,
Corning
430829, 430791 und 430897
Centrifugation of volumes more than 2 ml
PCR tubes 0,2 ml, Brand 781300 In PCR
Reservoirs, 60 ml solution volume with
cover, Eppendorf
To allow the use of the multichannel
pipettes in determination of protein
concentration by using BCA method and for
the in vitro kinase assay of the CaNik1p.
Disposable Petri dishes For cultivation of microorganism on solid
media
Immunoblot PVDF Membrane, Bio-Rad
162-077 Western blot
Extra thick filter paper, Bio-Rad 1703960 Western blot
96-well Costar microtiter plates with
white opaque-bottom, Corning 3917
Measurement of luminescence in the kinase
assay by using Kinase Glo plus Kit.
CytoOne 96-Well Plate, TC-treated, USA
Scientific.
Cultivation of transformed yeast strains in
the determination their susceptibility to
antifungals
96-well microtiter plates without cover,
W.O. Schmidt
For measurement of OD of cultures and in
protein determination
30, 50, and 100 kDa MWCO Vivaspin20
and 500 spin columns, Sartorius CaNik1p purification
Appendix II (Mascot search results and peptide mass fingerprint after
MALD-TOF analysis of certain proteins)
Purified CaNik1p
Interacting protein with CaNik1p(N627D) and CaNik1p(G663A, G665A)
Appendix III (Sequences of various mutated variants of CaNIK1)
Sequence of pYES2-CaNIK1-TAG, CaNIK1 starts from 5794 (ATG) till 9105 (TGA):
1  tcgagtcgac ttgattctag agggccgcat catgtaatta gttatgtcac
51  gcttacattc acgccctccc cccacatccg ctctaaccga aaaggaagga
101  gttagacaac ctgaagtcta ggtccctatt tattttttta tagttatgtt
151  agtattaaga acgttattta tatttcaaat ttttcttttt tttctgtaca
201  gacgcgtgta cgcatgtaac attatactga aaaccttgct tgagaaggtt
251  ttgggacgct cgaaggcttt aatttgcggc cctgcattaa tgaatcggcc
301  aacgcgcggg gagaggcggt ttgcgtattg ggcgctcttc cgcttcctcg
351  ctcactgact cgctgcgctc ggtcgttcgg ctgcggcgag cggtatcagc
401  tcactcaaag gcggtaatac ggttatccac agaatcaggg gataacgcag
451  gaaagaacat gtgagcaaaa ggccagcaaa agcccaggaa ccgtaaaaag
501  gccgcgttgc tggcgttttt ccataggctc cgcccccctg acgagcatca
551  caaaaatcga cgctcaagtc agaggtggcg aaacccgaca ggactataaa
601  gataccaggc gtttccccct ggaagctccc tcgtgcgctc tcctgttccg
651  accctgccgc ttaccggata cctgtccgcc tttctccctt cgggaagcgt
701  ggcgctttct catagctcac gctgtaggta tctcagttcg gtgtaggtcg
751  ttcgctccaa gctgggctgt gtgcacgaac cccccgttca gcccgaccgc
801  tgcgccttat ccggtaacta tcgtcttgag tccaacccgg taagacacga
851  cttatcgcca ctggcagcag ccactggtaa caggattagc agagcgaggt
901  atgtaggcgg tgctacagag ttcttgaagt ggtggcctaa ctacggctac
951  actagaagga cagtatttgg tatctgcgct ctgctgaagc cagttacctt
1001  cggaaaaaga gttggtagct cttgatccgg caaacaaacc accgctggta
1051  gcggtggttt ttttgtttgc aagcagcaga ttacgcgcag aaaaaaagga
1101  tctcaagaag atcctttgat cttttctacg gggtctgacg ctcagtggaa
1151  cgaaaactca cgttaaggga ttttggtcat gagattatca aaaaggatct
1201  tcacctagat ccttttaaat taaaaatgaa gttttaaatc aatctaaagt
1251  atatatgagt aaacttggtc tgacagttac caatgcttaa tcagtgaggc
1301  acctatctca gcgatctgtc tatttcgttc atccatagtt gcctgactcc
1351  ccgtcgtgta gataactacg atacgggagc gcttaccatc tggccccagt
1401  gctgcaatga taccgcgaga cccacgctca ccggctccag atttatcagc
1451  aataaaccag ccagccggaa gggccgagcg cagaagtggt cctgcaactt
1501  tatccgcctc cattcagtct attaattgtt gccgggaagc tagagtaagt
1551  agttcgccag ttaatagttt gcgcaacgtt gttggcattg ctacaggcat
1601  cgtggtgtca ctctcgtcgt ttggtatggc ttcattcagc tccggttccc
1651  aacgatcaag gcgagttaca tgatccccca tgttgtgcaa aaaagcggtt
1701  agctccttcg gtcctccgat cgttgtcaga agtaagttgg ccgcagtgtt
1751  atcactcatg gttatggcag cactgcataa ttctcttact gtcatgccat
1801  ccgtaagatg cttttctgtg actggtgagt actcaaccaa gtcattctga
1851  gaatagtgta tgcggcgacc gagttgctct tgcccggcgt caatacggga
1901  taatagtgta tcacatagca gaactttaaa agtgctcatc attggaaaac
1951  gttcttcggg gcgaaaactc tcaaggatct taccgctgtt gagatccagt
2001  tcgatgtaac ccactcgtgc acccaactga tcttcagcat cttttacttt
2051  caccagcgtt tctgggtgag caaaaacagg aaggcaaaat gccgcaaaaa
2101  agggaataag ggcgacacgg aaatgttgaa tactcatact cttccttttt
2151  caatgggtaa taactgatat aattaaattg aagctctaat ttgtgagttt
2201  agtatacatg catttactta taatacagtt ttttagtttt gctggccgca
2251  tcttctcaaa tatgcttccc agcctgcttt tctgtaacgt tcaccctcta
2301  ccttagcatc ccttcccttt gcaaatagtc ctcttccaac aataataatg
2351  tcagatcctg tagagaccac atcatccacg gttctatact gttgacccaa
2401  tgcgtctccc ttgtcatcta aacccacacc gggtgtcata atcaaccaat
2451  cgtaaccttc atctcttcca cccatgtctc tttgagcaat aaagccgata
2501  acaaaatctt tgtcgctctt cgcaatgtca acagtaccct tagtatattc
2551  tccagtagat agggagccct tgcatgacaa ttctgctaac atcaaaaggc
2601  ctctaggttc ctttgttact tcttctgccg cctgcttcaa accgctaaca
2651  atacctgggc ccaccacacc gtgtgcattc gtaatgtctg cccattctgc
2701  tattctgtat acacccgcag agtactgcaa tttgactgta ttaccaatgt
2751  cagcaaattt tctgtcttcg aagagtaaaa aattgtactt ggcggataat
2801  gcctttagcg gcttaactgt gccctccatg gaaaaatcag tcaagatatc
2851  cacatgtgtt tttagtaaac aaattttggg acctaatgct tcaactaact
2901  ccagtaattc cttggtggta cgaacatcca atgaagcaca caagtttgtt
2951  tgcttttcgt gcatgatatt aaatagcttg gcagcaacag gactaggatg
3001  agtagcagca cgttccttat atgtagcttt cgacatgatt tatcttcgtt
3051  tcctgcaggt ttttgttctg tgcagttggg ttaagaatac tgggcaattt
3101  catgtttctt caacactaca tatgcgtata tataccaatc taagtctgtg
3151  ctccttcctt cgttcttcct tctgttcgga gattaccgaa tcaaaaaaat
3201  ttcaaagaaa ccgaaatcaa aaaaaagaat aaaaaaaaaa tgatgaattg
3251  aattgaaaag ctagcttatc gatgataagc tgtcaaagat gagaattaat
3301  tccacggact atagactata ctagatactc cgtctactgt acgatacact
3351  tccgctcagg tccttgtcct ttaacgaggc cttaccactc ttttgttact
3401  ctattgatcc agctcagcaa aggcagtgtg atctaagatt ctatcttcgc
3451  gatgtagtaa aactagctag accgagaaag agactagaaa tgcaaaaggc
3501  acttctacaa tggctgccat cattattatc cgatgtgacg ctgcagcttc
3551  tcaatgatat tcgaatacgc tttgaggaga tacagcctaa tatccgacaa
3601  actgttttac agatttacga tcgtacttgt tacccatcat tgaattttga
3651  acatccgaac ctgggagttt tccctgaaac agatagtata tttgaacctg
3701  tataataata tatagtctag cgctttacgg aagacaatgt atgtatttcg
3751  gttcctggag aaactattgc atctattgca taggtaatct tgcacgtcgc
3801  atccccggtt cattttctgc gtttccatct tgcacttcaa tagcatatct
3851  ttgttaacga agcatctgtg cttcattttg tagaacaaaa atgcaacgcg
3901  agagcgctaa tttttcaaac aaagaatctg agctgcattt ttacagaaca
3951  gaaatgcaac gcgaaagcgc tattttacca acgaagaatc tgtgcttcat
4001  ttttgtaaaa caaaaatgca acgcgacgag agcgctaatt tttcaaacaa
4051  agaatctgag ctgcattttt acagaacaga aatgcaacgc gagagcgcta
4101  ttttaccaac aaagaatcta tacttctttt ttgttctaca aaaatgcatc
4151  ccgagagcgc tatttttcta acaaagcatc ttagattact ttttttctcc
4201  tttgtgcgct ctataatgca gtctcttgat aactttttgc actgtaggtc
4251  cgttaaggtt agaagaaggc tactttggtg tctattttct cttccataaa
4301  aaaagcctga ctccacttcc cgcgtttact gattactagc gaagctgcgg
4351  gtgcattttt tcaagataaa ggcatccccg attatattct ataccgatgt
4401  ggattgcgca tactttgtga acagaaagtg atagcgttga tgattcttca
4451  ttggtcagaa aattatgaac ggtttcttct attttgtctc tatatactac
4501  gtataggaaa tgtttacatt ttcgtattgt tttcgattca ctctatgaat
4551  agttcttact acaatttttt tgtctaaaga gtaatactag agataaacat
4601  aaaaaatgta gaggtcgagt ttagatgcaa gttcaaggag cgaaaggtgg
4651  atgggtaggt tatataggga tatagcacag agatatatag caaagagata
4701  cttttgagca atgtttgtgg aagcggtatt cgcaatggga agctccaccc
4751  cggttgataa tcagaaaagc cccaaaaaca ggaagattgt ataagcaaat
4801  atttaaattg taaacgttaa tattttgtta aaattcgcgt taaatttttg
4851  ttaaatcagc tcatttttta acgaatagcc cgaaatcggc aaaatccctt
4901  ataaatcaaa agaatagacc gagatagggt tgagtgttgt tccagtttcc
4951  aacaagagtc cactattaaa gaacgtggac tccaacgtca aagggcgaaa
5001  aagggtctat cagggcgatg gcccactacg tgaaccatca ccctaatcaa
5051  gttttttggg gtcgaggtgc cgtaaagcag taaatcggaa gggtaaacgg
5101  atgcccccat ttagagcttg acggggaaag ccggcgaacg tggcgagaaa
5151  ggaagggaag aaagcgaaag gagcgggggc tagggcggtg ggaagtgtag
5201  gggtcacgct gggcgtaacc accacacccg ccgcgcttaa tggggcgcta
5251  cagggcgcgt ggggatgatc cactagtacg gattagaagc cgccgagcgg
5301  gtgacagccc tccgaaggaa gactctcctc cgtgcgtcct cgtcctcacc
5351  ggtcgcgttc ctgaaacgca gatgtgcctc gcgccgcact gctccgaaca
5401  ataaagattc tacaatacta gcttttatgg ttatgaagag gaaaaattgg
5451  cagtaacctg gccccacaaa ccttcaaatg aacgaatcaa attaacaacc
5501  ataggatgat aatgcgatta gttttttagc cttatttctg gggtaattaa
5551  tcagcgaagc gatgattttt gatctattaa cagatatata aatgcaaaaa
5601  ctgcattaac cactttaact aatactttca acattttcgg tttgtattac
5651  ttcttattca aatgtaataa aagtatcaac aaaaaattgt taatatacct
5701  ctatacttta acgtcaagga gaaaaaaccc cggatcggac tactagcagc
5751  tgtaatacga ctcactatag ggaatattaa gcttgagctc catatgaacc
5801  ccactaaaaa accacggtta tcaccaatgc agccctctgt ttttgaaata
5851  ctcaacgacc ctgagcttta tagtcagcac tgtcatagcc ttagggaaac
5901  acttcttgac catttcaacc atcaagctac acttatcgac acttatgaac
5951  atgaactaga aaaatccaaa aacgcgaaca aggccttcca acaagcactt
6001  agtgaaatag gtacagttgt tatatctgtt gctatgggag acttgtcgaa
6051  aaaagttgag attcacacag tagaaaatga ccctgagatt ttgaaagtca
6101  aaatcaccat caacaccatg atggatcaat tacagacatt tgctaatgag
6151  gttacaaaag tcgccaccga agtcgcaaat ggtgaactag gtggacaagc
6201  gaaaaatgat ggatctgttg gtatttggag atcacttaca gacaatgtta
6251  atattatggc tcttaattta accaaccaag tgcgagaaat tgctgatgtc
6301 acacgggctg ttgccaaggg ggacttgtca cgtaaaatta atgttcacgc
6351  ccagggtgaa atccttcaac ttcaacgtac aataaacact atggtggatc
6401  agttacgaac atttgcattt gaagtatcta aagttgctag agatgttggt
6451  gtgcttggta tcctaggagg acaagcgttg attgaaaatg ttgaaggtat
6501  ttgggaagag ttgactgata atgtcaatgc aatggctctt aatttgacta
6551  cacaagtgag aaatattgcc aatgtcacca ctgccgttgc caagggggat
6601  ttgtcgaaaa aagtcactgc tgattgtaag ggagaaattc ttgatttgaa
6651  acttactatt aatcaaatgg tggaccgatt acagaatttt gctcttgcgg
6701  tgacgacatt gtcgagagag gttggtactt tgggtatcct aggtggacaa
6751  gctaacgtac aggacgtcga aggtgcttgg aaacaggtta cagaaaatgt
6801  caacctaatg gctactaatt taactaacca agtgagatcc attgctacag
6851  ttactactgc tgttgcacat ggtgatttgt cgcaaaagat tgatgttcat
6901  gcccagggag agattttaca gttgaaaaat acaatcaaca agatggtgga
6951  ctctttgcag ttgtttgcat cagaagtgtc gaaagtggca caagatgttg
7001  gtattaatgg aaaattaggt attcaagcac aagttagtga cgtcgatgga
7051  ttatggaagg agattacgtc taatgtaaat acgatggctt caaatttaac
7101  ttcgcaagtg agagcttttg cacagattac tgctgctgct actgatgggg
7151  atttcactag atttattact gttgaagcat cgggagagat ggatgcgttg
7201  aaaacaaaga ttaatcaaat ggtgtttaac ctaagggaat cgcttcaaag
7251  gaatactgcg gctagagaag ctgctgagct tgccaatagt gcgaaatccg
7301  agtttctagc gaacatgtcg catgagatac gtacaccatt gaatgggatt
7351  attggtatga ctcagttgtc gcttgataca gagttgacac agtaccaacg
7401  agagatgttg tcgattgtgc ataacttggc aaattccttg ttgaccatta
7451  tagacgatat attggatatt tctaagattg aggcgaatag aatgacggtg
7501  gaacagattg atttttcatt aagagggaca gtgtttggtg cattgaagac
7551  gttagccgtc aaagctattg aaaaaaacct agacttgacc tatcaatgtg
7601  attcatcgtt tccagataat cttattggag atagttttag attacgacaa
7651  gttattctta acttggctgg taatgctatt aagtttacta aagaggggaa
7701  agttagtgtt agtgtgaaaa agtctgataa aatggtgtta gatagtaagt
7751  tgttgttaga ggtttgtgtt agcgacacgg gaataggtat agagaaagac
7801  aaattgggat tgattttcga taccttctgt caagctgatg gttctactac
7851  aagaaagttt ggtggtacag gtttagggtt gtcaatttcc aaacagttga
7901  tacatttaat gggtggagag atatgggtta cttcggagta tggatcaggg
7951  tcaaactttt attttacggt gtgcgtgtcg ccatctaata ttagatatac
8001  tcgacaaacc gaacaattat taccatttag ttcccattat gtgttatttg
8051  tatcgactga gcatactcaa gaagaacttg atgtgttgag agatggaatt
8101  atagaacttg gattgatacc tataatagtg agaaatattg aagatgcaac
8151  attgactgag ccggtgaaat atgatataat tatgattgat tcgatagaga
8201  ttgccaaaaa gttgaggttg ttatcggagg ttaaatatat tccgttggtt
8251  ttggtccatc attctattcc acagttgaat atgagagtat gtattgattt
8301  ggggatttct tcctatgcaa atacgccatg ttcgatcacg gacttggcaa
8351  gtgcgattat accagcgttg gagtcgagat ccatatcaca gaactcagac
8401  gagtcggtga ggtacaaaat attactagca gaggacaacc tcgtcaatca
8451  gaaacttgca gttaggatat tagaaaagca agggcattcg gtggaagtag
8501  ttgagaacgg actagaggcg tacgaagcga ttaagaggaa taaatatgat
8551  gtggtgttga tggatgtgca aatgcctgta atgggtgggt tcgaagctac
8601  ggagaagatt cgacaatggg agaaaaagtc taacccaata gactcgttga
8651  cgtttaggac tccaattatt gccctcactg cacacgccat gttaggtgat
8701  agagaaaagt cattggcaaa ggggatggac gattatgtga gtaagccatt
8751  gaagccgaaa ttgttaatgc agacgataaa caagtgtatt cataatatta
8801  accagttgaa agaattgtcg agaaatagta ggggtagcga ttttgcaaag
8851  aagatgaccc gaaacacacc cggaagcacg acccgtcagg ggagtgatga
8901  ggggagtgta gaggacatga ttggggacac tccccgtcaa gggagtgttg
8951  agggaggggg tacaagtagc agaccagtac agagaaggtc tgccacagag
9001  gggtcgatca ctacaattag tgaacaaatc gaccggttac gtaaggatcc
9051  gggtgattat aaagatgacg acgataaagg aggacatcat caccatcacc
9101  actgac
Sequence of CaNIK1(H510Q) in pYES2-CaNIK1(H510Q):
atgaaccccactaaaaaaccacggttatcaccaatgcagccctctgtttttgaaatactc
aacgaccctgagctttatagtcagcactgtcatagccttagggaaacacttcttgaccat
ttcaaccatcaagctacacttatcgacacttatgaacatgaactagaaaaatccaaaaac
gcgaacaaggccttccaacaagcacttagtgaaataggtacagttgttatatctgttgct
atgggagacttgtcgaaaaaagttgagattcacacagtagaaaatgaccctgagattttg
aaagtcaaaatcaccatcaacaccatgatggatcaattacagacatttgctaatgaggtt
acaaaagtcgccaccgaagtcgcaaatggtgaactaggtggacaagcgaaaaatgatgga
tctgttggtatttggagatcacttacagacaatgttaatattatggctcttaatttaacc
aaccaagtgcgagaaattgctgatgtcacacgggctgttgccaagggggacttgtcacgt
aaaattaatgttcacgcccagggtgaaatccttcaacttcaacgtacaataaacactatg
gtggatcagttacgaacatttgcatttgaagtatctaaagttgctagagatgttggtgtg
cttggtatcctaggaggacaagcgttgattgaaaatgttgaaggtatttgggaagagttg
actgataatgtcaatgcaatggctcttaatttgactacacaagtgagaaatattgccaat
gtcaccactgccgttgccaagggggatttgtcgaaaaaagtcactgctgattgtaaggga
gaaattcttgatttgaaacttactattaatcaaatggtggaccgattacagaattttgct
cttgcggtgacgacattgtcgagagaggttggtactttgggtatcctaggtggacaagct
aacgtacaggacgtcgaaggtgcttggaaacaggttacagaaaatgtcaacctaatggct
actaatttaactaaccaagtgagatccattgctacagttactactgctgttgcacatggt
gatttgtcgcaaaagattgatgttcatgcccagggagagattttacagttgaaaaataca
atcaacaagatggtggactctttgcagttgtttgcatcagaagtgtcgaaagtggcacaa
gatgttggtattaatggaaaattaggtattcaagcacaagttagtgacgtcgatggatta
tggaaggagattacgtctaatgtaaatacgatggcttcaaatttaacttcgcaagtgaga
gcttttgcacagattactgctgctgctactgatggggatttcactagatttattactgtt
gaagcatcgggagagatggatgcgttgaaaacaaagattaatcaaatggtgtttaaccta
agggaatcgcttcaaaggaatactgcggctagagaagctgctgagcttgccaatagtgcg
aaatccgagtttctagcgaacatgtcgcaagagatacgtacaccattgaatgggattatt
ggtatgactcagttgtcgcttgatacagagttgacacagtaccaacgagagatgttgtcg
attgtgcataacttggcaaattccttgttgaccattatagacgatatattggatatttct
aagattgaggcgaatagaatgacggtggaacagattgatttttcattaagagggacagtg
tttggtgcattgaagacgttagccgtcaaagctattgaaaaaaacctagacttgacctat
caatgtgattcatcgtttccagataatcttattggagatagttttagattacgacaagtt
attcttaacttggctggtaatgctattaagtttactaaagaggggaaagttagtgttagt
gtgaaaaagtctgataaaatggtgttagatagtaagttgttgttagaggtttgtgttagc
gacacgggaataggtatagagaaagacaaattgggattgattttcgataccttctgtcaa
gctgatggttctactacaagaaagtttggtggtacaggtttagggttgtcaatttccaaa
cagttgatacatttaatgggtggagagatatgggttacttcggagtatggatcagggtca
aacttttattttacggtgtgcgtgtcgccatctaatattagatatactcgacaaaccgaa
caattattaccatttagttcccattatgtgttatttgtatcgactgagcatactcaagaa
gaacttgatgtgttgagagatggaattatagaacttggattgatacctataatagtgaga
aatattgaagatgcaacattgactgagccggtgaaatatgatataattatgattgattcg
atagagattgccaaaaagttgaggttgttatcggaggttaaatatattccgttggttttg
gtccatcattctattccacagttgaatatgagagtatgtattgatttggggatttcttcc
tatgcaaatacgccatgttcgatcacggacttggcaagtgcgattataccagcgttggag
tcgagatccatatcacagaactcagacgagtcggtgaggtacaaaatattactagcagag
gacaacctcgtcaatcagaaacttgcagttaggatattagaaaagcaagggcattcggtg
gaagtagttgagaacggactagaggcgtacgaagcgattaagaggaataaatatgatgtg
gtgttgatggatgtgcaaatgcctgtaatgggtgggttcgaagctacggagaagattcga
caatgggagaaaaagtctaacccaatagactcgttgacgtttaggactccaattattgcc
ctcactgcacacgccatgttaggtgatagagaaaagtcattggcaaaggggatggacgat
tatgtgagtaagccattgaagccgaaattgttaatgcagacgataaacaagtgtattcat
aatattaaccagttgaaagaattgtcgagaaatagtaggggtagcgattttgcaaagaag
atgacccgaaacacacccggaagcacgacccgtcaggggagtgatgaggggagtgtagag
gacatgattggggacactccccgtcaagggagtgttgagggagggggtacaagtagcaga
ccagtacagagaaggtctgccacagaggggtcgatcactacaattagtgaacaaatcgac
cggttacgtaaggatccgggtgattataaagatgacgacgataaaggaggacatcatcac
catcaccactga
Sequence of CaNIK1(D924N) in pYES2-CaNIK1(D924N):
atgaaccccactaaaaaaccacggttatcaccaatgcagccctctgtttttgaaatactc
aacgaccctgagctttatagtcagcactgtcatagccttagggaaacacttcttgaccat
ttcaaccatcaagctacacttatcgacacttatgaacatgaactagaaaaatccaaaaac
gcgaacaaggccttccaacaagcacttagtgaaataggtacagttgttatatctgttgct
atgggagacttgtcgaaaaaagttgagattcacacagtagaaaatgaccctgagattttg
aaagtcaaaatcaccatcaacaccatgatggatcaattacagacatttgctaatgaggtt
acaaaagtcgccaccgaagtcgcaaatggtgaactaggtggacaagcgaaaaatgatgga
tctgttggtatttggagatcacttacagacaatgttaatattatggctcttaatttaacc
aaccaagtgcgagaaattgctgatgtcacacgggctgttgccaagggggacttgtcacgt
aaaattaatgttcacgcccagggtgaaatccttcaacttcaacgtacaataaacactatg
gtggatcagttacgaacatttgcatttgaagtatctaaagttgctagagatgttggtgtg
cttggtatcctaggaggacaagcgttgattgaaaatgttgaaggtatttgggaagagttg
actgataatgtcaatgcaatggctcttaatttgactacacaagtgagaaatattgccaat
gtcaccactgccgttgccaagggggatttgtcgaaaaaagtcactgctgattgtaaggga
gaaattcttgatttgaaacttactattaatcaaatggtggaccgattacagaattttgct
cttgcggtgacgacattgtcgagagaggttggtactttgggtatcctaggtggacaagct
aacgtacaggacgtcgaaggtgcttggaaacaggttacagaaaatgtcaacctaatggct
actaatttaactaaccaagtgagatccattgctacagttactactgctgttgcacatggt
gatttgtcgcaaaagattgatgttcatgcccagggagagattttacagttgaaaaataca
atcaacaagatggtggactctttgcagttgtttgcatcagaagtgtcgaaagtggcacaa
gatgttggtattaatggaaaattaggtattcaagcacaagttagtgacgtcgatggatta
tggaaggagattacgtctaatgtaaatacgatggcttcaaatttaacttcgcaagtgaga
gcttttgcacagattactgctgctgctactgatggggatttcactagatttattactgtt
gaagcatcgggagagatggatgcgttgaaaacaaagattaatcaaatggtgtttaaccta
agggaatcgcttcaaaggaatactgcggctagagaagctgctgagcttgccaatagtgcg
aaatccgagtttctagcgaacatgtcgcatgagatacgtacaccattgaatgggattatt
ggtatgactcagttgtcgcttgatacagagttgacacagtaccaacgagagatgttgtcg
attgtgcataacttggcaaattccttgttgaccattatagacgatatattggatatttct
aagattgaggcgaatagaatgacggtggaacagattgatttttcattaagagggacagtg
tttggtgcattgaagacgttagccgtcaaagctattgaaaaaaacctagacttgacctat
caatgtgattcatcgtttccagataatcttattggagatagttttagattacgacaagtt
attcttaacttggctggtaatgctattaagtttactaaagaggggaaagttagtgttagt
gtgaaaaagtctgataaaatggtgttagatagtaagttgttgttagaggtttgtgttagc
gacacgggaataggtatagagaaagacaaattgggattgattttcgataccttctgtcaa
gctgatggttctactacaagaaagtttggtggtacaggtttagggttgtcaatttccaaa
cagttgatacatttaatgggtggagagatatgggttacttcggagtatggatcagggtca
aacttttattttacggtgtgcgtgtcgccatctaatattagatatactcgacaaaccgaa
caattattaccatttagttcccattatgtgttatttgtatcgactgagcatactcaagaa
gaacttgatgtgttgagagatggaattatagaacttggattgatacctataatagtgaga
aatattgaagatgcaacattgactgagccggtgaaatatgatataattatgattgattcg
atagagattgccaaaaagttgaggttgttatcggaggttaaatatattccgttggttttg
gtccatcattctattccacagttgaatatgagagtatgtattgatttggggatttcttcc
tatgcaaatacgccatgttcgatcacggacttggcaagtgcgattataccagcgttggag
tcgagatccatatcacagaactcagacgagtcggtgaggtacaaaatattactagcagag
gacaacctcgtcaatcagaaacttgcagttaggatattagaaaagcaagggcattcggtg
gaagtagttgagaacggactagaggcgtacgaagcgattaagaggaataaatatgatgtg
gtgttgatgaatgtgcaaatgcctgtaatgggtgggttcgaagctacggagaagattcga
caatgggagaaaaagtctaacccaatagactcgttgacgtttaggactccaattattgcc
ctcactgcacacgccatgttaggtgatagagaaaagtcattggcaaaggggatggacgat
tatgtgagtaagccattgaagccgaaattgttaatgcagacgataaacaagtgtattcat
aatattaaccagttgaaagaattgtcgagaaatagtaggggtagcgattttgcaaagaag
atgacccgaaacacacccggaagcacgacccgtcaggggagtgatgaggggagtgtagag
gacatgattggggacactccccgtcaagggagtgttgagggagggggtacaagtagcaga
ccagtacagagaaggtctgccacagaggggtcgatcactacaattagtgaacaaatcgac
cggttacgtaaggatccgggtgattataaagatgacgacgataaaggaggacatcatcac
catcaccactga
Sequence of CaNIK1(H510Q, D924N) in pYES2-CaNIK1(H510Q, D924N):
atgaaccccactaaaaaaccacggttatcaccaatgcagccctctgtttttgaaatactc
aacgaccctgagctttatagtcagcactgtcatagccttagggaaacacttcttgaccat
ttcaaccatcaagctacacttatcgacacttatgaacatgaactagaaaaatccaaaaac
gcgaacaaggccttccaacaagcacttagtgaaataggtacagttgttatatctgttgct
atgggagacttgtcgaaaaaagttgagattcacacagtagaaaatgaccctgagattttg
aaagtcaaaatcaccatcaacaccatgatggatcaattacagacatttgctaatgaggtt
acaaaagtcgccaccgaagtcgcaaatggtgaactaggtggacaagcgaaaaatgatgga
tctgttggtatttggagatcacttacagacaatgttaatattatggctcttaatttaacc
aaccaagtgcgagaaattgctgatgtcacacgggctgttgccaagggggacttgtcacgt
aaaattaatgttcacgcccagggtgaaatccttcaacttcaacgtacaataaacactatg
gtggatcagttacgaacatttgcatttgaagtatctaaagttgctagagatgttggtgtg
cttggtatcctaggaggacaagcgttgattgaaaatgttgaaggtatttgggaagagttg
actgataatgtcaatgcaatggctcttaatttgactacacaagtgagaaatattgccaat
gtcaccactgccgttgccaagggggatttgtcgaaaaaagtcactgctgattgtaaggga
gaaattcttgatttgaaacttactattaatcaaatggtggaccgattacagaattttgct
cttgcggtgacgacattgtcgagagaggttggtactttgggtatcctaggtggacaagct
aacgtacaggacgtcgaaggtgcttggaaacaggttacagaaaatgtcaacctaatggct
actaatttaactaaccaagtgagatccattgctacagttactactgctgttgcacatggt
gatttgtcgcaaaagattgatgttcatgcccagggagagattttacagttgaaaaataca
atcaacaagatggtggactctttgcagttgtttgcatcagaagtgtcgaaagtggcacaa
gatgttggtattaatggaaaattaggtattcaagcacaagttagtgacgtcgatggatta
tggaaggagattacgtctaatgtaaatacgatggcttcaaatttaacttcgcaagtgaga
gcttttgcacagattactgctgctgctactgatggggatttcactagatttattactgtt
gaagcatcgggagagatggatgcgttgaaaacaaagattaatcaaatggtgtttaaccta
agggaatcgcttcaaaggaatactgcggctagagaagctgctgagcttgccaatagtgcg
aaatccgagtttctagcgaacatgtcgcaagagatacgtacaccattgaatgggattatt
ggtatgactcagttgtcgcttgatacagagttgacacagtaccaacgagagatgttgtcg
attgtgcataacttggcaaattccttgttgaccattatagacgatatattggatatttct
aagattgaggcgaatagaatgacggtggaacagattgatttttcattaagagggacagtg
tttggtgcattgaagacgttagccgtcaaagctattgaaaaaaacctagacttgacctat
caatgtgattcatcgtttccagataatcttattggagatagttttagattacgacaagtt
attcttaacttggctggtaatgctattaagtttactaaagaggggaaagttagtgttagt
gtgaaaaagtctgataaaatggtgttagatagtaagttgttgttagaggtttgtgttagc
gacacgggaataggtatagagaaagacaaattgggattgattttcgataccttctgtcaa
gctgatggttctactacaagaaagtttggtggtacaggtttagggttgtcaatttccaaa
cagttgatacatttaatgggtggagagatatgggttacttcggagtatggatcagggtca
aacttttattttacggtgtgcgtgtcgccatctaatattagatatactcgacaaaccgaa
caattattaccatttagttcccattatgtgttatttgtatcgactgagcatactcaagaa
gaacttgatgtgttgagagatggaattatagaacttggattgatacctataatagtgaga
aatattgaagatgcaacattgactgagccggtgaaatatgatataattatgattgattcg
atagagattgccaaaaagttgaggttgttatcggaggttaaatatattccgttggttttg
gtccatcattctattccacagttgaatatgagagtatgtattgatttggggatttcttcc
tatgcaaatacgccatgttcgatcacggacttggcaagtgcgattataccagcgttggag
tcgagatccatatcacagaactcagacgagtcggtgaggtacaaaatattactagcagag
gacaacctcgtcaatcagaaacttgcagttaggatattagaaaagcaagggcattcggtg
gaagtagttgagaacggactagaggcgtacgaagcgattaagaggaataaatatgatgtg
gtgttgatgaatgtgcaaatgcctgtaatgggtgggttcgaagctacggagaagattcga
caatgggagaaaaagtctaacccaatagactcgttgacgtttaggactccaattattgcc
ctcactgcacacgccatgttaggtgatagagaaaagtcattggcaaaggggatggacgat
tatgtgagtaagccattgaagccgaaattgttaatgcagacgataaacaagtgtattcat
aatattaaccagttgaaagaattgtcgagaaatagtaggggtagcgattttgcaaagaag
atgacccgaaacacacccggaagcacgacccgtcaggggagtgatgaggggagtgtagag
gacatgattggggacactccccgtcaagggagtgttgagggagggggtacaagtagcaga
ccagtacagagaaggtctgccacagaggggtcgatcactacaattagtgaacaaatcgac
cggttacgtaaggatccgggtgattataaagatgacgacgataaaggaggacatcatcac
catcaccactga
Sequence of CaNIK1(N627D) in pYES2-CaNIK1(N627D):
atgaaccccactaaaaaaccacggttatcaccaatgcagccctctgtttttgaaatactc
aacgaccctgagctttatagtcagcactgtcatagccttagggaaacacttcttgaccat
ttcaaccatcaagctacacttatcgacacttatgaacatgaactagaaaaatccaaaaac
gcgaacaaggccttccaacaagcacttagtgaaataggtacagttgttatatctgttgct
atgggagacttgtcgaaaaaagttgagattcacacagtagaaaatgaccctgagattttg
aaagtcaaaatcaccatcaacaccatgatggatcaattacagacatttgctaatgaggtt
acaaaagtcgccaccgaagtcgcaaatggtgaactaggtggacaagcgaaaaatgatgga
tctgttggtatttggagatcacttacagacaatgttaatattatggctcttaatttaacc
aaccaagtgcgagaaattgctgatgtcacacgggctgttgccaagggggacttgtcacgt
aaaattaatgttcacgcccagggtgaaatccttcaacttcaacgtacaataaacactatg
gtggatcagttacgaacatttgcatttgaagtatctaaagttgctagagatgttggtgtg
cttggtatcctaggaggacaagcgttgattgaaaatgttgaaggtatttgggaagagttg
actgataatgtcaatgcaatggctcttaatttgactacacaagtgagaaatattgccaat
gtcaccactgccgttgccaagggggatttgtcgaaaaaagtcactgctgattgtaaggga
gaaattcttgatttgaaacttactattaatcaaatggtggaccgattacagaattttgct
cttgcggtgacgacattgtcgagagaggttggtactttgggtatcctaggtggacaagct
aacgtacaggacgtcgaaggtgcttggaaacaggttacagaaaatgtcaacctaatggct
actaatttaactaaccaagtgagatccattgctacagttactactgctgttgcacatggt
gatttgtcgcaaaagattgatgttcatgcccagggagagattttacagttgaaaaataca
atcaacaagatggtggactctttgcagttgtttgcatcagaagtgtcgaaagtggcacaa
gatgttggtattaatggaaaattaggtattcaagcacaagttagtgacgtcgatggatta
tggaaggagattacgtctaatgtaaatacgatggcttcaaatttaacttcgcaagtgaga
gcttttgcacagattactgctgctgctactgatggggatttcactagatttattactgtt
gaagcatcgggagagatggatgcgttgaaaacaaagattaatcaaatggtgtttaaccta
agggaatcgcttcaaaggaatactgcggctagagaagctgctgagcttgccaatagtgcg
aaatccgagtttctagcgaacatgtcgcatgagatacgtacaccattgaatgggattatt
ggtatgactcagttgtcgcttgatacagagttgacacagtaccaacgagagatgttgtcg
attgtgcataacttggcaaattccttgttgaccattatagacgatatattggatatttct
aagattgaggcgaatagaatgacggtggaacagattgatttttcattaagagggacagtg
tttggtgcattgaagacgttagccgtcaaagctattgaaaaaaacctagacttgacctat
caatgtgattcatcgtttccagataatcttattggagatagttttagattacgacaagtt
attcttaacttggctggtgatgctattaagtttactaaagaggggaaagttagtgttagt
gtgaaaaagtctgataaaatggtgttagatagtaagttgttgttagaggtttgtgttagc
gacacgggaataggtatagagaaagacaaattgggattgattttcgataccttctgtcaa
gctgatggttctactacaagaaagtttggtggtacaggtttagggttgtcaatttccaaa
cagttgatacatttaatgggtggagagatatgggttacttcggagtatggatcagggtca
aacttttattttacggtgtgcgtgtcgccatctaatattagatatactcgacaaaccgaa
caattattaccatttagttcccattatgtgttatttgtatcgactgagcatactcaagaa
gaacttgatgtgttgagagatggaattatagaacttggattgatacctataatagtgaga
aatattgaagatgcaacattgactgagccggtgaaatatgatataattatgattgattcg
atagagattgccaaaaagttgaggttgttatcggaggttaaatatattccgttggttttg
gtccatcattctattccacagttgaatatgagagtatgtattgatttggggatttcttcc
tatgcaaatacgccatgttcgatcacggacttggcaagtgcgattataccagcgttggag
tcgagatccatatcacagaactcagacgagtcggtgaggtacaaaatattactagcagag
gacaacctcgtcaatcagaaacttgcagttaggatattagaaaagcaagggcattcggtg
gaagtagttgagaacggactagaggcgtacgaagcgattaagaggaataaatatgatgtg
gtgttgatggatgtgcaaatgcctgtaatgggtgggttcgaagctacggagaagattcga
caatgggagaaaaagtctaacccaatagactcgttgacgtttaggactccaattattgcc
ctcactgcacacgccatgttaggtgatagagaaaagtcattggcaaaggggatggacgat
tatgtgagtaagccattgaagccgaaattgttaatgcagacgataaacaagtgtattcat
aatattaaccagttgaaagaattgtcgagaaatagtaggggtagcgattttgcaaagaag
atgacccgaaacacacccggaagcacgacccgtcaggggagtgatgaggggagtgtagag
gacatgattggggacactccccgtcaagggagtgttgagggagggggtacaagtagcaga
ccagtacagagaaggtctgccacagaggggtcgatcactacaattagtgaacaaatcgac
cggttacgtaaggatccgggtgattataaagatgacgacgataaaggaggacatcatcac
catcaccactga
Sequence of CaNIK1(G663A, G665A) in pYES2-CaNIK1(G663A, G665A):
atgaaccccactaaaaaaccacggttatcaccaatgcagccctctgtttttgaaatactc
aacgaccctgagctttatagtcagcactgtcatagccttagggaaacacttcttgaccat
ttcaaccatcaagctacacttatcgacacttatgaacatgaactagaaaaatccaaaaac
gcgaacaaggccttccaacaagcacttagtgaaataggtacagttgttatatctgttgct
atgggagacttgtcgaaaaaagttgagattcacacagtagaaaatgaccctgagattttg
aaagtcaaaatcaccatcaacaccatgatggatcaattacagacatttgctaatgaggtt
acaaaagtcgccaccgaagtcgcaaatggtgaactaggtggacaagcgaaaaatgatgga
tctgttggtatttggagatcacttacagacaatgttaatattatggctcttaatttaacc
aaccaagtgcgagaaattgctgatgtcacacgggctgttgccaagggggacttgtcacgt
aaaattaatgttcacgcccagggtgaaatccttcaacttcaacgtacaataaacactatg
gtggatcagttacgaacatttgcatttgaagtatctaaagttgctagagatgttggtgtg
cttggtatcctaggaggacaagcgttgattgaaaatgttgaaggtatttgggaagagttg
actgataatgtcaatgcaatggctcttaatttgactacacaagtgagaaatattgccaat
gtcaccactgccgttgccaagggggatttgtcgaaaaaagtcactgctgattgtaaggga
gaaattcttgatttgaaacttactattaatcaaatggtggaccgattacagaattttgct
cttgcggtgacgacattgtcgagagaggttggtactttgggtatcctaggtggacaagct
aacgtacaggacgtcgaaggtgcttggaaacaggttacagaaaatgtcaacctaatggct
actaatttaactaaccaagtgagatccattgctacagttactactgctgttgcacatggt
gatttgtcgcaaaagattgatgttcatgcccagggagagattttacagttgaaaaataca
atcaacaagatggtggactctttgcagttgtttgcatcagaagtgtcgaaagtggcacaa
gatgttggtattaatggaaaattaggtattcaagcacaagttagtgacgtcgatggatta
tggaaggagattacgtctaatgtaaatacgatggcttcaaatttaacttcgcaagtgaga
gcttttgcacagattactgctgctgctactgatggggatttcactagatttattactgtt
gaagcatcgggagagatggatgcgttgaaaacaaagattaatcaaatggtgtttaaccta
agggaatcgcttcaaaggaatactgcggctagagaagctgctgagcttgccaatagtgcg
aaatccgagtttctagcgaacatgtcgcatgagatacgtacaccattgaatgggattatt
ggtatgactcagttgtcgcttgatacagagttgacacagtaccaacgagagatgttgtcg
attgtgcataacttggcaaattccttgttgaccattatagacgatatattggatatttct
aagattgaggcgaatagaatgacggtggaacagattgatttttcattaagagggacagtg
tttggtgcattgaagacgttagccgtcaaagctattgaaaaaaacctagacttgacctat
caatgtgattcatcgtttccagataatcttattggagatagttttagattacgacaagtt
attcttaacttggctggtaatgctattaagtttactaaagaggggaaagttagtgttagt
gtgaaaaagtctgataaaatggtgttagatagtaagttgttgttagaggtttgtgttagc
gacacggcaatagctatagagaaagacaaattgggattgattttcgataccttctgtcaa
gctgatggttctactacaagaaagtttggtggtacaggtttagggttgtcaatttccaaa
cagttgatacatttaatgggtggagagatatgggttacttcggagtatggatcagggtca
aacttttattttacggtgtgcgtgtcgccatctaatattagatatactcgacaaaccgaa
caattattaccatttagttcccattatgtgttatttgtatcgactgagcatactcaagaa
gaacttgatgtgttgagagatggaattatagaacttggattgatacctataatagtgaga
aatattgaagatgcaacattgactgagccggtgaaatatgatataattatgattgattcg
atagagattgccaaaaagttgaggttgttatcggaggttaaatatattccgttggttttg
gtccatcattctattccacagttgaatatgagagtatgtattgatttggggatttcttcc
tatgcaaatacgccatgttcgatcacggacttggcaagtgcgattataccagcgttggag
tcgagatccatatcacagaactcagacgagtcggtgaggtacaaaatattactagcagag
gacaacctcgtcaatcagaaacttgcagttaggatattagaaaagcaagggcattcggtg
gaagtagttgagaacggactagaggcgtacgaagcgattaagaggaataaatatgatgtg
gtgttgatggatgtgcaaatgcctgtaatgggtgggttcgaagctacggagaagattcga
caatgggagaaaaagtctaacccaatagactcgttgacgtttaggactccaattattgcc
ctcactgcacacgccatgttaggtgatagagaaaagtcattggcaaaggggatggacgat
tatgtgagtaagccattgaagccgaaattgttaatgcagacgataaacaagtgtattcat
aatattaaccagttgaaagaattgtcgagaaatagtaggggtagcgattttgcaaagaag
atgacccgaaacacacccggaagcacgacccgtcaggggagtgatgaggggagtgtagag
gacatgattggggacactccccgtcaagggagtgttgagggagggggtacaagtagcaga
ccagtacagagaaggtctgccacagaggggtcgatcactacaattagtgaacaaatcgac
cggttacgtaaggatccgggtgattataaagatgacgacgataaaggaggacatcatcac
catcaccactga
Sequence of pYES2-CaNIK1HAMPup (7629 bp), CaNIK1HAMPup starts from 507
(ATG) till 2364 (TGA):
1 ACGGATTAGA AGCCGCCGAG CGGGTGACAG CCCTCCGAAG GAAGACTCTC
51 CTCCGTGCGT CCTCGTCTTC ACCGGTCGCG TTCCTGAAAC GCAGATGTGC
101 CTCGCGCCGC ACTGCTCCGA ACAATAAAGA TTCTACAATA CTAGCTTTTA
151 TGGTTATGAA GAGGAAAAAT TGGCAGTAAC CTGGCCCCAC AAACCTTCAA
201 ATGAACGAAT CAAATTAACA ACCATAGGAT GATAATGCGA TTAGTTTTTT
251 AGCCTTATTT CTGGGGTAAT TAATCAGCGA AGCGATGATT TTTGATCTAT
301 TAACAGATAT ATAAATGCAA AAACTGCATA ACCACTTTAA CTAATACTTT
351 CAACATTTTC GGTTTGTATT ACTTCTTATT CAAATGTAAT AAAAGTATCA
401 ACAAAAAATT GTTAATATAC CTCTATACTT TAACGTCAAG GAGAAAAAAC
451 CCCGGATCGG ACTACTAGCA GCTGTAATAC GACTCACTAT AGGGAATATT
501 AAGCTTatga ggaatactgc ggctagagaa gctgctgagc ttgccaatag
551 tgcgaaatcc gagtttctag cgaacatgtc gcatgagata cgtacaccat
601 tgaatgggat tattggtatg actcagttgt cgcttgatac agagttgaca
651 cagtaccaac gagagatgtt gtcgattgtg cataacttgg caaattcctt
701 gttgaccatt atagacgata tattggatat ttctaagatt gaggcgaata
751 gaatgacggt ggaacagatt gatttttcat taagagggac agtgtttggt
801 gcattgaaga cgttagccgt caaagctatt gaaaaaaacc tagacttgac
851 ctatcaatgt gattcatcgt ttccagataa tcttattgga gatagtttta
901 gattacgaca agttattctt aacttggctg gtaatgctat taagtttact
951 aaagagggga aagttagtgt tagtgtgaaa aagtctgata aaatggtgtt
1001 agatagtaag ttgttgttag aggtttgtgt tagcgacacg ggaataggta
1051 tagagaaaga caaattggga ttgattttcg ataccttctg tcaagctgat
1101 ggttctacta caagaaagtt tggtggtaca ggtttagggt tgtcaatttc
1151 caaacagttg atacatttaa tgggtggaga gatatgggtt acttcggagt
1201 atggatcagg gtcaaacttt tattttacgg tgtgcgtgtc gccatctaat
1251 attagatata ctcgacaaac cgaacaatta ttaccattta gttcccatta
1301 tgtgttattt gtatcgactg agcatactca agaagaactt gatgtgttga
1351 gagatggaat tatagaactt ggattgatac ctataatagt gagaaatatt
1401 gaagatgcaa cattgactga gccggtgaaa tatgatataa ttatgattga
1451 ttcgatagag attgccaaaa agttgaggtt gttatcggag gttaaatata
1501 ttccgttggt tttggtccat cattctattc cacagttgaa tatgagagta
1551 tgtattgatt tggggatttc ttcctatgca aatacgccat gttcgatcac
1601 ggacttggca agtgcgatta taccagcgtt ggagtcgaga tccatatcac
1651 agaactcaga cgagtcggtg aggtacaaaa tattactagc agaggacaac
1701 ctcgtcaatc agaaacttgc agttaggata ttagaaaagc aagggcattc
1751 ggtggaagta gttgagaacg gactagaggc gtacgaagcg attaagagga
1801 ataaatatga tgtggtgttg atggatgtgc aaatgcctgt aatgggtggg
1851 ttcgaagcta cggagaagat tcgacaatgg gagaaaaagt ctaacccaat
1901 agactcgttg acgtttagga ctccaattat tgccctcact gcacacgcca
1951 tgttaggtga tagagaaaag tcattggcaa aggggatgga cgattatgtg
2001 agtaagccat tgaagccgaa attgttaatg cagacgataa acaagtgtat
2051 tcataatatt aaccagttga aagaattgtc gagaaatagt aggggtagcg
2101 attttgcaaa gaagatgacc cgaaacacac ccggaagcac gacccgtcag
2151 gggagtgatg aggggagtgt agaggacatg attggggaca ctccccgtca
2201 agggagtgtt gagggagggg gtacaagtag cagaccagta cagagaaggt
2251 ctgccacaga ggggtcgatc actacaatta gtgaacaaat cgaccggtta
2301 cgtaaggatc cgggtgatta taaagatgac gacgataaag gaggacatca
2351 tcaccatcac cactgacTCT AGAGGGCCGC ATCATGTAAT TAGTTATGTC
2401 ACGCTTACAT TCACGCCCTC CCCCCACATC CGCTCTAACC GAAAAGGAAG
2451 GAGTTAGACA ACCTGAAGTC TAGGTCCCTA TTTATTTTTT TATAGTTATG
2501 TTAGTATTAA GAACGTTATT TATATTTCAA ATTTTTCTTT TTTTTCTGTA
2551 CAGACGCGTG TACGCATGTA ACATTATACT GAAAACCTTG CTTGAGAAGG
2601 TTTTGGGACG CTCGAAGGCT TTAATTTGCG GCCCTGCATT AATGAATCGG
2651 CCAACGCGCG GGGAGAGGCG GTTTGCGTAT TGGGCGCTCT TCCGCTTCCT
2701 CGCTCACTGA CTCGCTGCGC TCGGTCGTTC GGCTGCGGCG AGCGGTATCA
2751 GCTCACTCAA AGGCGGTAAT ACGGTTATCC ACAGAATCAG GGGATAACGC
2801 AGGAAAGAAC ATGTGAGCAA AAGGCCAGCA AAAGCCCAGG AACCGTAAAA
2851 AGGCCGCGTT GCTGGCGTTT TTCCATAGGC TCCGCCCCCC TGACGAGCAT
2901 CACAAAAATC GACGCTCAAG TCAGAGGTGG CGAAACCCGA CAGGACTATA
2951 AAGATACCAG GCGTTTCCCC CTGGAAGCTC CCTCGTGCGC TCTCCTGTTC
3001 CGACCCTGCC GCTTACCGGA TACCTGTCCG CCTTTCTCCC TTCGGGAAGC
3051 GTGGCGCTTT CTCATAGCTC ACGCTGTAGG TATCTCAGTT CGGTGTAGGT
3101 CGTTCGCTCC AAGCTGGGCT GTGTGCACGA ACCCCCCGTT CAGCCCGACC
3151 GCTGCGCCTT ATCCGGTAAC TATCGTCTTG AGTCCAACCC GGTAAGACAC
3201 GACTTATCGC CACTGGCAGC AGCCACTGGT AACAGGATTA GCAGAGCGAG
3251 GTATGTAGGC GGTGCTACAG AGTTCTTGAA GTGGTGGCCT AACTACGGCT
3301 ACACTAGAAG GACAGTATTT GGTATCTGCG CTCTGCTGAA GCCAGTTACC
3351 TTCGGAAAAA GAGTTGGTAG CTCTTGATCC GGCAAACAAA CCACCGCTGG
3401 TAGCGGTGGT TTTTTTGTTT GCAAGCAGCA GATTACGCGC AGAAAAAAAG
3451 GATCTCAAGA AGATCCTTTG ATCTTTTCTA CGGGGTCTGA CGCTCAGTGG
3501 AACGAAAACT CACGTTAAGG GATTTTGGTC ATGAGATTAT CAAAAAGGAT
3551 CTTCACCTAG ATCCTTTTAA ATTAAAAATG AAGTTTTAAA TCAATCTAAA
3601 GTATATATGA GTAAACTTGG TCTGACAGTT ACCAATGCTT AATCAGTGAG
3651 GCACCTATCT CAGCGATCTG TCTATTTCGT TCATCCATAG TTGCCTGACT
3701 CCCCGTCGTG TAGATAACTA CGATACGGGA GCGCTTACCA TCTGGCCCCA
3751 GTGCTGCAAT GATACCGCGA GACCCACGCT CACCGGCTCC AGATTTATCA
3801 GCAATAAACC AGCCAGCCGG AAGGGCCGAG CGCAGAAGTG GTCCTGCAAC
3851 TTTATCCGCC TCCATTCAGT CTATTAATTG TTGCCGGGAA GCTAGAGTAA
3901 GTAGTTCGCC AGTTAATAGT TTGCGCAACG TTGTTGGCAT TGCTACAGGC
3951 ATCGTGGTGT CACTCTCGTC GTTTGGTATG GCTTCATTCA GCTCCGGTTC
4001 CCAACGATCA AGGCGAGTTA CATGATCCCC CATGTTGTGC AAAAAAGCGG
4051 TTAGCTCCTT CGGTCCTCCG ATCGTTGTCA GAAGTAAGTT GGCCGCAGTG
4101 TTATCACTCA TGGTTATGGC AGCACTGCAT AATTCTCTTA CTGTCATGCC
4151 ATCCGTAAGA TGCTTTTCTG TGACTGGTGA GTACTCAACC AAGTCATTCT
4201 GAGAATAGTG TATGCGGCGA CCGAGTTGCT CTTGCCCGGC GTCAATACGG
4251 GATAATAGTG TATCACATAG CAGAACTTTA AAAGTGCTCA TCATTGGAAA
4301 ACGTTCTTCG GGGCGAAAAC TCTCAAGGAT CTTACCGCTG TTGAGATCCA
4351 GTTCGATGTA ACCCACTCGT GCACCCAACT GATCTTCAGC ATCTTTTACT
4401 TTCACCAGCG TTTCTGGGTG AGCAAAAACA GGAAGGCAAA ATGCCGCAAA
4451 AAAGGGAATA AGGGCGACAC GGAAATGTTG AATACTCATA CTCTTCCTTT
4501 TTCAATGGGT AATAACTGAT ATAATTAAAT TGAAGCTCTA ATTTGTGAGT
4551 TTAGTATACA TGCATTTACT TATAATACAG TTTTTTAGTT TTGCTGGCCG
4601 CATCTTCTCA AATATGCTTC CCAGCCTGCT TTTCTGTAAC GTTCACCCTC
4651 TACCTTAGCA TCCCTTCCCT TTGCAAATAG TCCTCTTCCA ACAATAATAA
4701 TGTCAGATCC TGTAGAGACC ACATCATCCA CGGTTCTATA CTGTTGACCC
4751 AATGCGTCTC CCTTGTCATC TAAACCCACA CCGGGTGTCA TAATCAACCA
4801 ATCGTAACCT TCATCTCTTC CACCCATGTC TCTTTGAGCA ATAAAGCCGA
4851 TAACAAAATC TTTGTCGCTC TTCGCAATGT CAACAGTACC CTTAGTATAT
4901 TCTCCAGTAG ATAGGGAGCC CTTGCATGAC AATTCTGCTA ACATCAAAAG
4951 GCCTCTAGGT TCCTTTGTTA CTTCTTCTGC CGCCTGCTTC AAACCGCTAA
5001 CAATACCTGG GCCCACCACA CCGTGTGCAT TCGTAATGTC TGCCCATTCT
5051 GCTATTCTGT ATACACCCGC AGAGTACTGC AATTTGACTG TATTACCAAT
5101 GTCAGCAAAT TTTCTGTCTT CGAAGAGTAA AAAATTGTAC TTGGCGGATA
5151 ATGCCTTTAG CGGCTTAACT GTGCCCTCCA TGGAAAAATC AGTCAAGATA
5201 TCCACATGTG TTTTTAGTAA ACAAATTTTG GGACCTAATG CTTCAACTAA
5251 CTCCAGTAAT TCCTTGGTGG TACGAACATC CAATGAAGCA CACAAGTTTG
5301 TTTGCTTTTC GTGCATGATA TTAAATAGCT TGGCAGCAAC AGGACTAGGA
5351 TGAGTAGCAG CACGTTCCTT ATATGTAGCT TTCGACATGA TTTATCTTCG
5401 TTTCCTGCAG GTTTTTGTTC TGTGCAGTTG GGTTAAGAAT ACTGGGCAAT
5451 TTCATGTTTC TTCAACACTA CATATGCGTA TATATACCAA TCTAAGTCTG
5501 TGCTCCTTCC TTCGTTCTTC CTTCTGTTCG GAGATTACCG AATCAAAAAA
5551 ATTTCAAAGA AACCGAAATC AAAAAAAAGA ATAAAAAAAA AATGATGAAT
5601 TGAATTGAAA AGCTAGCTTA TCGATGATAA GCTGTCAAAG ATGAGAATTA
5651 ATTCCACGGA CTATAGACTA TACTAGATAC TCCGTCTACT GTACGATACA
5701 CTTCCGCTCA GGTCCTTGTC CTTTAACGAG GCCTTACCAC TCTTTTGTTA
5751 CTCTATTGAT CCAGCTCAGC AAAGGCAGTG TGATCTAAGA TTCTATCTTC
5801 GCGATGTAGT AAAACTAGCT AGACCGAGAA AGAGACTAGA AATGCAAAAG
5851 GCACTTCTAC AATGGCTGCC ATCATTATTA TCCGATGTGA CGCTGCAGCT
5901 TCTCAATGAT ATTCGAATAC GCTTTGAGGA GATACAGCCT AATATCCGAC
5951 AAACTGTTTT ACAGATTTAC GATCGTACTT GTTACCCATC ATTGAATTTT
6001 GAACATCCGA ACCTGGGAGT TTTCCCTGAA ACAGATAGTA TATTTGAACC
6051 TGTATAATAA TATATAGTCT AGCGCTTTAC GGAAGACAAT GTATGTATTT
6101 CGGTTCCTGG AGAAACTATT GCATCTATTG CATAGGTAAT CTTGCACGTC
6151 GCATCCCCGG TTCATTTTCT GCGTTTCCAT CTTGCACTTC AATAGCATAT
6201 CTTTGTTAAC GAAGCATCTG TGCTTCATTT TGTAGAACAA AAATGCAACG
6251 CGAGAGCGCT AATTTTTCAA ACAAAGAATC TGAGCTGCAT TTTTACAGAA
6301 CAGAAATGCA ACGCGAAAGC GCTATTTTAC CAACGAAGAA TCTGTGCTTC
6351 ATTTTTGTAA AACAAAAATG CAACGCGACG AGAGCGCTAA TTTTTCAAAC
6401 AAAGAATCTG AGCTGCATTT TTACAGAACA GAAATGCAAC GCGAGAGCGC
6451 TATTTTACCA ACAAAGAATC TATACTTCTT TTTTGTTCTA CAAAAATGCA
6501 TCCCGAGAGC GCTATTTTTC TAACAAAGCA TCTTAGATTA CTTTTTTTCT
6551 CCTTTGTGCG CTCTATAATG CAGTCTCTTG ATAACTTTTT GCACTGTAGG
6601 TCCGTTAAGG TTAGAAGAAG GCTACTTTGG TGTCTATTTT CTCTTCCATA
6651 AAAAAAGCCT GACTCCACTT CCCGCGTTTA CTGATTACTA GCGAAGCTGC
6701 GGGTGCATTT TTTCAAGATA AAGGCATCCC CGATTATATT CTATACCGAT
6751 GTGGATTGCG CATACTTTGT GAACAGAAAG TGATAGCGTT GATGATTCTT
6801 CATTGGTCAG AAAATTATGA ACGGTTTCTT CTATTTTGTC TCTATATACT
6851 ACGTATAGGA AATGTTTACA TTTTCGTATT GTTTTCGATT CACTCTATGA
6901 ATAGTTCTTA CTACAATTTT TTTGTCTAAA GAGTAATACT AGAGATAAAC
6951 ATAAAAAATG TAGAGGTCGA GTTTAGATGC AAGTTCAAGG AGCGAAAGGT
7001 GGATGGGTAG GTTATATAGG GATATAGCAC AGAGATATAT AGCAAAGAGA
7051 TACTTTTGAG CAATGTTTGT GGAAGCGGTA TTCGCAATGG GAAGCTCCAC
7101 CCCGGTTGAT AATCAGAAAA GCCCCAAAAA CAGGAAGATT GTATAAGCAA
7151 ATATTTAAAT TGTAAACGTT AATATTTTGT TAAAATTCGC GTTAAATTTT
7201 TGTTAAATCA GCTCATTTTT TAACGAATAG CCCGAAATCG GCAAAATCCC
7251 TTATAAATCA AAAGAATAGA CCGAGATAGG GTTGAGTGTT GTTCCAGTTT
7301 CCAACAAGAG TCCACTATTA AAGAACGTGG ACTCCAACGT CAAAGGGCGA
7351 AAAAGGGTCT ATCAGGGCGA TGGCCCACTA CGTGAACCAT CACCCTAATC
7401 AAGTTTTTTG GGGTCGAGGT GCCGTAAAGC AGTAAATCGG AAGGGTAAAC
7451 GGATGCCCCC ATTTAGAGCT TGACGGGGAA AGCCGGCGAA CGTGGCGAGA
7501 AAGGAAGGGA AGAAAGCGAA AGGAGCGGGG GCTAGGGCGG TGGGAAGTGT
7551 AGGGGTCACG CTGGGCGTAA CCACCACACC CGCCGCGCTT AATGGGGCGC
7601 TACAGGGCGC GTGGGGATGA TCCACTAGT
Sequence of CaNIK1HAMPup(H510Q) in pYES2-CaNIK1HAMPup(H510Q):
atgaggaatactgcggctagagaagctgctgagcttgccaatagtgcgaaatccgagttt
ctagcgaacatgtcgcaagagatacgtacaccattgaatgggattattggtatgactcag
ttgtcgcttgatacagagttgacacagtaccaacgagagatgttgtcgattgtgcataac
ttggcaaattccttgttgaccattatagacgatatattggatatttctaagattgaggcg
aatagaatgacggtggaacagattgatttttcattaagagggacagtgtttggtgcattg
aagacgttagccgtcaaagctattgaaaaaaacctagacttgacctatcaatgtgattca
tcgtttccagataatcttattggagatagttttagattacgacaagttattcttaacttg
gctggtaatgctattaagtttactaaagaggggaaagttagtgttagtgtgaaaaagtct
gataaaatggtgttagatagtaagttgttgttagaggtttgtgttagcgacacgggaata
ggtatagagaaagacaaattgggattgattttcgataccttctgtcaagctgatggttct
actacaagaaagtttggtggtacaggtttagggttgtcaatttccaaacagttgatacat
ttaatgggtggagagatatgggttacttcggagtatggatcagggtcaaacttttatttt
acggtgtgcgtgtcgccatctaatattagatatactcgacaaaccgaacaattattacca
tttagttcccattatgtgttatttgtatcgactgagcatactcaagaagaacttgatgtg
ttgagagatggaattatagaacttggattgatacctataatagtgagaaatattgaagat
gcaacattgactgagccggtgaaatatgatataattatgattgattcgatagagattgcc
aaaaagttgaggttgttatcggaggttaaatatattccgttggttttggtccatcattct
attccacagttgaatatgagagtatgtattgatttggggatttcttcctatgcaaatacg
ccatgttcgatcacggacttggcaagtgcgattataccagcgttggagtcgagatccata
tcacagaactcagacgagtcggtgaggtacaaaatattactagcagaggacaacctcgtc
aatcagaaacttgcagttaggatattagaaaagcaagggcattcggtggaagtagttgag
aacggactagaggcgtacgaagcgattaagaggaataaatatgatgtggtgttgatggat
gtgcaaatgcctgtaatgggtgggttcgaagctacggagaagattcgacaatgggagaaa
aagtctaacccaatagactcgttgacgtttaggactccaattattgccctcactgcacac
gccatgttaggtgatagagaaaagtcattggcaaaggggatggacgattatgtgagtaag
ccattgaagccgaaattgttaatgcagacgataaacaagtgtattcataatattaaccag
ttgaaagaattgtcgagaaatagtaggggtagcgattttgcaaagaagatgacccgaaac
acacccggaagcacgacccgtcaggggagtgatgaggggagtgtagaggacatgattggg
gacactccccgtcaagggagtgttgagggagggggtacaagtagcagaccagtacagaga
aggtctgccacagaggggtcgatcactacaattagtgaacaaatcgaccggttacgtaag
gatccgggtgattataaagatgacgacgataaaggaggacatcatcaccatcaccactga
Sequence of pYES2-CaNIK1HAMP, CaNIK1HAMP (7905 bp) starts from 507(ATG)
till 2548 (TGA):
1 ACGGATTAGA AGCCGCCGAG CGGGTGACAG CCCTCCGAAG GAAGACTCTC
51 CTCCGTGCGT CCTCGTCTTC ACCGGTCGCG TTCCTGAAAC GCAGATGTGC
101 CTCGCGCCGC ACTGCTCCGA ACAATAAAGA TTCTACAATA CTAGCTTTTA
151 TGGTTATGAA GAGGAAAAAT TGGCAGTAAC CTGGCCCCAC AAACCTTCAA
201 ATGAACGAAT CAAATTAACA ACCATAGGAT GATAATGCGA TTAGTTTTTT
251 AGCCTTATTT CTGGGGTAAT TAATCAGCGA AGCGATGATT TTTGATCTAT
301 TAACAGATAT ATAAATGCAA AAACTGCATA ACCACTTTAA CTAATACTTT
351 CAACATTTTC GGTTTGTATT ACTTCTTATT CAAATGTAAT AAAAGTATCA
401 ACAAAAAATT GTTAATATAC CTCTATACTT TAACGTCAAG GAGAAAAAAC
451 CCCGGATCGG ACTACTAGCA GCTGTAATAC GACTCACTAT AGGGAATATT
501 AAGCTTatga accccactaa aaaaccacgg ttatcaccaa tgcagccctc
551 tgtttttgaa atactcaacg accctgagct ttatagtcag cactgtcata
601 gccttaggga aacacttctt gaccatttca accatcaagc tacacttatc
651 gacacttatg aacatgaact agaaaaatcc aaaaacgcga acaggaatac
701 tgcggctaga gaagctgctg agcttgccaa tagtgcgaaa tccgagtttc
751 tagcgaacat gtcgcatgag atacgtacac cattgaatgg gattattggt
801 atgactcagt tgtcgcttga tacagagttg acacagtacc aacgagagat
851 gttgtcgatt gtgcataact tggcaaattc cttgttgacc attatagacg
901 atatattgga tatttctaag attgaggcga atagaatgac ggtggaacag
951 attgattttt cattaagagg gacagtgttt ggtgcattga agacgttagc
1001 cgtcaaagct attgaaaaaa acctagactt gacctatcaa tgtgattcat
1051 cgtttccaga taatcttatt ggagatagtt ttagattacg acaagttatt
1101 cttaacttgg ctggtaatgc tattaagttt actaaagagg ggaaagttag
1151 tgttagtgtg aaaaagtctg ataaaatggt gttagatagt aagttgttgt
1201 tagaggtttg tgttagcgac acgggaatag gtatagagaa agacaaattg
1251 ggattgattt tcgatacctt ctgtcaagct gatggttcta ctacaagaaa
1301 gtttggtggt acaggtttag ggttgtcaat ttccaaacag ttgatacatt
1351 taatgggtgg agagatatgg gttacttcgg agtatggatc agggtcaaac
1401 ttttatttta cggtgtgcgt gtcgccatct aatattagat atactcgaca
1451 aaccgaacaa ttattaccat ttagttccca ttatgtgtta tttgtatcga
1501 ctgagcatac tcaagaagaa cttgatgtgt tgagagatgg aattatagaa
1551 cttggattga tacctataat agtgagaaat attgaagatg caacattgac
1601 tgagccggtg aaatatgata taattatgat tgattcgata gagattgcca
1651 aaaagttgag gttgttatcg gaggttaaat atattccgtt ggttttggtc
1701 catcattcta ttccacagtt gaatatgaga gtatgtattg atttggggat
1751 ttcttcctat gcaaatacgc catgttcgat cacggacttg gcaagtgcga
1801 ttataccagc gttggagtcg agatccatat cacagaactc agacgagtcg
1851 gtgaggtaca aaatattact agcagaggac aacctcgtca atcagaaact
1901 tgcagttagg atattagaaa agcaagggca ttcggtggaa gtagttgaga
1951 acggactaga ggcgtacgaa gcgattaaga ggaataaata tgatgtggtg
2001 ttgatggatg tgcaaatgcc tgtaatgggt gggttcgaag ctacggagaa
2051 gattcgacaa tgggagaaaa agtctaaccc aatagactcg ttgacgttta
2101 ggactccaat tattgccctc actgcacacg ccatgttagg tgatagagaa
2151 aagtcattgg caaaggggat ggacgattat gtgagtaagc cattgaagcc
2201 gaaattgtta atgcagacga taaacaagtg tattcataat attaaccagt
2251 tgaaagaatt gtcgagaaat agtaggggta gcgattttgc aaagaagatg
2301 acccgaaaca cacccggaag cacgacccgt caggggagtg atgaggggag
2351 tgtagaggac atgattgggg acactccccg tcaagggagt gttgagggag
2401 ggggtacaag tagcagacca gtacagagaa ggtctgccac agaggggtcg
2451 atcactacaa ttagtgaaca aatcgaccgg ttacgtaagg atccgggtga
2501 ttataaagat gacgacgata aaggaggaca tcatcaccat caccactgaA
2551 AGCTTGGTAC CGAGCTCGGA TCCACTAGTA ACGGCCGCCA GTGTGCTGGA
2601 ATTCTGCAGA TATCCATCAC ACTGGCGGCC GCTCGAGCAT GCATCTAGAG
2651 GGCCGCATCA TGTAATTAGT TATGTCACGC TTACATTCAC GCCCTCCCCC
2701 CACATCCGCT CTAACCGAAA AGGAAGGAGT TAGACAACCT GAAGTCTAGG
2751 TCCCTATTTA TTTTTTTATA GTTATGTTAG TATTAAGAAC GTTATTTATA
2801 TTTCAAATTT TTCTTTTTTT TCTGTACAGA CGCGTGTACG CATGTAACAT
2851 TATACTGAAA ACCTTGCTTG AGAAGGTTTT GGGACGCTCG AAGGCTTTAA
2901 TTTGCGGCCC TGCATTAATG AATCGGCCAA CGCGCGGGGA GAGGCGGTTT
2951 GCGTATTGGG CGCTCTTCCG CTTCCTCGCT CACTGACTCG CTGCGCTCGG
3001 TCGTTCGGCT GCGGCGAGCG GTATCAGCTC ACTCAAAGGC GGTAATACGG
3051 TTATCCACAG AATCAGGGGA TAACGCAGGA AAGAACATGT GAGCAAAAGG
3101 CCAGCAAAAG CCCAGGAACC GTAAAAAGGC CGCGTTGCTG GCGTTTTTCC
3151 ATAGGCTCCG CCCCCCTGAC GAGCATCACA AAAATCGACG CTCAAGTCAG
3201 AGGTGGCGAA ACCCGACAGG ACTATAAAGA TACCAGGCGT TTCCCCCTGG
3251 AAGCTCCCTC GTGCGCTCTC CTGTTCCGAC CCTGCCGCTT ACCGGATACC
3301 TGTCCGCCTT TCTCCCTTCG GGAAGCGTGG CGCTTTCTCA TAGCTCACGC
3351 TGTAGGTATC TCAGTTCGGT GTAGGTCGTT CGCTCCAAGC TGGGCTGTGT
3401 GCACGAACCC CCCGTTCAGC CCGACCGCTG CGCCTTATCC GGTAACTATC
3451 GTCTTGAGTC CAACCCGGTA AGACACGACT TATCGCCACT GGCAGCAGCC
3501 ACTGGTAACA GGATTAGCAG AGCGAGGTAT GTAGGCGGTG CTACAGAGTT
3551 CTTGAAGTGG TGGCCTAACT ACGGCTACAC TAGAAGGACA GTATTTGGTA
3601 TCTGCGCTCT GCTGAAGCCA GTTACCTTCG GAAAAAGAGT TGGTAGCTCT
3651 TGATCCGGCA AACAAACCAC CGCTGGTAGC GGTGGTTTTT TTGTTTGCAA
3701 GCAGCAGATT ACGCGCAGAA AAAAAGGATC TCAAGAAGAT CCTTTGATCT
3751 TTTCTACGGG GTCTGACGCT CAGTGGAACG AAAACTCACG TTAAGGGATT
3801 TTGGTCATGA GATTATCAAA AAGGATCTTC ACCTAGATCC TTTTAAATTA
3851 AAAATGAAGT TTTAAATCAA TCTAAAGTAT ATATGAGTAA ACTTGGTCTG
3901 ACAGTTACCA ATGCTTAATC AGTGAGGCAC CTATCTCAGC GATCTGTCTA
3951 TTTCGTTCAT CCATAGTTGC CTGACTCCCC GTCGTGTAGA TAACTACGAT
4001 ACGGGAGCGC TTACCATCTG GCCCCAGTGC TGCAATGATA CCGCGAGACC
4051 CACGCTCACC GGCTCCAGAT TTATCAGCAA TAAACCAGCC AGCCGGAAGG
4101 GCCGAGCGCA GAAGTGGTCC TGCAACTTTA TCCGCCTCCA TTCAGTCTAT
4151 TAATTGTTGC CGGGAAGCTA GAGTAAGTAG TTCGCCAGTT AATAGTTTGC
4201 GCAACGTTGT TGGCATTGCT ACAGGCATCG TGGTGTCACT CTCGTCGTTT
4251 GGTATGGCTT CATTCAGCTC CGGTTCCCAA CGATCAAGGC GAGTTACATG
4301 ATCCCCCATG TTGTGCAAAA AAGCGGTTAG CTCCTTCGGT CCTCCGATCG
4351 TTGTCAGAAG TAAGTTGGCC GCAGTGTTAT CACTCATGGT TATGGCAGCA
4401 CTGCATAATT CTCTTACTGT CATGCCATCC GTAAGATGCT TTTCTGTGAC
4451 TGGTGAGTAC TCAACCAAGT CATTCTGAGA ATAGTGTATG CGGCGACCGA
4501 GTTGCTCTTG CCCGGCGTCA ATACGGGATA ATAGTGTATC ACATAGCAGA
4551 ACTTTAAAAG TGCTCATCAT TGGAAAACGT TCTTCGGGGC GAAAACTCTC
4601 AAGGATCTTA CCGCTGTTGA GATCCAGTTC GATGTAACCC ACTCGTGCAC
4651 CCAACTGATC TTCAGCATCT TTTACTTTCA CCAGCGTTTC TGGGTGAGCA
4701 AAAACAGGAA GGCAAAATGC CGCAAAAAAG GGAATAAGGG CGACACGGAA
4751 ATGTTGAATA CTCATACTCT TCCTTTTTCA ATGGGTAATA ACTGATATAA
4801 TTAAATTGAA GCTCTAATTT GTGAGTTTAG TATACATGCA TTTACTTATA
4851 ATACAGTTTT TTAGTTTTGC TGGCCGCATC TTCTCAAATA TGCTTCCCAG
4901 CCTGCTTTTC TGTAACGTTC ACCCTCTACC TTAGCATCCC TTCCCTTTGC
4951 AAATAGTCCT CTTCCAACAA TAATAATGTC AGATCCTGTA GAGACCACAT
5001 CATCCACGGT TCTATACTGT TGACCCAATG CGTCTCCCTT GTCATCTAAA
5051 CCCACACCGG GTGTCATAAT CAACCAATCG TAACCTTCAT CTCTTCCACC
5101 CATGTCTCTT TGAGCAATAA AGCCGATAAC AAAATCTTTG TCGCTCTTCG
5151 CAATGTCAAC AGTACCCTTA GTATATTCTC CAGTAGATAG GGAGCCCTTG
5201 CATGACAATT CTGCTAACAT CAAAAGGCCT CTAGGTTCCT TTGTTACTTC
5251 TTCTGCCGCC TGCTTCAAAC CGCTAACAAT ACCTGGGCCC ACCACACCGT
5301 GTGCATTCGT AATGTCTGCC CATTCTGCTA TTCTGTATAC ACCCGCAGAG
5351 TACTGCAATT TGACTGTATT ACCAATGTCA GCAAATTTTC TGTCTTCGAA
5401 GAGTAAAAAA TTGTACTTGG CGGATAATGC CTTTAGCGGC TTAACTGTGC
5451 CCTCCATGGA AAAATCAGTC AAGATATCCA CATGTGTTTT TAGTAAACAA
5501 ATTTTGGGAC CTAATGCTTC AACTAACTCC AGTAATTCCT TGGTGGTACG
5551 AACATCCAAT GAAGCACACA AGTTTGTTTG CTTTTCGTGC ATGATATTAA
5601 ATAGCTTGGC AGCAACAGGA CTAGGATGAG TAGCAGCACG TTCCTTATAT
5651 GTAGCTTTCG ACATGATTTA TCTTCGTTTC CTGCAGGTTT TTGTTCTGTG
5701 CAGTTGGGTT AAGAATACTG GGCAATTTCA TGTTTCTTCA ACACTACATA
5751 TGCGTATATA TACCAATCTA AGTCTGTGCT CCTTCCTTCG TTCTTCCTTC
5801 TGTTCGGAGA TTACCGAATC AAAAAAATTT CAAAGAAACC GAAATCAAAA
5851 AAAAGAATAA AAAAAAAATG ATGAATTGAA TTGAAAAGCT AGCTTATCGA
5901 TGATAAGCTG TCAAAGATGA GAATTAATTC CACGGACTAT AGACTATACT
5951 AGATACTCCG TCTACTGTAC GATACACTTC CGCTCAGGTC CTTGTCCTTT
6001 AACGAGGCCT TACCACTCTT TTGTTACTCT ATTGATCCAG CTCAGCAAAG
6051 GCAGTGTGAT CTAAGATTCT ATCTTCGCGA TGTAGTAAAA CTAGCTAGAC
6101 CGAGAAAGAG ACTAGAAATG CAAAAGGCAC TTCTACAATG GCTGCCATCA
6151 TTATTATCCG ATGTGACGCT GCAGCTTCTC AATGATATTC GAATACGCTT
6201 TGAGGAGATA CAGCCTAATA TCCGACAAAC TGTTTTACAG ATTTACGATC
6251 GTACTTGTTA CCCATCATTG AATTTTGAAC ATCCGAACCT GGGAGTTTTC
6301 CCTGAAACAG ATAGTATATT TGAACCTGTA TAATAATATA TAGTCTAGCG
6351 CTTTACGGAA GACAATGTAT GTATTTCGGT TCCTGGAGAA ACTATTGCAT
6401 CTATTGCATA GGTAATCTTG CACGTCGCAT CCCCGGTTCA TTTTCTGCGT
6451 TTCCATCTTG CACTTCAATA GCATATCTTT GTTAACGAAG CATCTGTGCT
6501 TCATTTTGTA GAACAAAAAT GCAACGCGAG AGCGCTAATT TTTCAAACAA
6551 AGAATCTGAG CTGCATTTTT ACAGAACAGA AATGCAACGC GAAAGCGCTA
6601 TTTTACCAAC GAAGAATCTG TGCTTCATTT TTGTAAAACA AAAATGCAAC
6651 GCGACGAGAG CGCTAATTTT TCAAACAAAG AATCTGAGCT GCATTTTTAC
6701 AGAACAGAAA TGCAACGCGA GAGCGCTATT TTACCAACAA AGAATCTATA
6751 CTTCTTTTTT GTTCTACAAA AATGCATCCC GAGAGCGCTA TTTTTCTAAC
6801 AAAGCATCTT AGATTACTTT TTTTCTCCTT TGTGCGCTCT ATAATGCAGT
6851 CTCTTGATAA CTTTTTGCAC TGTAGGTCCG TTAAGGTTAG AAGAAGGCTA
6901 CTTTGGTGTC TATTTTCTCT TCCATAAAAA AAGCCTGACT CCACTTCCCG
6951 CGTTTACTGA TTACTAGCGA AGCTGCGGGT GCATTTTTTC AAGATAAAGG
7001 CATCCCCGAT TATATTCTAT ACCGATGTGG ATTGCGCATA CTTTGTGAAC
7051 AGAAAGTGAT AGCGTTGATG ATTCTTCATT GGTCAGAAAA TTATGAACGG
7101 TTTCTTCTAT TTTGTCTCTA TATACTACGT ATAGGAAATG TTTACATTTT
7151 CGTATTGTTT TCGATTCACT CTATGAATAG TTCTTACTAC AATTTTTTTG
7201 TCTAAAGAGT AATACTAGAG ATAAACATAA AAAATGTAGA GGTCGAGTTT
7251 AGATGCAAGT TCAAGGAGCG AAAGGTGGAT GGGTAGGTTA TATAGGGATA
7301 TAGCACAGAG ATATATAGCA AAGAGATACT TTTGAGCAAT GTTTGTGGAA
7351 GCGGTATTCG CAATGGGAAG CTCCACCCCG GTTGATAATC AGAAAAGCCC
7401 CAAAAACAGG AAGATTGTAT AAGCAAATAT TTAAATTGTA AACGTTAATA
7451 TTTTGTTAAA ATTCGCGTTA AATTTTTGTT AAATCAGCTC ATTTTTTAAC
7501 GAATAGCCCG AAATCGGCAA AATCCCTTAT AAATCAAAAG AATAGACCGA
7551 GATAGGGTTG AGTGTTGTTC CAGTTTCCAA CAAGAGTCCA CTATTAAAGA
7601 ACGTGGACTC CAACGTCAAA GGGCGAAAAA GGGTCTATCA GGGCGATGGC
7651 CCACTACGTG AACCATCACC CTAATCAAGT TTTTTGGGGT CGAGGTGCCG
7701 TAAAGCAGTA AATCGGAAGG GTAAACGGAT GCCCCCATTT AGAGCTTGAC
7751 GGGGAAAGCC GGCGAACGTG GCGAGAAAGG AAGGGAAGAA AGCGAAAGGA
7801 GCGGGGGCTA GGGCGGTGGG AAGTGTAGGG GTCACGCTGG GCGTAACCAC
7851 CACACCCGCC GCGCTTAATG GGGCGCTACA GGGCGCGTGG GGATGATCCA
7901 CTAGT
Sequence of CaNIK1HAMP(H510Q) in pYES2-CaNIK1HAMP(H510Q):
atgaaccccactaaaaaaccacggttatcaccaatgcagccctctgtttttgaaatactc
aacgaccctgagctttatagtcagcactgtcatagccttagggaaacacttcttgaccat
ttcaaccatcaagctacacttatcgacacttatgaacatgaactagaaaaatccaaaaac
gcgaacaggaatactgcggctagagaagctgctgagcttgccaatagtgcgaaatccgag
tttctagcgaacatgtcgcaagagatacgtacaccattgaatgggattattggtatgact
cagttgtcgcttgatacagagttgacacagtaccaacgagagatgttgtcgattgtgcat
aacttggcaaattccttgttgaccattatagacgatatattggatatttctaagattgag
gcgaatagaatgacggtggaacagattgatttttcattaagagggacagtgtttggtgca
ttgaagacgttagccgtcaaagctattgaaaaaaacctagacttgacctatcaatgtgat
tcatcgtttccagataatcttattggagatagttttagattacgacaagttattcttaac
ttggctggtaatgctattaagtttactaaagaggggaaagttagtgttagtgtgaaaaag
tctgataaaatggtgttagatagtaagttgttgttagaggtttgtgttagcgacacggga
ataggtatagagaaagacaaattgggattgattttcgataccttctgtcaagctgatggt
tctactacaagaaagtttggtggtacaggtttagggttgtcaatttccaaacagttgata
catttaatgggtggagagatatgggttacttcggagtatggatcagggtcaaacttttat
tttacggtgtgcgtgtcgccatctaatattagatatactcgacaaaccgaacaattatta
ccatttagttcccattatgtgttatttgtatcgactgagcatactcaagaagaacttgat
gtgttgagagatggaattatagaacttggattgatacctataatagtgagaaatattgaa
gatgcaacattgactgagccggtgaaatatgatataattatgattgattcgatagagatt
gccaaaaagttgaggttgttatcggaggttaaatatattccgttggttttggtccatcat
tctattccacagttgaatatgagagtatgtattgatttggggatttcttcctatgcaaat
acgccatgttcgatcacggacttggcaagtgcgattataccagcgttggagtcgagatcc
atatcacagaactcagacgagtcggtgaggtacaaaatattactagcagaggacaacctc
gtcaatcagaaacttgcagttaggatattagaaaagcaagggcattcggtggaagtagtt
gagaacggactagaggcgtacgaagcgattaagaggaataaatatgatgtggtgttgatg
gatgtgcaaatgcctgtaatgggtgggttcgaagctacggagaagattcgacaatgggag
aaaaagtctaacccaatagactcgttgacgtttaggactccaattattgccctcactgca
cacgccatgttaggtgatagagaaaagtcattggcaaaggggatggacgattatgtgagt
aagccattgaagccgaaattgttaatgcagacgataaacaagtgtattcataatattaac
cagttgaaagaattgtcgagaaatagtaggggtagcgattttgcaaagaagatgacccga
aacacacccggaagcacgacccgtcaggggagtgatgaggggagtgtagaggacatgatt
ggggacactccccgtcaagggagtgttgagggagggggtacaagtagcagaccagtacag
agaaggtctgccacagaggggtcgatcactacaattagtgaacaaatcgaccggttacgt
aaggatccgggtgattataaagatgacgacgataaaggaggacatcatcaccatcaccac
tga
